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The massive occurrence of diarrhoeal disease due to S. enterica infection, the 
increased incidence of typhoidal mortality, and also the recent emergence of 
Salmonella multidrug-resistant (MDR) strains, underline the important role for the 
design of preventive immunisation strategies. Because early vaccines elaborated 
against S. enterica showed a low efficacy, the need for improved vaccines has 
emerged, which would stimulate the participation of both cellular and humoral 
immunity. GroEL was shown to be an immunodominant antigen and a major 
immunogen of many bacterial pathogens. When S. typhimurium is subjected to 
environmental stress, such as the intracellular milieu of the macrophage, the 
bacterium responds by inducing 30-40 proteins, and GroEL is among them. 
Elimination of S. typhimurium from its host involves the generation of a TH1 
response, and recent work performed in our laboratory (Taylor, 1997) has shown 
that S. typhimurium GroEL is able to induce significant humoral and DTH 
responses, suggesting that this protein is recognised in the context of a T1 immune 
response. 
Bacteriophages offer the advantage of non-replication in the host over animal 
viruses for foreign protein display and when genetically modified, are highly 
immunogenic and induce rapidly specific anti-bacteriophage antibodies. The hybrid 
T7 bacteriophage was used in this study for the display of S. typhimurium GroEL 
fused in-frame to the lOB minor capsid protein of the phage, as a vehicle to deliver 
GroEL to the immune system of BALB/c mice. The ability of this construct was 
investigated for the induction of anti-GroEL humoral immunity, after i.v. injection 
in a two-dose regimen, 14 days apart. Due probably to the low copy number of lOB-
GroEL estimated at less than 10% of the total capsid protein, this immunising agent 
barely stimulated detectable levels of anti-GroEL antibodies. These responses were 
significantly weaker than the anti-GroEL antibody levels induced in mice injected 
i.p. either with the purified S. typhimurium GroEL in the presence of alum, or with 
the aroA attenuated S. typhimurium strain (MPG479). This hybrid T7 bacteriophage 
xix 
to function as an immunising agent, probably because of insufficient antigen 
presentation and of administration in the absence of an adjuvant. However, 
detectable secondary antibodies (measured six and twelve days after challenge) 
directed against the major 1 OA capsid protein of the phage were present after 
immunisation with the hybrid phage, suggesting that the T7 phage is immunogenic 
by itself. 
Prior to immunising BALB/c mice, the hybrid T7 bacteriophage was purified 
through a CsC1 step gradient. This study reports the contamination of the hybrid T7 
particle with the exogenous, cellular GroEL protein from the E. coil host of the 
phage, regardless of the heterologous protein expressed on the phage capsid. 
However, it provides a solution for the de-contamination of the T7 CsC1-purified 
particle, by precipitation of the phage with 1% SDS, an anionic detergent which has 
the capacity of disrupting protein complexes, and leaves the phage viable. The 
present work reports also the full DNA sequence of the groEL gene from S. 




1.1 SALMONELLA AND SALMONELLOSES 
1.1.1 Bacteriology of Salmonella 
Salmonellae are named after the pathologist Salmon who first isolated S. 
choleraesuis from the porcine intestine. They are widely dispersed in nature, 
including the gastrointestinal tracts of domesticated and wild mammals, reptiles, 
birds and insects. They are effective commensals, as well as pathogens that cause a 
spectrum of diseases (Miller and Pegues, 2000). The genus Salmonella is a member 
of the family Enterobacteriaceae. Its closest known relative is Citrobacter and other 
close relatives include Escherichia, Shigella, Kiebsiella and Enterobacter (Le 
Minor, 1984; Farmer, 1995). Salmonella are Gram-negative, non-spore-forming, 
motile, facultatively anaerobic bacilli (Le Minor, 1984). Most salmonellae are 
aerogenic, producing gas from glucose, although S. typhi is an important exception. 
Most salmonellae produce hydrogen sulfide, but a few types, such as most strains of 
S. paratyphi A, do not (Le Minor, 1984). 
Based on the principle that bacteria, which are related by more then 70% on the 
basis of DNA/DNA hybridisation studies, belong to the same "genospecies", all 
Salmonella isolates are classified as a single species (Crosa et al., 1973) and given 
the name S. enterica. This species can be sub-classified into eight subspecific 
groups, based on DNA similarity and host range (Groisman and Ochman, 2000). 
Members of each sub-group can be serotyped into more than 2,300 serovars 
according to somatic 0 antigens, surface capsular polysaccharide (Vi), and flagellar 
(H) antigens, which determine the organisms' reaction to specific antisera (Popoff et 
al., 1996; Groisman and Ochman, 2000; Miller and Pegues, 2000). For example, S. 
typhi and S. paratyphi C produce the polysaccharide Vi antigen, which is a 
homopolymer of N-acetyl galactosaminouronic acid (Daniels et al., 1989). Most 
antigenic variability occurs in the 0 antigen, which is composed of chains of 
oligosaccharide repeats, attached to a core oligosaccharide, which in turn is linked 
covalently to lipid A (Gray, 1995). 
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For the purpose of this thesis, the use of the genus name, S. enterica, will be used 
when referring to or discussing general properties or features of the serovars that 
form the genus. Serovars of S. enterica will de identified initially by their official 
designation, but subsequently referred to by their commonly used serovar name, e.g 
typhimurium, which will be displayed in adjacent brackets. 
Some Salmonella serovars are strictly adapted to one particular host whilst others 
are ubiquitous (Le Minor, 1984). Some serovars are highly adapted to humans and 
have no other known natural hosts (Rubin and Weinstein, 1977), such as serovar 
Typhi (S. lyphi), serovar Paratyphi (S. paratyphi) and S. sendai, and usually cause 
grave diseases with septicaemia-typhoidic syndrome. In general, they are not 
pathogenic for other animal species. Other serovars are adapted to one animal 
species. For example, S. abortusovis is a major cause of abortion in ewes, and S. 
typhisuis and S. gallinarum (S. pullorum) are adapted to swine and poultry, 
respectively. Some salmonellae such as S. dublin (cattle) and S. arizonae (reptiles), 
are associated mainly with a particular species, but occasionally infect humans 
(Waterman et al., 1990; Fang and Fierer, 1991). Other organisms such as the 
ubiquitous S. enterica serovar Typhimurium (S. typhimurium) have a broad host 
range and can infect a wide variety of animal hosts. As such, these are a frequent 
cause of food-borne infections in humans and cause a typhoid-like disease in mice. 
The widespread distribution of salmonellae in the environment, their increasing 
prevalence in the global food chain, and their virulence and adaptability result in an 
enormous medical, public health and economic impact world-wide. 
Diseases resulting from S. enterica infection 
The diseases associated with infection by S. enterica are collectively termed 
salmonelloses. Specific Salmonella serovars most often produce characteristic 
clinical manifestations of gastroenteritis (food-poisoning), enteric fever, bacteremia 
and vascular infection, localised infection or development of chronic carrier state 
(Miller and Pegues, 2000). One of the most important health problems faced 
nowadays by the whole world comes from the high incidence of diarrhoeal diseases 
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(Maurice, 1994; Pang et al., 1995). Recent statistics issued by the World Health 
Organisation (WHO), have reported that approximately 3 million deaths result 
annually from the estimated 1.3 billion incidences of acute gastroenteritis/diarrhoea 
due to non-typhoidal salmonellosis (Pang et al., 1995). 
Non-typhoidal salmonellae also cause a small but significant proportion of diarrhoea 
in travellers and in young children in developing countries (Molbak et al., 1994) and 
the most common serotypes isolated from human sources were S. enteritidis and S. 
typhimurium (Miller and Pegues, 2000). In humans, non-typhoidal Salmonella 
infections are often associated with food products and such infections are the second 
most frequently identified cause of food-borne disease outbreaks (Todd, 1997). 
Foods of animal origin, including meat, poultry, eggs or dairy products, are 
recognised vectors for Salmonella infections. Many countries have also become 
infected with S. hadar introduced by imported turkeys, or with S. agona introduced 
by fish meals imported from South America (Le Minor, 1984). S. enterica infection 
of animals such as chickens, calves, swine and sheep, has economic consequences in 
farming and animal husbandry (Coynault et al., 1996). 
The ingested dose is an important determinant of the incubation period, symptoms 
and disease severity of salmonellosis. Data from outbreaks of salmonellosis suggest 
that, under some circumstances, even a low inoculum (less than 103  organisms) may 
produce non-typhoidal gastroenteritis (Blaser and Newman, 1982). Infection with 
non-typhoidal Salmonella most often results in self-limited acute gastroenteritis 
manifested by nausea, vomiting and diarrhoea within 6 to 48 hours after the 
ingestion of contaminated food or water. Fever (380  to 390C), abdominal cramping 
and chills are frequently reported. Headache, myalgia and other systemic symptoms 
may also occur. The diarrhoea is usually self-limited, typically lasting for 3 to 7 days 
and after resolution of gastroenteritis, the mean duration of carriage of non-typhoidal 




Human typhoid and paratyphoid fevers are severe systemic illnesses characterised 
by clinical syndromes of abdominal pain and fever distinct from acute 
gastroenteritis, and are collectively termed enteric fever. It has been estimated that 
each year more than 33 million cases (nearly 600,000 deaths) occur world-wide due 
to typhoid fever (Ivanoff and Levine, 1997). The disease is endemic in many 
developing countries, particularly the Indian subcontinent, South and Central 
America and Africa, with annual incidence rates estimated to be as high as 900 per 
100,000 population in Asia (Ivanoff, 1994). In endemic areas the incidence of S. 
typhi infection is highest in children older than 1 year and probably reflects their 
lack of acquired immunity (Thikyakorn et al., 1987). Recently, mortality rates of 10 
to 30% have been reported in certain Asian and African countries and have been 
associated with multi-drug resistant strains and delays in antibiotic therapy (Arand et 
al., 1990; Bhutta et al., 1991; Carmeli et al., 1993; Sugandhi et al., 1993). 
Enteric fever is caused by S. lyphi, but a less severe syndrome, paratyphoid fever, is 
caused by S. paratyphi A, B and C. Acquisition of organisms occurs by ingestion of 
food or water contaminated with human excreta. Usually, water borne transmission 
involves the ingestion of fewer microorganisms and, as a result, has a longer 
incubation period and lower attack rate than food borne transmission. With the 
introduction of water treatment in the 201h  century, including sand filtration and 
chlorination, the incidence of typhoid fever waned massively in the developed 
world, but remained endemic in less developed areas, where faecal contamination of 
water sources still occurs (Plotkin and Orenstein, 1999; Miller and Pegues, 2000). 
Since the beginning of 1990s, 12% of multi-drug resistant strains of S. lyphi with 
plasmid-encoded resistance to chioramphenicol, ampicillin and trimethoprim have 
emerged in the Indian subcontinent, Southeast Asia and Africa (Threlfall et al., 
1997), compared to 0.6% during 1984 to 1989 (Miller and Pegues, 2000). 
Treatment and prevention 
Most symptoms of typhoid fever resolve by the fourth week of infection without 
antimicrobial therapy in the approximately 90% of patients who survive (Miller and 
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Pegues, 2000). Where antibiotic treatment is recommended, chioramphenicol has 
been the treatment of choice for typhoid fever since its introduction in 1948, but 
since 1970s, this therapy has been associated with the emergence of plasmid-
mediated resistance (Paniker and Vimala, 1972; Olarte and Galindo, 1973; Lampe et 
al., 1974; Bhutta et al., 1991). This prompted the use of amoxicillin and 
trimethoprim-sulfamethoxazole, but recent emergence of multidrug-resistant (MDR) 
strains of S. typhi diminished the efficacy of these drugs (Threlfall et al., 1997). In 
areas with high prevalence of MDR Salmonella infection, patients suspected of 
having typhoid fever should be treated with quinolones or third-generation 
cephalosporins (ceftriaxone). Also for patients who are chronic carriers of S. iyphi, 
the treatment of choice is ceftriaxone or ciprofloxacin, but also cholecystectomy 
may be necessary. Chromosomal- and plasmid-encoded resistance is emerging not 
only among human, but also among animal Salmonella strains (Anand et al., 1990; 
Heisig, 1993; Griggs et al., 1996). 
Of particular interest is the recent emergence of a distinct strain of multidrug-
resistant S. typhimurium in the U.K., characterised as definitive phage 104 (DT104), 
that is resistant to five antibiotics such as ampicillin, chloramphenicol, streptomycin, 
sulfonamides and tetracyclines. S. typhimurium DT104 is the second most prevalent 
Salmonella strain in the U.K. and resistance to trimethoprim and fluoroquinolones 
are also emerging (Threlfall et al., 1997). Infection with S. typhimurium DT 104 has 
been associated with contact with ill farm animals and exposure to meat products 
(Wall et al., 1995). The present and anticipated future problems with multidrug-
resistant salmonellae underline the vital role of preventive immunisation and make a 
strong motivation for the present study. 
1.2 INTERACTIONS OF S. ENTERICA WITH HOST CELLS 
1.2.1 Pathogenesis of enteric fever 
S. typhi and S. paralyphi are highly invasive bacteria that pass through the intestinal 
mucosa of humans rapidly and efficiently to eventually reach the network of tissue 
macrophages, endothelial cells and polymorphs, known as the reticuloendothelial 
system (Levine et al., 1983; Roitt et al., 1998). 
Ingested salmonellae firstly pass through the acid barrier of the stomach, which is 
the first line of defence against enteric infections (Giannella et al., 1972; Blaser and 
Newman, 1982). Organisms survive poorly at normal gastric pH (less than 1.5), but 
they can develop an adaptive acid-tolerance response that may promote survival at 
low pH (Foster and Hall, 1990; Gorden and Small, 1993). After leaving the stomach, 
the bacilli reach the small intestine and rapidly penetrate the mucosal epithelium by 
one of two alternative mechanisms to arrive in the lamina propria (Brandtzaeg, 
1989). Secretory products of the intestine (e.g., antimicrobial defensin-like peptides 
secreted by Paneth cells), pancreas and gallbladder (e.g., bile salts) (Lehrer et al., 
1991; Selsted et al., 1992), secretory IgA and intestinal mucus may play roles in 
preventing penetration of the enterocytes that line the intestine (Michetti et al., 
1992). One mechanism of invasion involves active uptake of typhoid bacilli by the 
microfold cells (M cells), and other organised lymphoid tissue of the gut (Plotkin 
and Orenstein, 1999). From here they enter the underlying lymphoid cells. The 
second invasive mechanism consists in internalisation of typhoid bacilli by 
enterocytes through membrane-bound vacuoles that pass through the cell and 
ultimately release the bacteria at the basal portion of the cell without destroying the 
enterocyte (Takeuchi, 1967; Plotkin and Orenstein, 1999). After reaching the lamina 
propria in the non-immune host, typhoid bacilli rapidly interact with macrophages 
and lymphocytes in Peyer's patches and other lymphoid tissues located in the small 
intestinal sub-mucosa (Hackett et al., 1986). Recruitment of additional mononuclear 
cells and lymphocytes can result in marked enlargement and necrosis of the Peyer's 
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patches after several weeks of infection, which may be the cause of the characteristic 
abdominal pain (Rubin and Weinstein, 1977; McCormick et al., 1995). The ability 
of salmonellae to survive within macrophages is likely to be essential to typhoid 
fever pathogenesis and spread of the organisms to the systemic circulation. 
Clinical illness occurs only when a critical number of organisms have replicated and 
is accompanied by a fairly sustained secondary bacteremia. Eventually, organisms 
are taken up by tissue macrophages in the bone marrow and Peyer's patches, but 
particularly in the liver and spleen (Hornick et al., 1970). Symptoms such as fever 
and abdominal tenderness may result from the secretion of cytokines by 
macrophages in response to bacterial infection (Edelman and Levine, 1986). 
1.3 EXPERIMENTAL METHODS FOR INVESTIGATING S. ENTERICA 
INTERACTIONS WITH HOST CELLS 
Many of the features and the outcome of S. enterica infection are dependent upon 
interaction with epithelial and phagocytic cells, especially macrophages. Pathogenic 
salmonellae can be studied in convenient in vivo and in vitro models that offer a 
good environment for understanding the events that occur during host-infection by 
S. enterica. Such models are being used to identify Salmonella genes required for 
virulence (Chatfield et al., 1992). 
The mouse model of S. enterica infection 
Many mice strains are highly susceptible to infections by isolates of several 
serotypes including S. typhimurium, S. dublin and S. enteritidis (Collins, 1974). 
These mouse virulent isolates normally cause invasive, systemic infections, which in 
many ways resemble typhoid. The murine model is often referred to as mouse 
typhoid or murine salmonellosis. However, mice do not develop gastroenteritis or 
diarrhoeal disease and cannot be used as a model for food poisoning (Chatfield et 
al., 1992). 
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Perhaps one of the most useful properties of the mouse model is the amenability to 
examination of Salmonella genes involved in the overall virulence process. Strains 
of S. typhimurium carrying mutations in the genes of interest with possible 
involvement in virulence can be compared against an otherwise isogenic parental 
strain, using the LD50 test (50% lethal dose). Although the murine model is readily 
accessible and is yielding valuable information, caution must be taken when 
extrapolating data obtained in the mouse to other hosts (Chatfield et al., 1992). 
A genetic locus in mice that correlates with susceptibility to Salmonella infection 
It has been known for some time that host resistance to murine salmonellosis is 
under genetic control (Robson and Vas, 1972; Plant and Glynn, 1976). With inbred 
mice, susceptibility to S. typhimurium, Mycobacterium sp. and Leishmania sp., 
segregates in a dominant mendelian pattern, and a locus (termed Ity, Bcg or Lsh, 
respectively), identified on mouse chromosome 1, controls this susceptibility 
through an alteration in macrophage function (Lissner et al., 1983). It has been 
demonstrated that resident peritoneal macrophages from ItyR  mice exhibit a greater 
bactericidal capacity against S. typhimurium than those from Ity5 mice (Lissner et 
al., 1985). A gene designated Nramp (natural resistance associated macrophage 
protein) has been identified within the Ity locus and this gene, associated with 
susceptibility to Salmonella infection, encodes an integral membrane protein with 
structural similarity to transport proteins. It may function in macrophages to 
transport microbicidal substances into phagosomes (Vidal et al., 1996; Gruenheid et 
al., 1997; Govoni et al., 1999). 
IVET and STM 
Other sophisticated systems have been developed to study interactions of S. enterica 
with its host, which take advantage of the amenability of this bacterium to genetic 
manipulation and the fact that it has been extensively investigated (Gulig, 1996). 
These systems include mammalian cell culture systems that simulate intestinal 
epithelial cell or macrophage interactions with S. enterica. These allow Salmonella 
invasiveness to be investigated prior to in vivo testing for attenuation (Finlay and 
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Falkow, 1989; Galan and Curtiss, 1989; Galan and Sansonetti, 1996). Also, to select 
for genes that are wholly required for the survival of S. enterica during infection, 
some investigators (Mahan et al., 1993, 1994), used the mouse model to develop the 
new strategy of in vivo expression technology (IVET). More recently, signature-
tagged mutagenesis (STM) has been developed as a genomic technique to determine 
whether a specific genetic change results in attenuated virulence in a host. This 
novel methodology allows investigators to test many different insertional mutants 
simultaneously in a living host (Shea and Holden, 2000). 
1.4 INTERACTIONS OF S. ENTERICA WITH EPITHELIAL CELLS 
1.4.1 Cellular mechanisms 
The entrance of salmonellae into the 184 human colon epithelial cell line has been 
demonstrated to result in the production of D-myoinositol 1,4,5,6-tetrakisphosphate. 
This substance may promote chloride flux in the mammalian host and subsequent 
diarrhoea (Eckmann et al., 1997). 
The primary sites of entry of S. enterica into the intestinal mucosa are the 
enterocytes (the columnar epithelial cells that line the intestine) and microfold cells 
(M cells), which are dome-like epithelial cells that cover Peyer's patches 
(Brandtzaeg, 1989; Finlay and Falkow, 1989; Siebers and Finlay, 1996). Peyer's 
patches consist of lymphoid follicles and form part of the gut-associated lymphoid 
tissue (GALT). In mice, M cells represent 5-10% of these cells. Electron microscope 
studies have demonstrated that S. typhimurium enters both M cells and cultured 
epithelial cells within 30 minutes of contact (Finlay and Falkow, 1990; Jones et al., 
1994). 
One mechanism of invasion involves typhoid bacilli being actively internalised by 
M cells and other organised lymphoid tissue of the gut. From here they are 
transported into the underlying lymphoid cells from where they enter the systemic 
circulation. S. lyphi has been demonstrated to attach to and invade murine M cells, 
but is rapidly cleared from the Peyer's patches without destruction of the M cells. In 
contrast, invasion of murine M cells by S. typhimurium is accompanied by 
destruction of M cells and subsequently sloughing of the epithelium (Weinstein et 
al., 1998). The invading bacteria do not seem to replicate to any extent within the M 
cells, but move through the cell. 
In the second invasive mechanism, bacilli are internalised by enterocytes via a 
process termed bacterial-mediated endocytosis (BME). S. typhimurium stimulates 
these normally non-phagocytic cells to undergo significant cytoskeletal 
rearrangements similar to those induced by exposure of cells to growth factors, that 
are visualised as localised membrane ruffling around the bacteria (Finlay and 
Falkow, 1988, 1990; Francis et al., 1992, 1993; Galan et al., 1992a; Jones et al., 
1993; Pace et al., 1993; Garcia-del Portillo and Finlay, 1994; Ginocchio et al., 
1994). Salmonellae are then internalised within membrane-bound vacuoles through 
which organisms transcytose from the apical to the basolateral surface of cell, 
without destroying the enterocyte (Takeuchi, 1967; Finlay et al., 1988). Leung and 
Finlay (1991) have shown that the ability of S. typhimurium to replicate in cultured 
epithelial cells is essential for virulence. After a lag period of 5-6 hours, typhoid 
bacilli replicate in these vacuoles, with a generation time of approximately 40-50 
minutes (Finlay and Falkow, 1989). In response to S. typhimurium, the intestinal 
epithelium promotes an intense inflammatory response, clinically expressed by 
enteritis. It consists largely of the migration of polymorphonuclear leukocytes 
(PMN) toward and ultimately across the epithelial monolayer into the intestinal 
lumen (Kumar et al., 1982). 
The formation of host filamentous structures named Salmonella-induced filaments 
(sif) has been demonstrated, which correlates with the start of intracellular 
replication of S. typhimurium (Garcia-del Portillo et al., 1993). The 16-kb sfA is a 
Salmonella-specific gene required for the bacterial-promoted formation of 
filamentous structures in the lysosomal vacuoles of infected epithelial cells. It has 
been suggested that these filaments may help deliver nutrients to the vacuole-bound 
S. typhimurium, contributing to the pathogenicity in the murine typhoid fever model 
(Garcia-del Portillo et al., 1993; Stein et al., 1996). 
1.4.2 Molecular and genetic mechanisms 
Role of fimbriae and flagella 
Surface components including fimbriae and flagella have been investigated for their 
role in mediating entry into eucaryotic cells. However, the role of fimbriae and 
flagella in infection remains controversial and is dependent upon the serovar of S. 
enterica examined and possibly also, the nature of the experimental model used. 
Recent evidence suggests that fimbrial adhesins of S. typhimurium play a role during 
bacterial attachment and invasion of the intestinal mucosa in vitro and in vivo 
(Lockman and Curtiss, 1992; Baumler et al., 1996; 1996a; 1997). Attachment 
mediated by fimbrial adhesins appears to be important for invasion of cultured 
epithelial cell lines in vitro (Ernst et al., 1990; Baumler et al., 1996b). Previous 
studies have shown that inactivation of biosynthetic genes for type I fimbriae, LP 
fimbriae or PE fimbriae, attenuate S. typhimurium mouse virulence approximately 
five-fold (Lockman and Curtiss, 1992; Baumler et al., 1996, 1996a). Plasmid-
encoded fimbriae found only in Salmonella have been shown to bind specifically to 
M cells in the intestine (Low et al., 1996; Baumler et al., 1997a). 
More recent studies have demonstrated that different fimbriae are involved in 
serovar-specific virulence traits. Enteric bacteria possess multiple fimbriae, many of 
which play critical roles in attachment to epithelial cell surfaces, but for example S. 
enteritidis fimbriae (SEF14) are restricted only to S. enteritidis (Clouthier et al., 
1993). It has been recently shown that SEF14 and SEF17 fimbriae mediate bacterial 
cell aggregation on inanimate surfaces (Woodward et al., 2000), and mutations that 
disrupt the sefoperon decrease virulence in mice more than 1,000-fold (Edwards et 
al., 2000). Another example has been given more recently by Wilson and co-workers 
(2000), who expressed S typhimurium type I fimbriae within S. enterica serovars 
Gallinarum (S. gallinarum) and Pullorum (S. pullorum). Serovars Gallinarum and 
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Pullorum expressing S. typhimurium type I fimbriae exhibited 10- to 20-fold 
increased ability to adhere to and 20- to 60-fold increased invasion efficiency of the 
human epithelial Hep-2 cell line. 
Recent experimental results have shown that the type IVB pili might be used by S. 
enterica serovar Typhi (S. typhi) as an intestinal cell adhesin, although a pil mutant 
retained 5% to 25% of the adherence and/or invasion ability of the wild type strain, 
using a human intestinal epithelial cell line as a model (Zhang et al., 2000). 
S. typhi entry into epithelial cells is dependent on intact flagella, as well as motility 
functions (Liu et al., 1988). Recent studies have shown that a non-flagellated (fiG) 
mutant of S. enteritidis was 50-fold less invasive for Caco-2 cells, than the wild 
type, whereas bacterial adherence remained unaffected (Van Asten et al., 2000). Of 
interest, combining a non-attenuatingfimA mutation with a mutation in the flagellum 
synthesis, resulted in a 1,000-fold increase in attenuation of the S. typhimurium 
strain upon oral challenge in BALB/c mice (Lockman and Curtiss, 1992). 
Motility is also linked with the chemotactic responses of the bacterium and 
chemotaxis may have a role to play in host cell entry (Khoramican-Falsafi et al., 
1990; Jones et al., 1992), particularly if host cells are damaged (Uhlman and Jones, 
1982). However, no difference in invasiveness of non-flagellate and non-motile 
flagellate S. typhimurium cells has been found (Khoramican-Falsafi et al., 1990). 
Also, S. typhimurium mutants lacking flagella or motility are as virulent as the wild 
type strain (Lockman and Curtiss, 1990). 
Role of lipopolysaccharide (LPS) 
LPS has been demonstrated to have a role in mediating the entry of organisms into 
epithelial cells in a serovar-dependent manner. Rough mutants (unable to form a 
complete LPS molecule) and wild type (smooth) S. typhimurium, both have the 
ability to invade cultured HeLa cells (Kilhlstran and Ebedo, 1976). In contrast, 
rough mutants of S. typhi and S. choleraesuis are both incapable of entry into 
epithelial cells and for S. choleraesuis, the LPS deficiency has been shown to affect 
the ability of bacteria to transcytose through cells (Finlay et al., 1988; Mroczenski-
Wildey et al., 1989). 
In S. enterica and E. coil, the LPS molecule is divided into three distinct regions: (1) 
the hydrophobic membrane anchor designated lipid A, (2) a short chain of sugar 
residues with multiple phosphoryl substituents, referred to as the core 
oligosaccharide, and (3) the 0 antigen, a structurally diverse polymer composed of 
oligosaccharide repeats (Raetz, 1996). In E. coil, the waaP gene product has been 
recently shown to be responsible for phosphorylation of the first heptose residue of 
the LPS inner core region. WaaP was also shown to be necessary for the formation 
of a stable outer membrane (Yethon et al., 1998). A S. typhimurium waaP mutant 
has been recently demonstrated to elicit a rough phenotype, be sensitive to 
polymyxin and showed complete loss of virulence in mouse infection models 
(Yethon et al., 2000). 
1.4.3 Salmonella pathogenicity islands (SPI) 
Pathogenicity islands are chromosomal clusters of virulence genes found in 
pathogenic organisms, but absent or sporadically present in related nonpathogenic 
species (Groisman and Ochman, 2000). They are often found adjacent to tRNA 
genes, suggesting transfer into these broadly conserved sites, and contain atypical 
guanine and cytosine content from that of the rest of the chromosome. They are 
thought to be of extraneous origin (Groisman and Ochman, 2000). 
sPI-1 
SPI-1, a 40-kb segment, encodes virulence factors involved in invasion of intestinal 
epithelial cells, induction of neutrophil recruitment and secretion of intestinal fluid 
(Galan and Curtiss, 1989; Jones et al., 1994; McCormick et al., 1995; Watson et al., 
1995; Galyov et al., 1997). SPI-1 is localised at centisome 63 on the S. typhimurium 
chromosome and contains 31 genes encoding the typical components of a type III 
secretion system, which plays a role in invasion (see below), the effector proteins 
secreted by this system, and the corresponding effector chaperones, transcriptional 
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regulatory factors, and a few proteins of unknown function (Galan, 1996; Groisman 
and Ochman, 2000). Indeed, the majority of genes encoded by mv (invasion), spa 
(surface presentation of antigens), and prg (PhoP repressed genes) operons, are 
believed to encode the structural components of the invasion-protein-export system 
(Klein et al., 2000). In mice, mutations in SPI-1 attenuate S. enterica serotype 
Typhimurium (S. typhimurium) between 15- to 50-fold after oral infection, but have 
no attenuating phenotype following intraperitoneal injection (Galan and Curtiss, 
1989; Baumler et al., 1997). The Inv/Spa system has been also implicated in 
macrophage apoptosis in vitro (Groisman and Ochman, 2000). 
Role of the invasion-protein-export system 
Secreted or surface-exposed bacterial proteins have long been known to play central 
roles in bacterial-host interactions. In Gram-negative bacteria, these proteins must 
pass through both the inner membrane and the outer membrane. There are three 
types of protein secretion systems and all use ATP hydrolysis to drive secretion 
(MacBeth and Lee, 1993; Mecsas and Strauss, 1996). Proteins secreted by the type I 
system cross directly from the cytoplasm to the cell surface, by-passing the general 
secretory pathway completely. Type II secreted proteins use the general secretory 
pathway to reach the periplasm, where they make an intermediate stop, and then 
traverse the outer membrane through distinct channel proteins. Both type I and type 
II systems secrete proteins that are involved in pathogenesis. For example, a-
hemolysin of E. coil uses a type I system, and pili of the enteropathogenic and 
enterotoxigenic E. coii use type II systems for export (Mecsas and Strauss, 1996). 
The multicomponent, highly conserved type III secretion system has been found in 
many Gram-negative bacteria that cause disease in humans and plants (Van 
Gijsegem et al., 1995; Galan, 1996; Galan and Sansonetti, 1996) and is responsible 
for transporting effector molecules directly from the cytoplasm to the cell surface, 
where they interact with mammalian cells and modify host cell proteins (Michiels et 
al., 1990). Type I and type III systems do not remove any part of the secreted protein 
(Mecsas and Strauss, 1996). In contrast to the type I and type II systems, type III 
secretion is triggered when a pathogen comes in close contact with host cells and 
hence, has been called contact-dependent secretion (Ginocchio et al., 1994; Rosqvist 
15 
et al., 1994; Watarai et al., 1995; Galan, 1996). Temperature, growth phase, and salt 
conditions are environmental cues known to induce synthesis of the secretion 
apparatus in various pathogens (Lee and Falkow, 1990; Hromockyj et al., 1992; 
Straley and Perry, 1995). 
The biochemical functions of all effector proteins delivered by the Inv/Spa system 
are beginning to be elucidated (Groisman and Ochman, 2000). Recent findings 
suggest that genes from S. lyphimurium SPI-1 are required for lethal infection, but 
are not essential for diarrhoea (Tso!is et al., 2000). One of the striking properties of 
the Inv/Spa system of Salmonella is its capacity to translocate effector proteins 
encoded outside the SPI- 1 into the cell, as part of the signalling mechanism for 
bacterial internalisation (Kaniga et al., 1995; Hakansson et al., 1996). These include 
proteins of the sip locus (Salmonella invasion proteins), sipABCD, immediately 
downstream of the Inv/Spa secretion apparatus (Groisman and Ochman, 2000). 
Secreted effector proteins are also located on the sop locus (Salmonella outer 
proteins) and on the invJ, spaO and sptP genes (Hueck et al., 1995; Galan, 1996; 
Kaniga et al., 1996; Wood etal., 1996). 
Mutations in some of the S. lyphimurium genes, such as invA, invC and invG, result 
in cells which do not produce the invasion structure, namely the invasome, or do not 
secrete Sip proteins (Galan and Sansonetti, 1996). The invH gene located on SPI- 1 
encodes a non-fimbrial adhesin involved in adherence and disruption reduces both 
attachment to and invasion of cultured epithelia! cells (Altmeyer et al., 1993; Boyd 
et al., 1997). In contrast, mutations in invA and invE encoded on SPI-1, renders. 
enterica serotypes non-invasive, but have no effect on adhesion to cultured epithelial 
cells (Galan and Curtiss, 1989; Ginocchio et al., 1992). The observation that SPI-1-
mediated adhesion and invasion can be genetically separated, suggests that entry of 
S. enterica into epithelial cells is a two-step process. New results using a ziSPI-I 
mutant (Murray and Lee, 2000) suggest that hilA is also required for bacterial 
colonisation of the host intestine. 
Ir1 
Regulation of expression of the invasion system, including the type III secretion 
machinery and the invasome, appears complex. A number of different 
environmental factors, especially those associated with the intestine, such as oxygen 
tension, osmolarity, carbohydrate availability and bacterial growth phase, have been 
shown to influence the expression of the invasion genes in S. lyphimurium (Ernst et 
al., 1990; Clark et al., 1998). SPI-1 encodes regulatory proteins governing the 
expression of genes located within the island, such as Hi1A, InvF, PhoP and SirA 
(Lee et al., 1992; Bajaj et al., 1995, 1996; Galan, 1996, Johnston et al., 1996). InvF 
is required for the optimal expression of several genes encoding SPI- 1-secreted 
proteins (Darwin and Miller, 1999). Hi1A, a transcription factor encoded on SPI- 1, 
has been shown to activate expression of many invasion genes encoded also on SPI-
1 (Bajaj et al., 1995, 1996; Eichelberg and Galan, 1999). However, HilA expression 
is itself influenced by PhoP (Bajaj et al., 1995, 1996), and by a recently identified 
regulator, SirA (Salmonella invasion regulator; Johnston et al., 1996). How all these 
signals and regulators interact to affect the secretion apparatus and their substrates is 
unknown, but it has been proposed that the induction of S. enterica invasion proteins 
in response to multiple environmental cues, ensures that bacterial entry is limited to 
the specific sites where an invasion phenotype is required (Galan et al., 1992; Bajaj 
et al., 1995; Lucas et al., 2000). 
SPI-2 
Salmonella is unique among Gram-negative pathogens in that it harbours two 
distinct type III secretion systems, each contributing to distinct stages of the 
infectious process. This second type III system, designated Spi/Ssa and encoded 
within the SPJ-2 pathogenicity island, differs from the Inv/Spa system in genetic 
organisation, phylogenetic distribution and function (Groisman and Ochman, 2000). 
The SPI-2 is a 40-kb segment located at centisome 30 on Salmonella chromosome 
(Ochman et al., 1996; Shea et al., 1996), immediately adjacent to the valV tRNA 
gene (Shea et al., 1996). The 32 genes constituting SPI-2, encode components of the 
Spi/Ssa secretion system, the putative effectors of the Spi/Ssa system, a two-
component regulatory system (SpiR/SsrA) positively regulated by OmpR (Lee et al., 
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2000), and several proteins whose functions are unknown (Groisman and Ochman, 
2000). 
The Spi/Ssa system is essential for causing systemic disease (Ochman et al., 1996; 
Shea et al., 1996). Specifically, the SPI-2 appears to enhance bacterial replication, 
rather than survival within host macrophages. One of the secreted proteins, SpiC, 
inhibits fusion of the Salmonella-containing phagosome with lysosomes (Groisman 
and Ochman, 2000). Nevertheless, Salmonella remains within a membrane-bound 
vacuole in both epithelial cells and macrophages. 
Other Salmonella pathogenicity islands 
Other Salmonella pathogenicity islands have been localised on the Salmonella 
chromosome. The SPI-3, a 17-kb segment that harbours 10 genes organised into 6 
transcriptional units, has been identified at the seiC tRNA gene locus (Blanc-Potard 
and Groisman, 1997). This includes the mgtCB operon encoding the macrophage 
survival protein MgtC required for virulence in mice, and the Mg 
2+  transporter 
MgtB, as well as a putative transcriptional regulator (SsrB) and proteins of unknown 
function (Groisman and Ochman, 2000). Recent studies have uncovered at least two 
additional pathogenicity islands in Salmonella. One of them, SPI-4, is a 27-kb 
region situated next to a putative tRNA gene at 92 minutes on the Salmonella 
chromosome map. One of the 18 genes within SPI-4 is known to be required for 
intramacrophage survival (Wong et al., 1998). A further pathogenicity island, SPI-5, 
is a 7.5-kb region that maps to the serT tRNA locus. Four, out of the six genes in 
this locus, have been implicated in cattle enteritis by S. enterica serovar Dublin (S. 
dublin). However, recent experiments suggest that SPI-5 does not play a role in 
systemic disease (Groisman and Ochman, 2000). 
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1.5 INTERACTIONS OF S. ENTERICA WITH MACROPHAGES 
1.5.1 Cellular mechanisms 
The ability of salmonellae to survive within macrophages is essential to 
pathogenesis and spread of the organisms into the systemic circulation. Studies on 
patients with typhoid fever and positive blood cultures have revealed that all the 
organisms are contained in the mononuclear cell fraction (Rubin et al., 1990). 
Eventually, organisms are taken up by tissue macrophages in the bone marrow, liver, 
spleen and Peyer's patches (Hornick et al., 1970; Rubin and Weinstein, 1977). 
During the asymptomatic incubation of typhoid fever, most organisms are localised 
intracellularly within macrophages and possibly epithelial cells (Looney and 
Steigbigel, 1986), but symptoms of typhoid fever occur only when a critical number 
of organisms have accumulated (Miller and Pegues, 2000). 
Macrophages are able to ingest bacteria by phagocytosis because of the presence of 
membrane receptors for the Fc segment of antibody (IgG and 1gM) and also for the 
components of the complement system (C1R and OR). Using time-lapse light 
microscopic techniques, Alpuche-Aranda and collaborators (1994) proved that S. 
typhimurium cells do not always enter J774 macrophages by conventional 
phagocytosis. They demonstrated that salmonellae induce membrane ruffling in 
macrophages, a process similar to that observed in epithelial cells. This is followed 
by internalisation of bacteria into small 2- to 5-j.im membrane-bound vacuoles, with 
a large amount of extracellular fluid, termed macropinosomes through fusion of the 
ends of membrane ruffles. After endocytosis, macropinosomes can fuse to form 
large vacuoles containing Salmonella cells that are termed spacious phagosomes 
(SP). The Salmonella-containing vacuole appears to fuse with the lysosomal 
compartment, although the phagosome may have delayed acidification and novel 
trafficking to the lysosomal compartment (Alpuche-Aranda et al., 1992; Oh et al., 
1996; Rathman et al., 1997). The ability to induce internalisation by macrophages 
and epithelial cells could also protect Salmonella from phagocytosis by neutrophils. 
Typhoid bacilli are rapidly killed by neutrophils, with less than 10% of an initial 
inoculum surviving after phagocytosis (Weiss et al., 1982). 
S. enterica is cytotoxic to macrophages and this phenomenon has been correlated 
with expression of the specialised type III secretion system (Chen et al., 1996; 
Monack et al., 1996). Cytotoxicity has been believed to be the result of the induction 
of apoptosis in the macrophage, occurring between 20 minutes and 14 hours post-
infection (Chen et al., 1996; Lindgren et al., 1996; Monack et al., 1996). More 
recently, Watson and co-workers (2000) proved that Salmonella strains are able to 
kill bovine alveolar macrophages by a mechanism distinct from apoptosis and that 
other types of macrophages may be killed by a similar, non-apoptotic mechanism. 
This has important implications for future studies of Salmonella-induced 
macrophage lysis. 
Experiments with macrophages from outbred and inbred mice with different 
resistances to S. typhimurium, indicated that a host component was essential to SP 
formation. The result that SPs were formed or maintained more easily in susceptible 
mice suggested that SP formation may be a factor in host susceptibility to 
Salmonella. For example, ItyS  mice are defective in restricting the growth of 
intracellular pathogens within macrophages. In addition to Ity, other loci which 
contribute to mouse susceptibility to S. typhimurium have been identified. These 
include Xid, a locus within the major histocompatibility complex, which controls B 
lymphocyte function in CBA!HN mice (O'Brien et al., 1979), and Lpsd,  a locus 
responsible for lipopolysaccharide hyporesponsiveness in C3H!HeJ mice (O'Brien 
et al., 1980). 
Serotype-specific bacterial factors are necessary for disease production and 
outcome. For example, both opsonised and non-opsonised, invasive serovar 
Typhimurium can enter into spacious phagosomes of murine macrophages, replicate, 
and apparently utilise these host vehicles to disseminate via the lymphatic system 
(Alpuche-Aranda et al., 1995; Mills and Finlay, 1998). Conversely, non-opsonised 
serovar Typhi strains can enter and thrive in human macrophages, but these same 
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bacteria are killed more rapidly in murine macrophages (Alpuche-Aranda et al., 
1995; Schwan and Kopecko, 1997). Studies suggest that non-opsonised 
Typhimurium enters, multiplies within, and causes death of macrophages, leading to 
a highly virulent infection and death of the mice within 14 days. In striking contrast, 
non-opsonised Typhi survives silently and chronically within human macrophages, 
causing little cell death, which allows intra-host dissemination and typhoid fever 
with low host mortality (Schwan et al., 2000). 
1.5.2 Genetic and molecular mechanisms 
Microbicidal mechanisms of phagocytes 
The antimicrobial mechanisms of professional phagocytes have been classified as 
oxygen-dependent and oxygen-independent. The oxygen-dependent mechanisms 
generate reactive molecules, such as superoxide anion, hydrogen peroxide, 
hypochiorite molecules and hydroxyl radicals, on binding the bacteria to the host 
cell surface and also within the phagosome. Alternatively, the oxygen-independent 
mechanisms include the acidification of the phagosome to approximately pH 3.0, the 
activation of degradative enzymes dumped into the phagosome at the time of fusion 
with the lysosome, and the antibiotic actions of small cationic peptides called 
defensins, which have been discovered in polymorphonuclear leukocytes in a 
number of species (Karlsson et al., 1995). Only oxygen-independent killing 
mechanisms are required to kill salmonellae within neutrophils (Looney and 
Steigbigel, 1986) and resistance to oxygen-dependent killing mechanisms may be 
more important within macrophages (Miller and Pegues, 2000). 
Recent studies (Bums-Keliher et al., 1998) focused on examination of different 
protein patterns exhibited by S. typhimurium during growth within three different 
cell types, including intestinal epithelial cells, macrophages and liver cells. It has 
been shown that S. lyphimurium responds to these different cellular environments 
with specific patterns of protein synthesis unique to each cell type. 142 proteins 
were detected in epithelial cells, of which 58 appear to be unique to growth within 
this cell line. 413 proteins were observed within macrophages, of which 157 appear 
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to be unique, and 183 proteins were detected in liver cells, of which 91 appear to be 
unique. The greatest number of proteins was synthesised within the macrophage and 
a possible explanation for this result is that de novo synthesis of a larger set of 
proteins may be required for survival and multiplication within these cells than 
within the epithelial cell lines, which do not mount an actively antimicrobial 
response upon invasion by bacteria. 
During intra-macrophage survival and replication, salmonellae respond dynamically 
to the particular stresses of the microenvironment through the expression and/or 
repression of groups of genes, each designed to confer a selective advantage. Such 
genes, which are selectively activated in vivo, encode virulence factors that enable 
typhoid bacilli to survive the clearance mechanisms of the host cells. The size of the 
Salmonella genome has been estimated at 4.9 x 106  bp and it encodes approximately 
4,800 genes (Liu et al., 1993). Recently has been proved that mutations in about 4% 
of the Salmonella genome lead to 1,000-fold or greater attenuation in the mouse 
typhoid model of infection and most of these genes appear to be required during 
early stages of a natural infection (Bowe et al., 1998). The set of stresses within the 
macrophage and mechanisms employed by S. enterica to promote its survival will 
not be reviewed here as they do not form the subject of this project. However, the 
following section will focus mostly on the heat shock response and the proteins 
involved, which are the basis of this study. 
1.6 IMMUNITY TO S. ENTERICA INFECTION 
1.6.1 Introduction 
The defence mechanisms appropriate for a particular bacterial infection are related 
to the structure of the invading bacteria, and hence the immunological mechanisms 
to which they are susceptible, and to the mechanism of their pathogenicity (Roitt et 
al., 1998). A characteristic of S. enterica, a facultative intracellular bacterium, is its 
22 
ability to survive, and even replicate, within phagocytes. Since this microorganism is 
able to find a niche where it is inaccessible to circulating antibodies, effective 
elimination requires immune mechanisms that are very different from the 
mechanisms of defence against extracellular bacteria. The following section will be 
focussed on the role of the different arms of the immune system in the control of 
Salmonella infection. 
1.6.2 The use of a murine model to study S. enterica infection 
The need to develop effective vaccines to the causative agent of typhoid fever, has 
stimulated the study of the immune responses to S. enterica infection. Most 
experiments with S. enterica infection employ S. typhimurium, which causes an 
invasive systemic disease in mice that resembles human typhoid fever (Collins, 
1974). Genetically resistant mice can eliminate S. typhimurium through innate 
immune responses, but susceptible mice require both cell-mediated and humoral 
immunity, a characteristic of the responses generated by humans to typhoid fever 
(Collins, 1974; Hormaeche, 1979; Hormaeche et al., 1985; Mastroeni et al., 1993). 
Therefore, a murine model of the S. enterica infection is used, in which inbred mice 
strains that are genetically susceptible to S. typhimurium infection 
(J1yS;  discussed 
earlier in this chapter) are infected with low virulence strains of S. typhimuirum. 
1.6.3 General immunologic principles 
Any immune response involves, firstly, recognition of the pathogen, and secondly, 
mounting a reaction against it to eliminate it. Broadly speaking, the different types 
of immune response fall into two categories: innate (or non-adaptive) immune 
responses and adaptive immune responses. The important difference between these 
is that an adaptive immune response is highly specific for a particular pathogen 
(Roitt et al., 1998). Innate immunity consists of factors which are present prior to 
any contact with a particular microorganism and which are not enhanced by such 
exposure. Conversely, specific immunity is stimulated by the identification of 
specific macromolecules (antigens) and responses are enhanced, and defensive 
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capabilities increased, with each successive exposure to that antigen. Moreover, 
although the innate response does not alter on repeated exposure to a given 
infectious agent, the adaptive immune system "remembers" the infectious agent and 
can act to prevent it form causing disease later (Roitt et al., 1998). It is important, 
however, that both elements of immunity, although distinct, interact with each other. 
The different stages of S. lyphimurium infection are reflected in a variety of 
mechanisms of innate and acquired immunity that contribute to the response of this 
bacterium, and that differ in their importance during distinct infection stages 
(Makela and Hormaeche, 1997). 
1.6.4 Innate immunity 
The first line of defence against pathogenic bacteria consists of simple 
physicochemical barriers, such as the skin or mucous membranes, which prevent 
organisms gaining direct entry into the underlying tissues of the body (Finlay and 
Falkow, 1989a). In addition, humoral factors present in the blood and tissue fluid 
have anti-microbial activities. These include the complement system, a family of 
serum proteins activated in a proteolytic cascade, which can be triggered by the 
surface of the microorganism (Joiner et al., 1984). Complement proteins, such as 
C5-C9, can form a hydrophobic complex in the cell membrane of the bacterium, 
called a membrane attack complex, which results in the lysis of the bacterium by 
osmotic swelling (Joiner et al., 1984). Additionally, various components generated 
in the enzymatic cascade of the complement system, can themselves stimulate 
inflammatory processes (e.g. C5a and C3a), or act as chemoattractants (e.g. C5a) to 
draw phagocytic cells to the site of infection (Adams and Hamilton, 1984). 
Moreover, phagocytes have specific cell surface receptors for components of 
complement (e.g. C3b) and so, act as a mechanism to opsonise and phagocytose the 
bacterium (Adams and Hamilton 1984; Joiner et al., 1984). 
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1.6.5 Role of phagocytic cells in bacterial infection 
The major factor in preventing microorganisms entering the body, is the 
involvement of professional phagocytes, namely mononuclear phagocytes 
(monocytes and macrophages) and polymorphonuclear leukocytes, such as 
neutrophils (Abbas et al., 1997; Roitt et al., 1998). Mononuclear phagocytes develop 
in the bone marrow, then migrate via the blood as monocytes, to organs such as 
liver, spleen and draining lymph nodes, where they mature into tissue-resident 
macrophages (Roitt et al., 1998). Such macrophages constitute the 
reticuloendothelial system (RES). The Kuppfer cells (liver-resident macrophages) 
are quantitatively the most important component of this system (Adams and 
Hamilton, 1984; Kaufmann, 1993). Although macrophages are a part of the innate 
immune system, they also play an important role in acting as, and generating 
effectors of specific immunity (Abbas et al., 1997). Neutrophils mature in the bone 
marrow and are released into the blood where they function for approximately 4-5 
days. In contrast, mononuclear phagocytes have a much longer life span (Gulig, 
1996). 
Phagocytes respond rapidly to the invading bacteria, by chemotaxis through 
stimulation by inflammatory products (C5a) or components derived from bacteria, 
followed by target recognition, ingestion and then degradation (Abbas et al., 1997; 
Roitt et al., 1998). Phagocytosis involves the internalisation of the bacterial cell into 
a membrane-bound vesicle, the phagosome, and represents the first step in an 
endocytic pathway. The contents of the phagosome are destined to be destructed by 
fusion with azurophilic lysosomes. The anti-microbial activity of phagocytes is 
exerted before and after engulfment of the bacteria and involves two mechanisms: 
oxygen-independent and oxygen-dependent killing (Adams and Hamilton, 1984; 
Hasset and Cohen, 1989; Roitt et al., 1998). 
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Oxygen-independent mechanisms 
These mechanisms may be more important than previously thought. Many bacteria 
can be killed by cells from patients with chronic granulomatous disease, whose 
macrophages lack a respiratory burst, or from patients with myeloperoxidase 
deficiency, which cannot produce hypohalous acids. Some of the bactericidal 
activities in these cases may be due to nitric oxide, but many microorganisms can 
also be killed anaerobically, so the oxygen-independent mechanisms have been 
extensively investigated (Roitt et al., 1998).The factors involved in oxygen-
independent killing are very complex and they may all require phagolysosome 
fusion (Roitt et al., 1998). A large number of proteins and peptides are associated 
with the anti-microbial environment of the phagolysosome. For example, lysozyme 
is capable of breaking the peptidoglican layer of the bacterial cell wall and acid 
hydrolases manifest their degradative abilities. Also, lactoferrin can bind iron and 
render it unavailable to bacteria, even at an acid pH. Thus, the ability of polymorphs 
to kill some bacteria is lost if they are loaded with iron (Foster and Spector, 1995). 
Furthermore, there are a wider range of proteins with cytotoxic activities, which 
include azurocidin, cathepsin G, bactenencins, major basic protein (MBP), and 
bactericidal permeability increasing protein (BPI), but their mode of action is not yet 
understood (Lehrer et al., 1990). Cathepsin G and azurocidin are cationic proteins 
with a different pH optimum, both are related to elastase and have anti-bacterial 
properties, unrelated to their enzyme activity (Roitt et al., 1998). 
Another important feature of the phagolysosome is the low pH. Following lysosome 
fusion, there is a transient rise in pH before acidification of the phagolysosome takes 
place and this occurs within 10-15 minutes (Roitt et al., 1998). The low pH (3.5-4.0) 
is created by the acidification of the phagolysosome using a Na'/H' antiporter, and 
is inhibitory to a vast range of bacteria (Seguin et al., 1990, 1991; Foster, 1992; 
Slonczewski and Foster, 1996). Killing of microorganisms may be due to the 
acidification itself, though it is more likely to be related to the low pH optimum of 
lysosomal enzymes (Roitt et al., 1998). 
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Oxygen-dependent mechanisms 
The oxygen-dependent killing mechanisms are initiated upon contact and 
engulfment of bacteria into the phagocyte, and are mediated via a respiratory burst 
associated with the hexose monophosphate shunt system. Lysosome fusion is not 
required for this pathway, and the reactions take place spontaneously during 
formation of the phagosome (Roitt et al., 1998). The principal enzyme involved in 
triggering the oxidative killing is NADPH-oxidase, an enzyme in the phagosome 
membrane, which reduces oxygen to superoxide anion (02) (Adams and Hamilton, 
1984; Morel et al., 1991). This can then give rise to other reactive oxygen species 
(ROS), which are potentially toxic, such as hydroxyl radicals (OH), singlet oxygen 
(102) and hydrogen peroxide (11202). There is no detectable activity of NADPH-
oxidase within unstimulated macrophages, but immunological evidence suggests 
that the enzyme is present in these cells (Morel et al., 1991). 
Another important component of the oxygen-dependent killing mechanisms in 
phagocytes is nitric oxide (NO) (Vidal et al., 1993; Pacelli et al., 1995). NO is 
formed by the biotransformation of L-arginine into L-citrulline, by a nitric oxide 
synthase. NO is toxic for bacteria and its toxicity may be increased by interactions 
with products of the oxygen reduction pathway, such as H202, through formation of 
peroxynitrites and other toxic nitric oxide derived intermediates (Pacelli et al., 
1995). If lysosome fusion occurs, myeloperoxidase may enter the phagosome. 
Myeloperoxidase or, under some circumstances, catalase from peroxisomes, acts on 
peroxides in the presence of halides to form additional toxic oxidants, such as 
hypohalite (1110, HC1O) (Roitt et al., 1998). For optimal expression of this 
mechanism, mouse macrophages need both activation by interferon gamma (IFN-'y), 
and triggering by tumour necrosis factor (TNF). Bacterial cells subjected to all these 
reactive oxygen species can be damaged at all fundamental levels, nucleic acids, 
lipids and proteins (Adams and Hamilton, 1984; Imlay and Linn, 1986). 
Phagocytes ingest and attempt to destroy bacteria. However, at least to some degree, 
pathogenic intracellular bacteria, such as S. enterica, are resistant to degradation 
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within phagocytes. For effective control and eradication of Salmonella, acquired 
immunity is necessary (Mittrucker and Kaufmann, 2000). 
The specific role of phagocytic cells 
During the initial stages of infection by S. typimurium, both macrophages and 
neutrophilic granulocytes are critical for survival of the infected mice 
(Vassiloyanakopoulos et al., 1998). Macrophages phagocytose S. typhimurium and 
this process is enhanced by receptor-mediated uptake after opsonisation of 
salmonellae with IgG antibodies or complement (Mosser, 1994). However, by 
means of the specialised type III secretion system, bacterial proteins are injected into 
the host cells, allowing S. typhimurium to interfere with the signalling machinery. 
These interactions can force the uptake of S. typhimurium into macrophages, 
promote the intracellular survival of the pathogen, or cause macrophage apoptosis 
(Fields et al., 1986; Alpuche-Aranda et al., 1994; Monack et al., 1996). 
Macrophage activation by cytokines, such as IFN-y or TNF-c, appears to be a 
prerequisite for the destruction of S. typhimurium. Both cytokines are essential 
during the initial stages of Salmonella infection because they are involved in the 
induction of bactericidal mechanisms in macrophages (Gulig et al., 1997). These 
mechanisms include not only the production of reactive oxygen and nitrogen 
intermediates, but also improved handling of bacteria-containing phagosomes, 
rendering the bacteria accessible to lytic effector molecules from the lysosomes. 
Overall, it is important to note that interactions between macrophages and S. 
typhimurium do not necessarily result in bacterial killing. This process is critically 
dependent on several factors, including: (1) the presence of functional Nrampl 
molecules in macrophages, (2) the way S. typhimurium is engulfed by the 
macrophages, and (3) the activation state of the macrophage when it comes into 
contact with S. typhimurium (Mittrucker and Kaufmann, 2000). 
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Role of NK cells 
Intracellular Salmonella also activates natural killer (NK) cells, either directly or by 
stimulating macrophage production of IL-12. NK cells produce IFN-'y, which in turn 
activates macrophages and promotes killing of phagocytosed bacteria. Thus, NK 
cells provide an early defence against salmonellae, prior to the development of 
specific immunity (Abbas et al., 1997). 
Role of cytokines 
During the initial stages of infection, cell wall components of Salmonella, such as 
lipopolysaccharide (LPS) and certain lipoproteins, induce a massive inflammatory 
response in the surrounding tissue, resulting in the expression of inflammatory 
cytokines (e.g. TNF-a, IL-I, IL-6, IL-12, IL-18), and a variety of chemokines that 
recruit cells of the immune system to these sites (Jung et al., 1995; Eckmann et al., 
1996; McCormick et al., 1998). IFN-y is also produced during early infection, as 
discussed earlier, with NK cells and macrophages as important sources at this stage 
(Schafer and Eisenstein, 1992; Ramarathinam et al., 1993). Macrophages and 
dendritic cells are major sources of IL-12 and IL-18, which induce production of 
IFN-y, and in turn expression of IL-12 is enhanced by IFN-y through a feedback 
loop (Trinchieri, 1995; Mastroeni et al., 1996, 1999). 
1.6.6 Specific immunity 
Although the innate mechanisms of the immune system are effective in restricting 
the initial growth of S. lyphimurium for several days, these mechanisms fail to 
achieve sterile elimination of Salmonella from the host. Only the generation of a 
specific lymphocyte response allows their eventual effective eradication (Mittrucker 
and Kaufmann, 2000). 
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1.6.7 Role of T lymphocytes 
Specific immunity is regulated by T lymphocytes, which identify antigens through a 
membrane-bound receptor, the T cell receptor (TCR) (Abbas et al., 1997). However, 
T cells require accessory cells to process and display the antigen. Such antigen 
presenting cells (APC) include cells such as monocytes, macrophages, Langerhans 
cells (specialised epithelial cells), and B cells (Abbas et al., 1997; Roitt et al., 1998). 
To some extent, many cell types can be stimulated to perform the function of antigen 
presentation during bacterial infection, including endothelial and epithelial cells 
(Abbas et al., 1997). This allows for activation and regulation of immune responses 
in almost any part of the host. 
T cells are generally considered to mediate the effects of the immune system by 
producing soluble messengers called cytokines (Abbas et al., 1997; Roitt et al., 
1998). These molecules modulate the activity of other cells, such as B cells or 
macrophages, and also enhance the activity of T cells. There is evidence that in early 
stages of bacterial infection cells of the immune system help dictate which type of 
specific immune response develops (Abbas et al., 1997). 
There are a number of cell surface molecules, which are essential in determining the 
type of immune response generated during infection. These include molecules found 
on T cells, such as CD4 and CD8, and the major histocompatibility molecules I and 
II (MI-ICI and MHCII), which are found on APC (reviewed in Abbas et al., 1997; 
Roitt et al., 1998). T cells can only identify a processed antigen when it is associated 
with the products of MHCI or MHCII (Abbas et al., 1997) and this ability is 
restricted only to T cells expressing CD8 or CD4 on their surface, respectively. 
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1.6.8 The forms of antiiens recognised by lvmnhocvtes 
Humoral responses and cell-mediated reactions are generally directed against 
different determinants on the antigens. Protein antigens do not induce antibody 
responses in the absence of T lymphocytes and they require the participation of 
helper T cells. For this reason, proteins are considered thymus-dependent antigens. 
Non-protein antigens, such as lipopolysaccharides and lipids, induce antibody 
responses without the requirement of helper T lymphocytes. Therefore they are 
called T-independent antigens (Abbas et al., 1997). Protein antigens are not 
presented by MHC molecules as intact proteins, but rather as processed peptides at 
the cell surface. The cells that process antigens are specialised APC, which are 
capable of stimulating T cell division (Roitt et al., 1998). The CD4CD8 and CD4 
CD8 T cell subsets produce very different immune responses and this is largely 
dependent upon the type and source of the antigen. 
The specificity of T lymphocytes for complexes of peptide antigens and MHC 
molecules determines several characteristics of T cell antigen recognition, which 
differ in fundamental ways from antigen recognition by antibody molecules. Most T 
lymphocytes recognise only peptides, whereas B cells can specifically recognise 
peptides, proteins, nucleic acids, polysaccharides, lipids and small chemicals (Abbas 
et al., 1997). Also, T cells recognise only linear determinants of peptides. In 
contrast, B cells may recognise conformational determinants that exist when proteins 
are in their native tertiary (folded) configuration or determinants that are exposed by 
denaturation or proteolysis. T cells recognise and respond to foreign peptide 
antigens only when the antigen is attached to the surfaces of other cells, whereas B 
cells and secreted antibodies bind soluble antigens in body fluids or cell surface 
antigens. This is because MHC molecules form part of the complex that T cells 
recognise (as reviewed in Abbas et al., 1997). 
As mentioned previously, CD4CD8 T cells recognise peptides bound to class II 
MHC molecules. The major source of such peptides are extracellular proteins, 
including microbial proteins, which are endocytosed by APCs, and then enter the 
31 
acidic vesicular pathway that cells use to break down internalised proteins. In 
contrast, CD4CD8 T cells recognise peptides bound to class I MHC molecules. 
Such peptides are usually proteins found in the cytosol of APCs, including viral and 
tumoral proteins. Therefore, the association of antigens with class I or class II MHC 
molecules, is dependent upon whether the antigen is from an exogenous or 
endogenous source, and the trafficking of the antigens through different intracellular 
compartments (Brodsky and Guagliardi, 1991). The recognition of exogenous 
antigens by CD4CD8 helper T cells (TH) results in cytokines being secreted that 
enhance the ability of phagocytes to kill bacteria or stimulate B cells to produce 
antibodies. In contrast, host cells expressing endogenous antigens associated with 
class I MHC molecules, are destroyed by CD8CD4 cytolitic T cells (CTL) that 
recognise this complex (Abbas et al., 1997). 
1.6.9 Co-operation within the immune system 
In order for an immune response to develop, antigen must come into contact with 
APCs, which in turn require cell to cell contact with T cells. Firstly, the immune 
system is organised into specialised lymphoid tissues into which many different 
types of cells, including B and T cells and APCs, can enter and reside (Abbas et al., 
1997). This facilitates the close contact required for displaying antigens and for 
developing the required immune response. These lymphoid tissues include the 
spleen, liver, draining lymph nodes, and the Peyer's patches of the gut, and are 
connected by the blood and the lymph system. The antigen that enters into any part 
of the body, such as the skin or the intestine, is therefore likely to migrate to these 
tissues. 
Secondly, antigens are structurally diverse and only a small population of B and T 
cells are likely to recognise specific portions of any particular antigen. These cells 
therefore migrate between tissues, a process called lymphocyte recirculation, such 
that the chances of antigen-specific lymphocytes coming into contact with the 
antigen are increased (Abbas et al., 1997). Thus, the organisation of the immune 
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system and the behaviour of the lymphoid cells act to produce a highly efficient 
monitoring system against infection. 
1.6.10 Humoral immunity 
Humoral immunity is mediated by antibodies produced by activated cells of the B 
lymphocyte lineage. B cells are formed in the bone marrow and possess membrane-
bound antibody molecules which act as antigen-specific receptors (reviewed in Roitt 
et al., 1998). 
Previously unstimulated B cells, which are exposed to antigens, generally produce 
1gM, which has multiple antigen-binding sites. This is called the primary response, 
whereas secondary responses are due to stimulation of expanded clones of memory 
B cells. Therefore, secondary responses develop more rapidly than primary 
responses, and larger amounts of antibodies are produced in the secondary 
responses. In general, a primary response to an antigen can be seen within 5-10 days 
after exposure to that antigen, and consists of 1gM antibody. However, in the 
secondary response, the lag time in appearance of antibodies is greatly reduced and 
specific antibodies, mainly IgG, can be observed 1-3 days post-challenge. The 
production of different Ig isotypes enables humoral immune response to eliminate 
different types of microorganisms. Affinity maturation of antibodies makes an 
individual better able to combat persistent or recurrent infections and is also a reason 
why the optimal antigen doses required for secondary responses are lower than those 
for primary responses (Roitt et al., 1998). 
1.6.11 The role of antibodies 
Antibody has a number of roles in mediating protective immunity. It binds bacterial 
toxins and receptors (opsonisation) to prevent interaction with their respective 
targets, but also can activate the complement system via the classical pathway 
(Joiner et al., 1984). Macrophages and PMNs, in addition to having receptors for 
complement proteins (e.g. C1R and OR), possess receptors for the carboxyl- 
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terminal region (Fc) of immunoglobulins, especially IgG1 and IgG3 in humans. 
Uptake of bacteria via these receptors is extremely efficient (Adams and Hamilton, 
1984). Moreover, the binding of antibody or complement to these receptors 
stimulates the respiratory burst of phagocytes, increasing their anti-microbial 
activity (Joiner et al., 1984; Gulig, 1996). 
1.6.12 Humoral immunity to S. enterica infection 
Infection of mice with S. typhimurium results in a profound antibody response 
against both non-protein antigens, such as LPS, and protein antigens (Brown and 
Hormaeche, 1989). Vaccination of resistant mice with either attenuated or killed 
Salmonella induces protection against secondary infection with an otherwise lethal 
dose of virulent bacteria, and this protection could be passively transferred to naïve 
mice with serum (Eisenstein et al., 1984). It is known that people infected with S. 
typhi, or vaccine derivatives that have been attenuated, produce significant levels of 
1gM and IgG. Moreover, most of this is likely to be due to the polyclonal stimulation 
of B cells with LPS (Forrest et al., 1991; Tacket et al., 1992a). Insusceptible mice, 
however, the situation is different. Killed bacterial vaccines generate only partial 
protection against challenge with virulent Salmonella, and protection cannot be 
transferred by serum alone (Eisenstein et al., 1984). Vaccination of susceptible mice 
with live vaccines induced protection against challenge with virulent bacteria (Killar 
and Eisenstein, 1985), but both serum and T cells are required for successfully 
transferred protection (Mastroeni et al., 1993). 
Infection of B-cell deficient mice (from the inherently susceptible C57BL/6 
background) confirmed that antibodies were dispensable for control of attenuated 
Salmonella. However, these mice were more susceptible to oral infection with wild-
type bacteria during both primary and secondary responses (Izhar et al., 1990). 
When challenged intravenously with virulent Salmonella, vaccinated mice were 
more susceptible than wild-type control animals, although a fraction of B cell-
deficient mice survived challenge. 
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These data demonstrate the involvement of antibody-independent mechanisms in the 
control of S. typhimurium (Mittrucker et al., 2000). Hence, antibodies participate in 
protection against S. typhimurium, and in resistant mice, antibodies alone are 
sufficient for control of virulent bacteria. In susceptible mice, where the infection 
with virulent S. typhimurium imposes a more stringent challenge on the immune 
system, antibodies participate in control, but protection depends on additional 
mechanisms (Mittrucker and Kaufmann, 2000). 
Specific roles of antibodies 
Antibodies could perform several functions during the different stages of Salmonella 
infection. In the intestinal lumen, antibodies (particularly 1gM and IgA) could block 
penetration of salmonellae into deeper tissues. Therefore, the mucosal immune 
system is thought to provide an early line of defence against Salmonella. In the gut 
mucosa, there are sites that contain organised mucosal lymphoid tissue that sample 
lurnenal antigens, resulting in the stimulation of both T cells and B lymphoblasts 
committed to IgA synthesis. This leads to secretion of IgA with specificity for the 0-
antigen of LPS (Slauch et al., 1993). This prevents the bacteria from contacting the 
mucosal surface by agglutination, and subsequently they are cleared by peristalsis 
(Mittrucker and Kaufmann, 2000). Indeed, injection of a B cell hybridoma 
producing Salmonella-specific IgA has been shown to prevent oral infection of mice 
(Michetti et al., 1992) by the inhibition of cellular adhesion and infection (Michetti 
et al., 1994). 
After bacterial migration from the intestine into the Peyer's patches, mesenteric 
lymph nodes, and ultimately spleen and liver, antibodies could enhance bacterial 
engulfment and macrophage activation via Fc-receptor-mediated or complement-
receptor-mediated phagocytosis (Armstrong and Hart, 1975; Mosser, 1994), 
although salmonellae seem to be insensitive to complement lysis directly. The 
presence of such mechanisms was revealed in experiments that analysed the kinetics 
of bacterial clearance from blood after systemic infection (Cheers and Ho, 1983; 
Saxen, 1984). 
1.6.13 Cell-mediated immunity 
Differentiation of CD4 T cells into TH subsets 
CD4 T cells (TH) have two different profiles of cytokine production (TH1 and TH2) 
and these patterns select between the two basic types of response mediated by CD4 
T helper cells. All CD4 T cells come from a common origin and upon interaction 
with the antigen, these cells produce IL-2 (a T cell growth factor) and then develop 
into a population called THU. THU cells produce various mixtures of cytokines and, 
depending upon the source of antigen, type of APCs which present the antigen, and 
cytokines produced, the THU cells subsequently develop into either a TH1 or TH2 
subset (reviewed in Abbas et al., 1996) (see Figure 1.1). 
The composition of the cytokines produced early on in the immune response 
determines which type of immune response develops. For example, both IL-12 and 
IFN-y have been shown to promote a TH1 type of immune response (Abbas et al., 
1996). Macrophages that come in contact with bacteria secrete IL-12, which in turn 
causes T cells and NK cells (large granular lymphocytes) to produce IFN--y. As 
previously described, IFN-y activates macrophages and down-regulates TH2 
responses thereby helping polarise the immune responses towards the TH 1 type. In 
contrast, during helminth infection for example, IL-4, IL-10 and IL-13 are released 
and these cytokines help down-regulate a TH1  immune response (Abbas et al., 
1996). 
TH 1-based immune responses are mainly cell-mediated, especially by macrophages 
(Roitt et al., 1998), therefore are particularly effective at eliminating bacteria, such 
as S. enterica. The antibodies produced in a TH1 response generally act to assist cell-
mediated immune responses (Abbas et al., 1996). In contrast, TH2 cells encourage 
production of antibodies, especially IgE. TH2 responses are associated with 
regulation of strong antibody and allergic responses (Roitt et al., 1998) and tend to 
be phagocyte-independent. Characteristically they show lack of ability to induce 
cell-mediated immunity, such as DTH (discussed later in this section). Cytokines 
from TH 1 cells inhibit the actions of TH2 cells and vice versa. Such an antagonistic 
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Effector functions ofTH l and TH2 cells. 
The cytokines produced by TH1  and  TH2  lymphocyte populations determine their 
opposing effector (pointed arrowheads) and inhibitory (blunt arrowheads) functions. 
The TH1  and  TH2 pathways are symmetrical, each controlling a unique set of 
immune responses, and each augmenting the development of cells of the same 
subset, while suppressing the expansion and/or effector functions of the other 
subset. IL-2 and IL-4 are shown as autocrine growth factors for TH1  and  TH2  cells, 
respectively (adapted from Abbas et al., 1996). 
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activity polarises the immune responses towards the most appropriate pathway for 
dealing with a particular pathogen. 
The delayed-type hypersensitivity reaction (DTH) 
The delayed-type hypersensitivity reaction (DTH) is a form of cell-mediated 
reaction in which the ultimate effector cell is the activated macrophage (Abbas et al., 
1997), and also is an important method of investigating cell-mediated immunity 
against intracellular pathogens. Eradication of these organisms requires 
enhancement of the microbicidal function of phagocytes by T cell-derived cytokines. 
Purified protein derivative (PPD), a protein prepared from M tuberculosis, will 
elicit a DTH response when injected into individuals who have recovered from 
primary tuberculosis or who have been vaccinated against tuberculosis. DTH 
reactions to most protein antigens may be transferred by antigen-sensitised CD4 T 
cells. In vivo, it is likely that DTH reactions elicited by phagocytosed bacteria, are 
predominantly mediated by CD4 TH1 cells (Abbas et al., 1997). 
1.6.14 Cell-mediated immunity to S. enterica infection 
The role of T cells 
A bulk of information on the role of T cells in Salmonella infection has accumulated 
since the first description of a DTH reaction after injection of Salmonella antigens 
into the footpad of S. typhimurium-infected mice (Collins and Mackaness, 1968). 
Experiments where T cell populations were depleted by antibodies or where T cell-
enriched fractions of spleen cells were adaptively transferred, demonstrated that T 
cells are required for recovery from a primary infection with attenuated and virulent 
strains of S. typhimurium, and that I cells participate in protective immunity, which 
develops after vaccination with attenuated Salmonella strains (Chander et al., 1986; 
Nauciel, 1990; Mastroeni et al., 1992, 1993). Furthermore, nude mice or mice 
deficient in a3T cells infected with attenuated strains of S. typhimurium fail to 
control infection and develop chronic disease or die (Hess et al., 1996; Sinha et al., 
1997). Additionally, the generation of Salmonella-specific memory T cells at high 
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frequency at least in part explains the fast and efficient response that occurs in 
secondary Salmonella infection. 
Besides the T cell-mediated mechanisms, there are other aspects of the immune 
response against S. typhimurium where T cells could have a regulatory or protective 
role. For example, it could easily be envisaged that T cells play a critical role in 
granuloma formation and in the containment of bacteria to local foci (Mittrucker and 
Kaufmann, 2000). T cells could regulate these processes either by direct cell-cell 
contact or by the secretion of lymphokines and chemokines. 
The role of T cells and the importance of cytokines 
The depletion of CD4 T cells, as opposed to CD8 T cells, was found to have a 
more pronounced effect on the control of primary Salmonella infection and on 
protection induced by vaccination with attenuated strains of S. typhimurium. Also, 
transfer of CD4 T cells from vaccinated mice into naïve recipients resulted in 
higher levels of protection than transfer of CD8 cells (Nauciel, 1990; Mastroeni et 
al., 1992; Pie et al., 1997). A large number of studies demonstrate that infection of 
mice with Salmonella induces a TO response, characterised by the production of 
large amounts of cytokines associated with the TH1 type of response, such as IL-12 
and IFN-y (Thatte etal., 1993; Eckmann et al., 1996; Pie et al., 1997). 
The importance of IFN-' and IL- 12 was demonstrated by the observation that mouse 
mutants deficient in the IFN-y receptor were highly susceptible to attenuated 
salmonellae (Hess et al., 1996). In addition, injection of resistant mice (CBA or AJJ) 
with monoc!onal antibodies specific to either IFN-y or IL-12, resulted in these mice 
being overcome by the disease much more rapidly than a control group (Mastroeni 
et al., 1996). Moreover, addition of IFN-y or IL-12 to susceptible mice (BALB/c) 
infected with S. typhimurium greatly enhanced their resistance to infection 
(Mastroeni et al., 1996). There are several reports indicating that neutralisation of 
IFN-y is only critical during the initial phase of Salmonella infection (Muotiala and 
Makela, 1993; Pie et al., 1997). Furthermore, production of IFN-y by T cells 
preceded the clearance of bacteria by several days (Pie et al., 1996, 1997). 
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Interestingly, it has been shown that IL-12 is critical for the induction of nitric 
oxide-mediated immunosuppression following attenuated S. typhimurium 
inoculation and, through its ability to stimulate IFN-y production, can induce nitric 
oxide-producing suppressor macrophages (Schwacha and Eisenstein, 1997). 
Because IL- 12 plays a central role in both the induction and magnitude of a primary 
TH 1 response, recent studies have focussed on the use of native or recombinant IL-
12 as an adjuvant in the administration of soluble protein antigens (Bliss et al., 1996; 
Mountford et al., 1996; Jankovic et al., 1997; Arulandam et al., 1999; Park et al., 
2000; Stobie et al., 2000). This has led to the conclusion that IL-12 may be essential 
to sustain a sufficient number of memory and effector TH1 cells to mediate long-
term protection to an intracellular pathogen (Park et al., 2000; Stobie et al., 2000). 
TH1  cells can produce large amounts of TNF-a, which is crucial for immunity 
against S. typhimurium and in vivo neutralisation of YNF-a results in fatal infection 
(Mastroeni et al., 1991, 1992, 1993a; Gulig et al., 1997). It is believed to act 
synergistically with IFN-y (Nakano et al., 1990; Ramarathinam et al., 1993; 
Berbanou and Nauciel, 1994). IL-10, which is produced by a variety of cells, 
including T cells, is able to counter-regulate both the production of other cytokines 
and macrophage activation, and a correlation between bacterial load and serum 
levels of IL-10 was observed in Salmonella-infected susceptible and resistant mice. 
However, neutralising anti-IL-10 antibodies did not modify the course of infection. 
It was therefore suggested that IL- 10 is not involved in protection, but rather reflects 
severity of disease (Pie et al., 1996). Mice deficient in IL-4 production, a TH2 
cytokine, appeared to be more resistant to S. typhimurium than wild-type controls. 
They died later after infection with a wild-type strain of S. typhimurium and were 
less susceptible to infection with an attenuated strain. Furthermore, the mice failed 
to develop detectable lesions in the liver (Everest et al., 1997). 
There is also evidence for participation of CD8 T cells in immunity to S. 
typhimurium. CD8 T cells can differentiate into cytolytic T cells (CTL), and 
antigen-specific target cell lysis is regarded as one of the main tasks of CD8 T cells 
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(Kaufmann, 1988). Because S. typhimurium is a facultative intracellular bacterium, 
it is possible that lysis of infected cells by CTLs would release bacteria from their 
protective habitat, rendering them accessible for activated phagocytes. Granules of 
CTLs contain granulysin, a protein that has been shown to express direct 
antibacterial activity against a wide range of bacteria, including S. typhimurium 
(Stenger et al., 1998). Moreover, depletion of CD8 T cells has been shown to 
reduce the ability to transfer protection against virulent S. typhimurium (Nauciel, 
1990; Mastroeni et al., 1992). Also, it has been demonstrated that CD8 T cells can 
respond to bacterial structures that are conserved in different Gram-negative bacteria 
and presented by non-classical MHC class lb molecules, such as Qa-1 (Lo et al., 
1999). 
Limited information is available on the role of 73T cells in immunity to Salmonella 
infection. Mice of a susceptible background and deficient in 73T cells were able to 
control systemic infection with an attenuated strain of S. typhimurium (Hess et al., 
1996). However, c3T cells appear to be far more important for protective immunity 
against Salmonella infection (Mixter et al., 1994; Weintraub et al., 1997), but at sites 
where 76T cells represent a large fraction of T cells, such as the intestinal epithelium 
(Mixter et al., 1994), cells might gain some importance. 
Host immuno-suppression mediated by S. enterica 
In comparison to Listeria monocyto genes, eradication of S. typhimurium is rather a 
slow process. In normal mice, L. monocytogenes is eradicated between 7 and 10 
days, whereas it takes around 6 weeks to eliminate even an attenuated strain of S. 
typhimurium (Hess et al., 1996; Mittrucker and Kaufmann, 2000). This difference 
can at least partly be explained by the observation that S. typhimurium causes 
immuno-suppression, partially mediated by NO, which is produced by macrophages 
during infection (MacFarlane et al., 1999). Although T cell activation occurs during 
the early stages of infection, it is possible that the lymphocyte response is blocked 
by this suppression and so bacterial eradication is delayed (Mittrucker and 
Kaufmann, 2000). 
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1.7 IMMUNISATION STRATEGIES AGAINST S. ENTER/CA 
1.7.1 Introduction 
The following section will discuss the immunisation strategies developed against S. 
enterica infection and new directions towards elaborating new and effective 
vaccines against this pathogen. 
1.7.2 Methods of vaccination against Salmonella infection 
Three populations are at particularly high risk of developing typhoid fever and 
would benefit from immuno-prophylaxis with a vaccine. These include children in 
endemic areas (Ferreccio et al., 1984), travellers and military personnel from 
industrialised countries who visit endemic areas (Taylor et al., 1983), and clinical 
microbiology technicians (Blaser and Lofgren, 1981). 
Passive protection by means of antiserum or immunoglobulin is not used to prevent 
typhoid or paratyphoid fever. The typhoid vaccines that have been evaluated in 
clinical trials and the few that have been used as licensed vaccine products can be 
grouped in the following categories: (1) inactivated whole-cell parenteral vaccines, 
(2) subunit parenteral vaccines, (3) attenuated S. typhi strains as live oral vaccines. 
Currently used and commercially available typhoid vaccines include: (1) heat-
inactivated, phenol-preserved whole-cell parenteral vaccine (both liquid and 
lyophilised formulations and occasionally adsorbed to alum adjuvant), (2) acetone-
inactivated and dried whole-cell parenteral vaccine (lyophilised formulation), (3) 
purified (non-denatured) Vi polysaccharide parenteral vaccine, (4) attenuated galE, 
Vi-negative strain live oral vaccine Ty2 1 a. 
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1.7.3 Inactivated whole-cell parenteral vaccines 
The acetone-killed whole-cell human typhoid vaccine given subcutaneously has 
been in use for many years because preservation of the Vi capsular antigen made the 
vaccine more immunogenic and protective than the previously used heat-phenol-
killed vaccine that lacked the Vi antigen Jacket and Levine, 1995). However, this 
acetone-killed whole-cell vaccine did not elicit good cell-mediated immunity, had 
limited protection, low efficacy and excessive reactogenicity (Levine et al., 1989). 
Inactivated (heat-killed, phenol-preserved) S. typhi was utilised as a parenteral 
vaccine as far back as 1896 by Pfeiffer and Kolle in Germany and Wright in Great 
Britain. Wright administered his vaccine to troops embarking for the Boer War in 
South Africa and by the World War I, typhoid vaccination became virtually routine 
in the British Army (Plotkin and Orenstein, 1999). This heat-inactivated phenol-
preserved vaccine is by far the most widely available and utilised parenteral whole-
cell vaccine world-wide. The heat-inactivated (phenol-preserved) vaccine must be 
maintained in the cold chain to maintain potency, but the lyophilised version 
retained potency even after 12 weeks of storage at high temperatures and was still 
antigenic after 5 years of storage at 40C (Plotkin and Orenstein, 1999). 
With parenteral vaccines, the circulating antibody response is substantial and 
presumably provides the predominant protective effect. The most protective killed 
whole-cell parenteral vaccines stimulated the highest levels of H antibody, and a 
strain of S. lyphi that lacked the H antigen failed to confer significant protection 
(Wahdan et al., 1975) after inoculation with parenteral inactivated whole-cell 
typhoid. The H antibody response is initially 1gM and then becomes IgG (Kantele et 
al., 1991). These vaccines involve minimal mucosal secretory IgA antibody (Forrest 
et al., 1991; Nisini et al., 1993) and the cell-mediated response is not prominent 
(D'Amelio et al., 1988). However, effective immunity to S. enterica requires the 
development of a strong cell-mediated response and protection is short-lived with 
these vaccines (Collins, 1974; Chatfield et al., 1992). 
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1.7.4 Subunit parenteral vaccines 
Many attempts were made to prepare extracts and sonicates of S. typhi and to purify 
antigens for use as parenteral vaccines. The various subunit immunising agents 
(which in the 1960s were referred to as "chemical vaccines") that have been 
evaluated for efficacy include: freeze and thaw extract vaccines, trypsinised extract 
vaccines and purified lipopolysaccharide (LPS 0 antigen) vaccines (hot water-
phenol extraction method). Three major antigens have been identified: the capsular 
polysaccharide or Vi antigen, the 0 or somatic antigen (cell wall lipopolysaccharide) 
and the H or flagellar antigen. S. typhi is distinctive among the Salmonella spp. in 
possessing the Vi antigen composed of polygalacturonic acid, which is necessary for 
virulence (Hessel et al., 1999). The Vi antigen (named after its virulent properties in 
mice) physically prevents antibody binding to the 0 antigen and is also associated 
with inhibition of complement activation, lysis and phagocytosis (Robbins and 
Robbins, 1984; Looney and Steigbigel, 1986). Thus, the Vi antigen allows S. typhi 
to survive in the blood, leading to septicaemia. A report from a South African trial 
showed that over 3 years of follow-up, the single-dose Vi vaccine efficacy was 55% 
(Klugman et al., 1996) and depended solely on humoral immunity (Collins, 1974; 
Mastroeni et al., 1993). Purified Vi polysaccharide behaves like a T-lymphocyte-
independent antigen and the serum antibody response is not boosted by 
administration of additional doses of Vi vaccine. 
1.7.5 Attenuated S. typhi strains as live oral vaccines 
Attenuated live bacteria have played a major role in recent vaccine development, as 
they not only are attenuated to the level where they do not produce the disease, but 
also they persist in the host long enough to stimulate protective immunity. 
Attenuated Salmonella generate long-term protection and their efficacy over dead 
vaccines in mice reflects their ability to elicit both an antibody response and cell-
mediated immunity. The superior protection conferred in mice by live attenuated S. 
typhimuriuni vaccines correlates with a strong cellular T1 type response coupled 
with high levels of anti-LPS IgG2a antibodies. A number of attenuated S. typhi 
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strains were evaluated in early phases of clinical trials, but were abandoned from 
further development. 
Stocker and co-workers pioneered the use of auxotrophic mutants of Salmonella by 
transduction of an aroA : : Tn 10 lesion from the weakly pathogenic S. typhimurium 
LT2 into the fully virulent strain SL1344. The prototype aroA strains that also 
harboured deletion mutations in purA, were inhibited in their ability to proliferate, 
but remained viable. Hone and colleagues (199 1) made precise deletion mutations in 
aroC and aroD in wild-type parent Ty2 (the wild type from which Ty2 1 a was 
derived) resulting in the vaccine strain CVD908. This was the first engineered S. 
typhi vaccine that proved to be clinically well tolerated and highly immunogenic as a 
single-dose oral vaccine (Tacket et al., 1992a). CVD908 triggered strong cell-
mediated immune responses, including cytokine production(particularly IFN-'y) 
(Sztein et al., 1994). Because S. typhi are intracellular pathogens, the cytotoxic 
lymphocytes (CTLs) may limit the progression of infection by destroying host cells 
harbouring the bacteria, a fact proved by S. typhi CVD908 immunised individuals 
who exhibited CTL effectors in blood, capable of killing B lymphocytes infected 
with the wild-type S. typhi (Sztein et al., 1995). Chatfield and co-workers observed 
that inactivation of htrA, a gene encoding a stress protein that functions as a serine 
protease, attenuates wild-type S. typhimurium in mice (Chatfield et al., 1992a). They 
further reported that mice immunised orally with S. typhimurium harbouring a 
deletion mutation in htrA were protected against challenge with a lethal dose of 
wild-type S. typhimurium. Also, it has been recently shown that htrA mutants of S. 
typhimurium are more susceptible in vitro to oxidative stress than the wild-type, 
suggesting that the mutants may be less able to withstand oxidative killing within 
macrophages (Tacket et al., 2000). Based on these observations, an additional 
attenuating mutation was introduced into htrA of CVD908, resulting in strain 
CVD908-htrA that remains well tolerated and highly immunogenic (Levine et al., 
1995; Tacket et al., 1997). This supports further development of CVD908-htrA as a 
single-dose vaccine against typhoid fever and a possible live vector for oral delivery 
of other vaccine antigens. 
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Moreover, the S. typhi vaccine strain CVD909 was created from CVD908-htrA 
(Virlogeux et al., 1996), resulting in a constitutive expression of the Vi antigen, even 
under high osmolarity conditions. After single intra-nasal immunisation with 
CVD909, the vaccine strain proved to be well tolerated in mice and elicited serum 
IgG anti-Vi antibodies in addition to other humoral, mucosal and cell-mediated 
immune responses observed after immunisation with CVD908-htrA (Wang et al., 
2000). More extensive studies on CVD909 are in progress. 
Curtiss and co-workers constructed the vaccine candidate strain X3927, a cya, crp 
double mutant of S. typhi strain Ty2 (Curtiss and Kelly, 1987; Curtiss et al., 1994). 
This was insufficiently attenuated to serve as a live oral vaccine in humans because 
subjects developed high temperatures and typhoid-like symptoms (Tacket et al., 
1992). To achieve a greater degree of attenuation, it was introduced into X3927 a 
deletion mutation in cdt, a gene that affects the dissemination of Salmonella from 
gut-associated lymphoid tissue to deeper organs such as liver, spleen and bone 
marrow (Kelly et al., 1992). The resultant cya, crp, cdt triple mutant strain (X4073) 
was well tolerated given orally in single doses. 
Hohmann and colleagues constructed two candidate S. typhi strains harbouring 
deletions in phoP/phoQ: strain Ty800, a derivative of Ty2 deleted in phoP, phoQ, 
which was well tolerated and immunogenic (Hohmann et al., 1996), and strain 
Ty445 which harbours an additional deletion in aroA and was overly attenuated and 
minimally immunogenic (Hohmann et al., 1996a). In a search for further attenuating 
lesions, investigators (Sydenham et al., 2000) employed the TnphoA transposon to 
identify S. typhimurium derivations which are substantially attenuated in mice by the 
oral route of infection. One of these transposon mutants has an insert in the surA 
gene, a homologue that encodes a peptidyl-cis,trans-isomerase described initially in 
E. coli. The level of protection against challenge with the wild-type strain, following 
a single oral immunisation with the surA mutant, was comparable to levels reported 
for aro vaccines (Sydenham et al., 2000). 
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The attenuated live oral vaccine, which is currently available, is the galE-negative S. 
lyphi strain Ty2 1 a derived from the wild-type strain Ty2 by treatment with the 
mutagen N'-nitro-N-nitroso-guanidine (Germanier and Furer, 1975). Galactose 
residues are an important component of the smooth LPS 0-antigen and the enzyme 
encoded by the galE gene, UDP-galactose-4-epimerase, isomerises UDP-glucose to 
UDP-galactose (and viceversa), providing galactose residues for incorporation into 
the 0 antigen. Ty2 1 a exhibited complete loss of galE and lacked the Vi antigen. In 
the light of more recent data, it is recognised that the galE and Vi mutations in 
Ty2la do not explain the attenuation (Hone et al., 1988), but other mutations 
induced by chemical mutagenesis contributed to the diminished virulence. A 
mutation in rpoS (katF), which encodes an RNA polymerase sigma factor in 
particular, is thought to be important and this mutation diminishes the ability of the 
bacteria to survive a range of stress conditions (Robbe-Saule et al., 1995). Ty2la 
remains the most widely used vaccine at present and a liquid suspension formulation 
containing 2 to 10 x 109 c.f.u. of Ty2la has been licensed in several countries 
(Plotkin and Orenstein, 1999). 
For live attenuated oral vaccines, the circulating antibody response is modest, but 
vigorous, intestinal secretory immunoglobulin A (sIgA) and cell-mediated immune 
responses are believed to be responsible for the protection conferred. The mucosal 
IgA and systemic cell-mediated immune responses appear to be directed toward the 
0 and H antigens (Levine et al., 1989). The Vi is absent (Levine et al., 1990). The 
liquid formulation of Ty2la vaccine given in three doses conferred a high level of 
protection (96%) that persisted for the three years of surveillance (Wahdan et al., 
1982). Three doses of vaccine in enteric-coated capsules given at an interval of 
every other day, conferred 62% protection over seven years of follow-up and with 
very little adverse reactions (Ivanoff et al., 1994). 
New recombinant S. tphi strains as live oral vaccines 
There is an ambitious need to apply recombinant DNA technology in order to 
engineer new S. typhi vaccine strains that will be as well tolerated as Ty2la, but 
much more immunogenic so that protective immunity can be elicited with a single 
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dose. Most research has focused on S. typhimurium because of its amenability to 
genetic manipulation and also because it produces a comparable typhoid-like disease 
in susceptible mice (although they do not develop gastro-enteritis and lack 
symptoms of diarrhoea). It has been shown that several genetic lesions that attenuate 
S. typhimurium in the murine model were effective in attenuating S. lyphi in humans. 
Putative attenuated vaccine strains have been prepared by inactivating genes 
encoding various biochemical pathways, global regulatory systems, stress proteins, 
putative virulence properties, other regulatory genes. 
1.7.6 Future vaccines 
Subunit vaccines 
For practical use, subunit vaccines are usually preferred over live vaccines, as live 
vaccines present a greater risk of complications. New vaccines based on the subunit 
principle have been developed, e.g. the hepatitis B surface protein vaccine. 
Nevertheless, live vaccines are believed to be more effective in inducing cell-
mediated immunity because of protein synthesis by S. enterica in response to the 
host environment, and because of repeated antigen presentation (Kagaya et al., 
1992). It is likely that a combination of proteins capable of stimulating TH cells 
could be used as a protective vaccine. For example, the injection of S. typhimurium-
derived porins or a hydrogen peroxide-inducible catalase (KatG) into mice, was 
shown to induce DTH and antibody responses and to provide protective immunity 
against a subsequent challenge with the virulent strain S. typhimurium LT2 
(Udhayakumar and Muthukkaruppan, 1987; Kagaya et al., 1992). 
Although they are less reactogenic, subunit vaccines have a tendency to be less 
immunogenic than the live vaccines (Dertzbaugh, 1998). To enhance the 
immunogenicity of an antigen, an adjuvant is essential to elicit an appropriate 
immune response. The adjuvant enhances deposition and persistence of the antigen, 
recruiting inflammatory cells and altering the balance between THI  and T1-12 type of 
immune response (Gupta and Siber, 1995; Vogel, 1995; Gupta et al., 1996). For 
example, vaccination with purified recombinant Yersinia Hsp60 induced antibody 
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responses, but only weak T-cell responses. However, when IL-12 was used as an 
adjuvant, purified Y-Hsp60 induced significant Y-Hsp60-specific T-cell responses 
and protection against subsequent challenge with Yersiniae (Noll and Autenrieth, 
1996). Also, the incorporation of either IL-i 3 or TNF-a in aqueous or alum vaccine 
formulations enhanced antibody responses to a recombinant protein antigen (Rothel 
et al., 1998). 
DNA vaccines 
The discovery that plasmid DNA can be directly transfected into animals to elicit an 
immune response, has opened a new approach for producing vaccines (Dertzbaugh, 
1998). Plasmid vectors used for DNA immunisation must have an origin of 
replication (on) to permit transcription of plasmid DNA in a suitable prokaryotic 
host, the eukaryotic ori site is omitted to ensure that the plasmid does not persist in 
the vaccinee's cells and a selectable marker is included in the construct to help 
maintain the plasmid in the transformed prokaryotic host. The plasmid DNA 
expresses protection-inducing antigens and for high-level expression of the gene in 
the eukaryotic cells, the plasmid must possess an eukaryotic promoter upstream the 
gene. A transcriptional terminationlpolyadenylation signal sequence must also be 
located downstream of the gene (Ulmer et al., 1996; Dertzbaugh, 1998). 
Genetic immunisation has been successfully used to elicit long-lasting humoral and 
cellular immune responses (Kumar and Sercarz, 1996) to a multitude of bacterial, 
viral and protozoan antigens (Donnelly et al., 1997). Indeed, when mice were 
injected with plasmid DNA encoding a single mycobacterial antigen (either the 65-
kilodalton heat-shock protein Hsp65 or the major secreted mycobacterial antigen 
85A), they developed specific cellular and humoral immune responses to the protein 
and proved protective against subsequent challenge with Mycobacterium 
tuberculosis (Huygen et al., 1996; Tascon et al., 1996; Lowrie et al., 1997; Lozes et 
al., 1997), whereas immunisation with the protein proved ineffective. It has been 
recently shown that vaccination with plasmid DNA encoding the mycobacterial 
antigen 85A generated particularly specific THI  T-cell responses and CD8-mediated 
cytotoxicity (Denis et al., 1998) and that intramuscular DNA vaccination was the 
49 
method of choice (Tanghe et al., 2000). More recent attempts (Lefevre et al., 2000), 
using a plasmid encoding a 22-kDa protein normally present in the culture fluid of 
M tuberculosis, proved ineffective after analysis of humoral and cell-mediated 
immunity, and of protection against intravenous challenge with M tuberculosis 
H37Rv. 
Because DNA vaccines produce the immunising material in the host, this is 
processed and presented by both class I and class II MHC molecules. The result is 
that DNA vaccines raise both cytolytic T-cells and antibodies. Part of the 
effectiveness of a "naked" DNA vaccine may be due to the immunostimulatory 
effect of the bacterial DNA, which differs in the relative frequency of CpG 
methylation compared to vertebrate DNA (Dertzbaugh, 1998; Sydenham et al., 
2000). S. typhi OmpC porin has been tested as a DNA vaccine and elicited an 
antibody response, but CTL responses and further protection were not determined 
(Ulmer et al., 1996). There are several safety issues that must be considered 
concerning DNA vaccines, such as the ability of the plasmid to integrate into the 
genome of cell, to induce immunological tolerance and the risk of the plasmid 
inducing an auto-immune response to the host cell's DNA (Dertzbaugh, 1998). 
1.8 S. ENTER/CA COMPONENTS INVOLVED IN VIRULENCE AND 
IMMUNITY 
1.8.1 Introduction 
In the most general sense, any product that a bacterium synthesises, which enhances 
the growth or survival of a bacterium during its interaction with the host, can be 
considered a virulence factor and its corresponding coding sequence, a virulence 
gene (Mahan et al., 1996). Included in the broad category of virulence properties are 
adaptive responses to environmental stresses, which have been involved in the 
control of bacterial virulence gene expression. Groups of genes responding to given 
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environmental stresses can be considered virulence regulons even if their 
contribution to the infection process and pathogenesis remains relatively obscure. 
The expression of some virulence factors is activated shortly after introduction of 
the pathogen into the host, in order to maximise the chance of establishing a 
successful infection, while other non-virulence genes whose functions are 
inappropriate to this new environment, are quickly repressed (Mahan et al., 1996). 
Consequently, expression of certain virulence factors must be modulated in response 
not only to transition signals from the external source to the host, but also to other 
environmental signals encountered throughout the infection cycle. Pathogens 
encounter changes in temperature, osmolarity, oxygen tension, pH, and nutrient 
deprivation during infection. This section briefly describes S. enterica proteins 
involved in virulence and immunity and then is focussed mainly on GroEL structure, 
function, and its role in the immune reactions towards bacterial intracellular 
pathogens, such as S. enterica. 
1.8.2 Environmental signals implicated in virulence gene expression 
During the course of infection, Salmonella respond to a number of various signals, a 
process which allows its intracellular survival. For most pathogens to adapt and 
grow in the host, they must acquire iron. Thus iron plays a significant role in 
pathogenesis. Indeed, injection of iron compounds into the host has been shown to 
enhance the virulence of a number of bacterial pathogens, including S. typhimurium 
(Bullen and Griffiths, 1987). It has been proposed that polymorphonuclear 
leukocytes, in response to IL-I, release lactoferrin at the site of infection. Lactoferrin 
then binds iron at low pH, and subsequently it is taken up by macrophages, thus 
removing iron from the immediate environment (Mahan et al., 1996). 
Salmonella has evolved a specialised iron-binding ligand, termed enterobactin, to 
acquire iron necessary for their multiplication (Neilands, 1993). Enterobactin, part of 
a chromosomally encoded system, competes with the host iron-binding proteins 
(transferrin and lactoferrin) to secure the iron. The role of enterobactin production in 
S. typhimurium virulence is controversial (Mahan et al., 1996), whereas S. typhi 
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strains defective in enterobactin synthesis were attenuated and showed a decreased 
ability to grow in cultured cells (Furman et al., 1994). Other virulence factors are 
also induced in response to low levels of iron, and regulation by iron acquisition in 
Salmonella is mediated by the Fur protein, an important virulence regulator 
(Stojiljkovic et al., 1994). 
Invasiveness of S. typhimurium into cultured mammalian cells is repressed under 
conditions of high oxygen and induced under low oxygen (Schiemann and Shope, 
1991). A regulatory screen designed to search for invasion mutants which invade 
aerobically (normally repressing conditions), has resulted in the isolation of the 
hyperinvasion locus (hil) on S. typhimurium chromosome (Lee et al., 1992). This 
region contained invasion genes (invHFGEABC) and spa (surface presentation 
antigen) (Galan and Curtiss, 1989). 
Survival in acid may have clinical relevance, as enteric pathogens, such S. enterica, 
must pass through the stomach at a pH less than 3.0, for up to 2 hours before 
colonisation of the intestine. S. typhimurium harbours acid resistance mechanisms 
that contribute to its survival in the acid environment of the stomach and 
phagolysosome. The S. typhimurium PhoP/Q regulatory system is essential for full 
virulence (Miller et al., 1989) and is modulated by multiple environmental factors 
such as pH, phosphate, carbon, nitrogen, and oxygen (Behlau and Miller, 1993). 
PhoP/Q is required for (1) resistance to low pH (Fields et al., 1986), (2) invasion of 
mammalian cells (Behlau and Miller, 1993), (3) inhibition of macrophage vacuole 
acidification (pH 5.0) and spacious phagosome formation (Alpuche-Aranda et al., 
1992), (4) resistance to antimicrobial peptides (Fields et al., 1989), (5) macrophage 
survival (Fields et al., 1989), (6) regulation of magnesium transport (Garcia-Vescovi 
et al., 1996), (7) resistance to the action of bile (Van Velkinburgh and Gunn, 1999), 
and (8) secretion of proteins by a type III mechanism (Pegues et al., 1995). It has 
been shown recently that the PhoP/Q system is responsible for regulating several 
modifications of the LPS, a mechanism that is likely to be necessary for Salmonella 
intracellular survival by providing resistance to the host innate immune system and 
by altering the immune recognition of this pathogen (Gunn etal., 2000). 
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Galan and Curtiss (1990) have showed that the ability of S. typhimurium to invade 
cultured epithelial cells was significantly impaired when the bacteria were grown in 
a low osmolarity medium. OmpR and EnvZ form a two-component system that 
regulates the major outer membrane porins, OmpF and OmpC, in response to 
medium osmolarity (for review, Slauch and Silhavy, 1996). Dorman and colleagues 
(1989) have showed that insertion mutations in ompR strongly attenuated virulence 
of S. typhimurium in a mouse model. Insertion mutations in ompF or ompC alone 
did not affect virulence. However, strains containing mutations in both ompF and 
ompC were attenuated, although the effect was not as severe as that seen in an ompR 
mutant (Chatfield et al., 1991). Pickard and co-workers (1994) have showed that 
synthesis and not export of the Vi antigen in S. typhi was affected by osmolarity and 
mutations in ompR. 
Neutrophils and macrophages have several mechanisms to kill bacteria. These 
include the oxygen-dependent respiratory burst that generates superoxide anion (02) 
and hydrogen peroxide (H202) (Adams and Hamilton, 1984; Morel et al., 1991). 
Activated murine macrophages also produce nitric oxide (NO) (Vidal et al., 1993; 
Pacelli et al., 1995). Neutrophils from patients with chronic granulomatous disease 
are incapable of producing a respiratory burst. These patients have a high mortality 
rate from bacterial infections including S. enterica, suggesting that the respiratory 
burst is crucial in the defence against bacterial pathogens (Mahan et al., 1996). 
S. typhimurium has regulons designed to deal with the cytotoxic products produced 
during the respiratory burst, with a large number of proteins being induced by OxyR 
or SoxRS in response to H202 or 02, respectively (as reviewed in Demple, 1991). 
The OxyR protein activates transcription of approximately nine genes in E. coil in 
response to H202. These include katG encoding a HPI catalase, dps (DNA-binding 
protein from starved cells), and ahpCF encoding an NADPH-dependent alkyl 
hydroperoxidase. The latter protein will be discussed in more detail in the following 
sub-section of this chapter, as it has relevance to the experiments conducted in this 
study. The SoxRS regulon may also be important for survival in macrophages, but 
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its role in virulence may extend beyond protection against superoxide (Mahan et al., 
1996). It has been shown that the SoxRS regulon is also activated in response to NO 
produced by activated murine macrophages (Nunoshiba et al., 1993). SoxR and 
SoxS control the expression of approximately ten genes in response to certain redox-
cycling agents. These include transcription of sodA (superoxide dismutase), nfo, 
micF (Demple, 1991). 
The alternative virulence factor RpoS regulates a variety of genes in response to 
starvation in S. enterica, and several of these genes could be considered as encoding 
virulence factors (as reviewed in Hengge-Aronis, 1996). In S. typhimurium, rpoS 
null strains are more sensitive to starvation, H202, acid stress, and DNA damage. 
These strains also show a 1,000-fold increase in oral 50% lethal dose compared to 
the parent strain (Fang et al., 1992). 
Construction of strains carrying mutations in defined genes provides an important 
experimental strategy to analysing the role of individual proteins in bacterial 
virulence. Two groups of heat shock proteins have been studied extensively so far: 
DnaK and its functionally associated partners DnaJ and GrpE, and GroEL and its 
partner GroES. Failure to isolate null mutants in the groE genes suggest that these 
proteins are essential for survival (Fayet et al., 1989), and in the case of the DnaK 
group, although null mutants can be isolated at 300C, they have multiple severe 
growth defects (Paek and Walker, 1987). It is clear therefore that both of these heat 
shock protein groups perform important functions during normal growth at all 
temperatures. With regard to other heat shock proteins, it has been shown that 
mutations in the htrA gene result in attenuation of S. typhimurium (Chatfield et al., 
1992b; Baumler et al., 1994). 
Non-typhoid Salmonella strains that cause invasive diseases in humans and animals 
usually harbour a large (90-kb) virulence plasmid (Guiney et al., 1994). The primary 
function of the plasmid is to facilitate bacterial survival and proliferation in liver and 
spleen. The 8-kb plasmid region required for virulence is highly conserved and 
contains genes spvABCD. It has been shown that the spy operon in S. dublin was 
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significantly induced in stationary phase or in response to carbon starvation (Fang et 
al., 1991). Two regulatory factors play a crucial role in the control of spy. One is 
RpoS that governs the expression of various stationary phase-induced genes (Fang et 
al., 1992), and the second regulator is SpvR, which is encoded by the virulence 
plasmid and is regulated by RpoS (Spink et al., 1994). 
1.8.3 Role of Salmonella components in immunity 
Early studies on the antibody response to Salmonella in mice and humans were 
performed using immunoblots and ELISA (Brown and Hormaeche, 1989). Sera 
from mice infected with attenuated salmonellae, including an aroA live vaccine 
strain, recognised up to 45 different bands on immunoblots at the height of the 
response, including lipoprotein, OmpA protein, porins, heat shock proteins and 
flagella. Adsorbtion of antisera with intact or sonicated smooth or rough salmonellae 
prior to immunoblotting showed that antibodies were directed against exposed, 
masked and intracellular antigens. The LPS response was much stronger in 
susceptible mice. 
However, only a few S. enterica-derived components have been identified that can 
induce partial or full protective immunity against a virulent bacterial challenge. For 
example, when S. lyphirnurium outer membrane proteins (OMPs) were 
subcutaneously injected into BALB/c mice, 100% of the mice survived a lethal 
challenge and the protective immunity derived from the injection of the OMPs was 
maintained, with up to 70% of the immunised mice surviving the challenge after 6 
months (Udhayakumar and Muthukkaruppan, 1987). Also, the injection of a S. 
typhimurium-derived hydrogen peroxide-inducible catalase (KatG) has been shown 
to induce varying degrees of protective immunity in mice (Kagaya et al., 1992). A 
number of studies have shown that various S. typhimurium proteins are recognised in 
a TH1-regulated immune response. For example, DTH reactions have been elicited 
in mouse footpads following injections with proteins associated with pili and 
flagella (Gupta et al., 1996). KatE, the normal cellular catalase, was also shown to 
induce a DTH reaction in mice which were previously infected with S. typhimuriuni 
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yet, immunisation of mice with KatE failed to protect mice against a subsequent 
challenge with virulent organisms (Kagaya etal., 1992). 
Early studies were focussed on the protective immunity against S. typhimurium 
infection in mice immunised with porins from mutant strains of S. typhimurium 
(Matsui and Arai, 1990). A high level of protection against infection was achieved in 
mice immunised with native porins from S. typhimurium LT2 (wild-type strain), but 
not from S. typhimurium mutant strains, which produce recombinant porins. 
However, antisera raised against these porins showed no significant differences in 
antibody titre against LT2 porin or LT2 whole cells. On the other hand, mice 
immunised with the native LT2 porin, but not recombinant or heat-denatured LT2 
porin, exhibited significant levels of DTH reaction and IL-2 production when they 
were challenged with whole cells of S. typhimurium LT2. These findings suggest 
that the high level of protection induced by the native LT2 porin immunisation is 
dependent on the induction of cell-mediated immunity. Recent studies (Singh et al., 
2000) that have investigated the antigenic specificity of the humoral immune 
response to infection by S. typhimurium revealed that immune sera from S. 
typhimurium LT2-immunised mice recognise OmpC and OmpD porins and the LPS 
(0 antigen). 
Fimbriae play a critical role in virulence by allowing bacteria to interact with host 
cells and other solid substrates. As mentioned earlier, it has been shown that 
inactivation of fimbriae-encoding genes attenuates S. typhimurium virulence 
(Lockman and Curtiss, 1992; Baumler et al., 1996, 1996a). Immunisation of mice 
with purified SEF14 fimbrial subunits induced a delayed-type hypersensitive 
response in mice to whole S. enterica, demonstrating that these fimbriae are 
expressed in vivo and stimulate cell-mediated immunity (Ogunniyi et al., 1994). 
Moreover, pretreatment of mice with anti-SEF14 antibodies has shown to protect 
mice from S. enterica infection (Peralta et al., 1994). However, other studies on the 
virulence of sef mutants have shown conflicting results (Thorns et al., 1996; 
Ogunniyi et al., 1997). 
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Since its initial description a decade ago, the surface display of heterologous 
peptides fused to the Salmonella flagellin has been extensively explored as a 
potential vaccine approach (Newton et al., 1989). Parenteral inoculation of live 
Salmonella cells or purified hybrid flagellalflagellin subunits, demonstrated the 
induction of antigen-specific immune responses (Wu et al., 1989; Stocker, 1991; 
McEwen et al., 1992; Newton et al., 1995; Verma et al., 1995a; Luna et al., 1996). 
Moreover, it has been demonstrated that S. typhimurium flagella (STF) are powerful 
monocytic activators and potent inducers of proinflammatory cytokine production. 
The lipopolysaccharide (LPS or endotoxin) component of S. typhimurium has been 
initially correlated with the virulence of wild-type LT2 strain. It has been shown that 
mutants of LT2 with truncated polysaccharide portions of LPS exhibit reduced 
virulence. Moreover, polyclonal T cells and monoclonal T-cell hybridomas have 
been more reactive to heat-killed rough mutants than to heat-killed smooth strains, 
as measured by IL-2 production (Zirk et al., 1999). High concentrations of LPS 
associated with high bacteremia can lead to a severe form of enteric fever referred to 
as endotoxic shock. Many of the local and systemic pathophysiologic phenomena 
produced by LPS in the exposed host result from the ability of LPS to activate host 
inflammatory cells. 
Of interest to the experiments performed over the course of this study is the ahpCF 
locus on S. typhimurium genome, which was found to contain two genes that encode 
the subunits of alkyl hydroperoxide reductase (Tartaglia et al., 1990). Ahp protects 
the cell membrane from lipid peroxidation during exposure to hydrogen peroxide or 
alkyl peroxides (such as cumene hydroperoxide) (Christman et al., 1985; Tartaglia et 
al., 1990). The ahp locus is known to be regulated by the transcriptional activator 
OxyR. Previous work in our laboratory has shown that the ahp operon of S. 
typhimurium is a macrophage-induced locus (Francis et al., 1997). Moreover, Taylor 
and co-workers (1998) in the laboratory showed that loss of ahp or oxyR did not 
significantly alter S. typhimurium SL1344 virulence in BALB/c mice. However, 
both cell-mediated and humoral immune responses to AhpC were found to develop 
during the course of infection, probably through type 1 T helper cells (TH 1) 
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activation. The presence of anti-AhpC antibodies from S. typhimurium, was detected 
at days 14 and 28 post-infection, indicating that this protein was recognised as part 
of the developing humoral response. It has been also shown that S. typhimurium 
derived AhpC protein induces significant DTH responses 33 and 104 days post-
infection, suggesting that this polypeptide is recognised in the context of a T 1 
response. 
1.8.4 Heat shock proteins and the immune response 
Heat shock proteins (HSPs) occupy an important position in the complex web of 
host-parasite interactions. Interest in the antigenicity of HSPs was initially 
stimulated by reports that a highly immunoreactive 65-kDa protein of Mycobacteria 
had homology with a 60-kDa heat shock protein of E. coli. This protein was also 
shown to be related to a strongly immunoreactive antigen found in virtually all 
Gram-negative bacteria (Shinnick et al., 1988; Thole et al., 1988). It is now realised 
that HSPs play a role in the immune responses to many bacterial and parasitic 
pathogens, including the etiological agents of malaria, schistosomiasis, 
trypanosomiasis, filariasis, syphilis, tuberculosis, leprosy, legionnaires' disease, 
Lyme disease, and Q fever (Shinnick, 1991). From the perspective of the infected 
host, members of the highly conserved HSP protein families provide a major 
stimulus for humoral and cell-mediated immune responses, and HSPs may also have 
an important self-defence role in cells involved in the inflammatory response. 
1.8.5 Factors that influence immunogenicity of HSPs 
The immunoreactivity of HSPs raises questions as to why such highly conserved 
proteins should be the targets of an immune response. Possible explanations for this 
include that HSPs (1) are abundant cellular proteins, (2) have conserved epitopes 
that may prime the host for an immune response to these proteins, (3) may be 
preferentially processed for presentation due to either structural or functional 
features, and (4) may be virulence factors. 
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Abundance 
During the growth of E. coli at 370C, Hsp60 and Hsp70 account for approximately 
1.6% and 1.4% of total cell protein, respectively (Neidhardt et al., 1984). These 
proteins accumulate to even higher levels in bacteria undergoing stress. For 
example, Hsp70, Hsp60 and GroES can account for more than 15% of cell protein in 
heat-shocked cells (Neidhardt et al., 1984). 
The synthesis and accumulation of subsets of HSPs can be stimulated by anoxia, 
amino acid or glucose deprivation, and exposure to H202, ethanol, or heavy metal 
ions. The stress exerted on internalised parasites by phagocytes may induce 
increased HSP synthesis in such pathogens in an attempt to protect themselves from 
host effector mechanisms. Indeed, even in the absence of a heat shock, two of the 
most abundantly expressed proteins of S. typhimurium following phagocytosis are 
Hsp70 and Hsp60 (Buchmeier and Heffron, 1990a). Moreover, mutants of S. 
typhimurium that do not increase the expression of stress response proteins upon 
phagocytosis are less able to survive within macrophages and less virulent in vivo 
than wild-type strain (Buchmeier and Heffron, 1990a). 
Immunological priming 
Since HSPs are highly conserved, infection by one pathogen might prime the host 
for an immune response against these proteins upon infection with a second 
pathogen. This suggests that the immune reactions should be directed primarily 
against conserved epitopes. However, this does not seem to be the case for antibody 
responses. Although antibodies directed against both conserved and non-conserved 
epitopes of Hsp60 are found following bacterial infections, the antibody response to 
parasite Hsp70 seems to be predominantly directed against non-conserved epitopes 
(Shinnick, 1991). On the other hand, T cells that recognise either conserved or non-
conserved epitopes of the mycobacterial Hsp60 or Hsp70 homologues can be readily 
isolated (Shinnick, 1991). 
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Structural and functional considerations 
Although most bacterial HSPs appear to be located intracellularly, some members of 
the Hsp70 and Hsp60 families appear to be surface accessible (Gillis et al., 1985; 
Shinnick, 1991; Ensgraber and Loos, 1992; Dunn et al., 1997). Also, certain 
eukaryotic cells undergoing heat shock or other stresses can express HSPs, including 
Hsp60, on their surfaces or even secrete them (Koga et al., 1989; Jarjour et al., 
1989). Because of these features, HSPs can be efficiently processed and presented 
on the macrophage surface and, hence, become readily available for interaction with 
other components of the immune system. Two of the functions of HSPs may 
facilitate their processing and presentation. That is, members of the host Hsp70 
family have been suggested to play roles in targeting intracellular proteins for 
lysosomal degradation and in antigen presentation on the macrophage cell surface 
(Chiang et al., 1989). 
1.8.6 Members of HSP families as immunogens 
Immunoreactive proteins have been identified that show homology with members of 
various HSP families. 
The Hsp70 family 
Perhaps the most highly conserved and abundant of the HSPs is the Hsp70 family 
(reviewed in Lindquist, 1986). The amino acid sequence of the human Hsp70 has 
50% identity with that of the E. coli Hsp70, encoded by dnaK (Garsia et al., 1989). 
Members of the FIsp70 family have been shown to be antigens of several parasites 
and bacteria including M leprae, M tuberculosis, and M bovis BCG. These 70-kDa 
HSPs react strongly with antibodies in sera from infected individuals and 
experimental animals. These proteins are potent T cell antigens that can elicit a DTH 
response in infected individuals, and can stimulate lymphocytes proliferation and 
IFN-y production. Both conserved and non-conserved epitopes are immunoreactive 
(Pais et al, 1998). Hsp70 from Mycobacterium, Chiamydia, Borrellia and Legionella 
spp. have been recognised as common antigens in the immune responses to bacterial 
infection and in autoimmune diseases (Sampson et al., 1986; Anzola et al., 1992). 
Recent studies have revealed that bacterial Hsp70 modulates immunity by directly 
inducing cytokine mRNA production in macrophages (Retzlaff et al., 1994). 
1.8.7 The Hsp60 family 
The GroEL protein (Hsp60) is the focus of this study. Before describing its 
involvement in the immune responses directed against the intracellular pathogen 
Salmonella enterica, it is useful to discuss briefly its structure and function. 
Characterisation of GroEL at the genetic level 
In E. coli and in many bacterial species, the 60-kDa GroEL protein is encoded in a 
bicistronic operon with the other heat-inducible protein, the 1 O-kDa GroES (Wong, 
1992). M tuberculosis is an exception and contains a gene encoding a second 
GroEL molecule (Shinnick et al., 1988). 
Conservation of GroEL molecules 
GroEL is highly conserved in both prokaryotes and eukaiyotes. For example, the S. 
typhi GroEL is approximately 51% identical to that of the mouse mitochondrial 
homologue, and shares 75% identity with the M tuberculosis homologue (see 
Figure 1.2 for an alignment). This homology can be easily explained in terms of the 
likely endosymbiotic origin of mitochondria and chloroplasts (Mayhew and Hard, 
1996). 
Protein sequence analysis allowed Schmidt and collaborators (1992) to find 
considerable conservation, about 72 to 84% sequence similarity, between GroEL 
proteins from eight different eubacterial species. Also, there is a high 98.5% amino 
acid identity between GroEL molecules from S. typhi and E. coli (Lindler and 
Hayes, 1994). Very recent studies (Brocchieri and Karlin, 2000) have found that, 
after multiple alignment across 43 diverse Hsp60 sequences, the most conserved 
residues in terms of evolution, relate to the ATP/ADP and Mg 2+ binding sites, and 
hydrophobic residues interacting with the substrate. 
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Alignment of various GroEL sequences illustrates a tandemly repeated Gly-Gly-Met 
motif found at the carboxyl terminus. This is repeated three times for the B. subtilis 
GroEL and four times for both the E. coil and C. burnetii homologues (Li and 
Wong, 1992). Similar GGM motifs are also observed for most of the eukaryotic 
Hsp60 homologues. 
Localisation of GroEL molecules within bacterial cells 
While eubacterial GroEL and GroES are cytosolic proteins, homologues of GroEL 
and GroES are found in mitochondria and chloroplasts of eukaryotes (Mayhew and 
Hard, 1996). None of the bacterial GroEL proteins possesses a leader sequence or 
other recognisable motifs that would indicate a secretory role (Craig et al., 1993). 
However, Ensgraber and Loos (1992) found that incubating S. typhimurium cells at 
500C resulted in secretion of the 66-kDa Hsp into the supernatant. A growing 
number of reports indicate an extracytoplasmatic location for chaperonins (Vodkin 
and Williams, 1988; Scorpio et al., 1994), raising the possibility of unique 
mobilisation mechanisms specific for chaperonins and perhaps indicating novel 
biological functions for this highly conserved group of proteins. The recent 
description of chaperonin filaments (Trent et al., 1997) and a novel membrane-
stabilising lipochaperonin activity (Torok et al., 1997) have expanded chaperonin 
function beyond protein folding and assembly. Surface-exposed Hsp60 has been 
reported in Mycobacterium leprae (Gillis et al., 1985), S. lyphimurium (Ensgraber 
and Loos, 1992), and Helicobacterpylori (Dunn etal., 1997). 
In Legioneiia pneumophila, Hsp60 is predominantly associated with the cell 
envelope and this bacterium has been demonstrated to have a novel mechanism, not 
present in E. coil, for transporting Hsp60 to the periplasm and for releasing it once 
the pathogen is within host cells (Garduno et al., 1998). In Bordetella pertussis, 
Pseudomonas fluorescens, and Pseudomonas aeruginosa surface exposure has been 
inferred by experiments in which whole cells were used to remove cross-reactive 
I-Isp60 antibodies from a L. pneumophila Hsp60 antiserum (Plikaytis et al., 1987). 
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1.8.8 The structure of GroEL and GroES 
The structures of the GroEL oligomer and its various complexes have been 
determined by X-ray crystallography (Boisvert et al., 1996) and by electron cryo-
microscopy (Roseman et al., 1996). GroEL is a tetradecameric complex of identical 
57-kDa subunits. The oligomer has a double toroidal structure revealed by electron 
microscopic analysis, is cylindrical and is formed from two heptameric rings stacked 
back-to-back. Each ring encloses a central cavity and there are holes in the sides of 
the structure (Saibil et al., 1993). The central cavity of the cylinder, the proposed site 
of polypeptide binding, is 4 to 6 nm in diameter and can expand considerably upon 
binding of the GroES cofactor. 
GroES is a single heptameric ring of identical 1 O-kDa subunits (Chandrasekhar et 
al., 1986). The stoichiometry of the GroES 7-mer binding to the GroEL 14-mer, has 
been demonstrated to be 1:1 by both biochemical experiments and electron 
microscopy (Langer et al., 1992). The contact with GroEL is made through a 
flexible loop region in each GroES subunit (Landry et al., 1993) and occurs on only 
one side of the GroEL double toroid (Langer et al., 1992; Saibil et al., 1993). ATP 
binding induces a conformational change in the ring structure (Langer et al., 1992) 
and a change in the orientation of the outer domain with respect to the inner domain 
of each GroEL subunit (Saibil et al., 1993). 
1.8.9 Functions of the GroEL-GroES chaperone team 
GroEL and GroES are involved in folding of nascent chains, in the translation 
process itself (Gragerov et al., 1992; Horwich et al., 1993), in maintaining proteins 
destined to be secreted in a translocation-competent form (Kusukawa et al., 1989), 
and in refolding proteins after thermal damage (Ziemienowicz et al., 1993). In 
addition to their general role in protein folding, GroEL and GroES are involved in 
certain specific processes such as mutagenesis (Donnelly and Walker, 1989) and 
morphogenesis of some bacteriophage (Georgopoulos et al., 1972, 1973). 
Furthermore, these chaperones participate in general proteolysis (Straus et al., 1988). 
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Also, there is recent experimental evidence that indicates that GroEL interacts with 
lipid layers through its carboxyl terminus, increasing the molecular order of the 
layers (Erickson et al., 1987). Thus, it has been proposed that GroEL possesses a 
lipochaperonin activity that transiently stabilises membranes under stress. Recently, 
McLennan and Masters (1998) reported that GroEL is likely to have a role in the 
synthesis of diaminopimelic acid (DAP). They found that cells deprived of GroE 
have insufficient levels of DapA, the first enzyme in the DAP-synthesis, and so lyse 
because they fail to make cell walls. 
It has been shown very recently that E. coil GroEL interacts strongly with a well-
defined set of approximately 300 newly translated polypeptides, including essential 
components of the transcription/translation machinery and metabolic enzymes. 
About one third of these proteins are structurally unstable and repeatedly return to 
GroEL for conformational maintenance (Houry et al., 1999). Notably, proteins in 
their native states did not interact with GroEL. Evidence suggests that the preferred 
substrate of DnaK is an extended chain with hydrophobic residues, an early folding 
intermediate, whilst GroEL prefers a molten globule state that is a later intermediate 
(Landry et al., 1992). This suggests that DnaK and GroEL, at least in some cases, 
may act sequentially in the protein folding pathway. 
Morpho genesis of bacteriophages 
GroE proteins were originally identified as host genes necessary for bacteriophage 
T4 head assembly (Georgopoulos et al., 1972) and both GroEL and GroES are 
required for head assembly of phage ? (for review, see Friedman et al., 1984), tail 
assembly of T5 phages (Tilly and Georgopoulos, 1982), and both head and tail 
assembly of bacteriophage Mu (Grimaud and Toussaint, 1998). 
1.8.10 The GroEL-GroES reaction cycle 
In contrast to the actual mechanism of folding, the cooperation between GroEL and 
GroES, as well as the nucleotide exchange reactions that occur during a folding 
reaction (ATP hydrolysis) are well understood (Horovitz, 1998; Ranson et al., 1998). 
65 
Firstly, the unfolded polypeptide binds to the trans ring of GroEL, the ring distal to 
GroES in the asymmetric GroEL-GroES complex, thus forming a ternary trans 
complex. Secondly, the GroES-facilitated ATP binding at the distal ring to GroES, 
and the ATP hydrolysis in the GroES-bound ring, stimulate the release of GroES 
and then its rebinding to the polypeptide-bound ring, resulting in the encapsulation 
of the substrate in the cis cavity. In the presence of ATP, productive folding of the 
polypeptide substrate occurs in the cavity. Then ATP binding to the ring distal to 
GroES and also ATP hydrolysis in the GroES-bound ring, are followed by the 
release of the native polypeptide and GroES. Dissociation of ADP allows a new 
cycle to begin (Horovitz, 1998; Ranson et al., 1998). 
1.8.11 Immunogenicity of GroEL and GroES 
Unlike the case in many eubacteria (Hemmingsen et al., 1988), in eukaryotes Hsp60 
homologues are not part of bicistronic operons, and GroES homologues have not 
been described (Hemmingsen et al., 1988). 
An 10-kDa protein of M bovis BCG reacts with antibodies and T cells elicited by M 
tuberculosis and M bovis (Minden et al., 1984), and a similarly sized antigen of M 
leprae has been reported (Shinnick, 1991). Moreover, oro-gastric immunisation of 
mice with the GroES protein from Helicobacter pylori protected 80% of the animals 
against a subsequent challenge dose of 104  H. fells. The anti-GroES antibodies were 
predominantly IgG1 , suggesting TH2 immunity (Ferrero et al., 1995). Very recently, 
Kimmel and colleagues (2000) have identified GroES as one of the 29 proteins from 
H. pylon, which strongly reacted with sera derived from H pylon-infected patients. 
The HsplO antigen from Chlamydia trachomatis is recognised by a significant 
proportion of infected females and correlates with disease severity (Laverda et al., 
2000). It should be also noted that Coxiella burnettii homologue does not appear to 
be antigenic (Vodkin and Williams, 1988). 
Independent studies by Kaijser (1975) and Hoiby (1975) identified a 60-kDa protein 
as a cross-reactive antigen of E. coli and of Pseudomonas aeruginosa. This protein 
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was named "common antigen". Subsequent studies have shown that proteins cross-
reactive with the common antigen are present in virtually all bacteria. Moreover, it 
was realised that the highly immunoreactive 65-kDa proteins of M tuberculosis and 
M bovis BCG are the mycobacterial counterparts of common antigen (Shinnick et 
al., 1988; Thole et al., 1988: Young et al., 1988). 
The evidence that GroEL is a major immunodominant antigen comes initially from 
studies on Mycobacteria. The evidence includes that (1) antibodies and T cells that 
react with GroEL are easily isolated from sera of individuals infected with M 
tuberculosis or M leprae and (2) monoclonal antibodies to GroEL are frequently 
isolated from mice immunised with whole Mycobacteria or crude sonicates. An 
additional observation was that 20% of the Mycobacteria-reactive T cells in the M 
tuberculosis-immunised mice reacted with GroEL (Kaufmann et al., 1987). The 
humoral and cellular immune responses to GroEL are directed against both 
conserved and non-conserved epitopes. T cells can be isolated from tuberculosis 
patients as well as from apparently uninfected individuals, which cross-react with 
GroEL from E. coli, Mycobacteria spp., and humans (Munk et al., 1989; Lamb et 
al., 1989). Recent studies have revealed that bacterial GroEL can modulate 
immunity by directly inducing cytokine mRNA production in macrophages (Retzlaff 
et al., 1994). 
Previous work in our laboratory has also indicated that GroEL is highly 
immunogenic. In BALB/c mice, immune responses to S. enterica infection are 
mainly controlled by CD4 T helper cells of the TH1 subset (Thatte et al., 1993; 
Eckmann et al., 1996; Pie et al., 1997). The development of antibody responses to 
GroEL during the course of infection with S. typhimurium in mice, was determined 
by examining the serum from mice at 14 and 28 days post-infection. The antibody 
response to GroEL was of great magnitude and duration. Moreover, the S. 
lyphimurium-derived GroEL has been shown to induce significant DTH responses in 
mouse footpads 33 and 104 days post-infection (Taylor, 1997). 
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Role of yT cells 
In the peripheral blood of healthy individuals, 1-10% of the I lymphocytes express 
the y6T cell receptor (TCR) (Kaufmann and Kabelitz, 1991). In general, y5T cells 
lack both the CD4 and the CD8 molecules on the surface, although some of them 
have been shown to express the CD8 or, to an even lesser extent, the CD4 molecule 
(Roitt et al., 1998). Interestingly, yöT cells represent the major T cell type in the 
epithelia of skin, small intestine, reproductive organs and respiratory tract of mice 
(Kaufmann and Kabelitz, 1991), and perform an important surveillance role at these 
locations. They exhibit non-specific killer activity, but also exhibit similar functional 
activities to c43T cells (Kaufmann and Kabelitz, 1991). yöT cells respond against 
infection by intracellular bacteria, such as M tuberculosis, Listeria monocytogenes, 
S. enterica (Janis et al., 1989; Ohga et al., 1990; Emoto et al., 1992), and other 
pathogens. 
That heat shock proteins represent antigens for yT cells have been revealed by 
O'Brien and collaborators (1989) who found that many of their PPD-reactive yöT 
cell hybridomas were also stimulated by the mycobacterial Hsp60. It has been 
demonstrated that yT cells contribute to antimicrobial immunity by recognising 
bacterial HSPs. Very importantly, HSP-reactive yöT cells may participate in 
autoimmune diseases. The isolation of a yöT cell clone with reactivity to HSPs from 
the synovial fluid of a rheumatoid arthritis patient may be taken as evidence of this 
(Holoshitz et al., 1989). Analysis of the specificity of T cells against GroEL using 
synthetic peptides revealed that many T cells recognise epitopes that are identical 
with or highly similar to the GroEL homologue in the host (Munk et al., 1989; Lamb 
et al., 1989). Such shared epitopes could induce autoimmune diseases under certain 
conditions. 
The development of many autoimmune diseases has been etiologically linked to 
exposure to various infectious agents. For example, patients with a history of 
Salmonella infection have been shown to develop reactive arthritis. Lo and co-
workers (2000) have indicated the involvement of MHC class lb molecules in 
infection-induced autoimmune recognition and identified an immuno-dominant 
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epitope derived from the S. lyphimurium GroEL molecule. This epitope was 
presented by the mouse MHC class lb molecule Qa-1 and was recognised by CD8 
cytotoxic T lymphocytes induced after natural infection. Elevated IgG and IgA 
antibodies to recombinant Hsp60 and stress proteins from Mycobacteria spp. have 
been reported in patients with reactive arthritis, systemic lupus erythematosus 
(SLE), and Crohn's disease (IgA class only) (Winfield and Jarjour, 1991). Handley 
and collaborators (1996) have reported that auto-antibodies to human Hsp60 in sera 
from patients with reactive arthritis, SLE, Reiter's syndrome and active tuberculosis, 
are best inhibited by E. coil GroEL, suggesting that exposure to normal 
environmental bacteria expressing GroEL, such as the normal gut flora, may be 
responsible for the induction of most human Hsp60 auto-antibodies. However, anti-
human Hsp60 auto-antibodies were not indicative of the autoimmune disease in 
reactive arthritis and SLE, since they were found in similar titre in normal sera. 
1.9 PHAGE DISPLAY SYSTEMS AS VECTORS USED IN IMMUNISATION 
1.9.1 Introduction 
Peptides can be used to raise epitope-specific antibodies, but in general such 
peptides are poor antigens per se and need to be coupled to a larger carrier or 
supplemented with an adjuvant. Many efforts have been made to circumvent these 
problems by encoding the peptide in a viral genome, in the hope that the peptide will 
be presented more effectively to the immune system as part of a coat protein in the 
assembled virion. Early studies in this direction have used the vaccinia virus, a large 
DNA virus, which has a wide host range, and may be able to stimulate both humoral 
and cell-mediated immunity (Moss and Flexner, 1987). It has been extensively used 
in humans as an element of a vaccination program to eradicate small pox. It is 
important to distinguish between vehicles, such as bacteria and viruses, which can 
propagate in the host organism, from vectors, such as plasmids or phages, which 
cannot (Hofnung and Charbit, 1993). 
69 
1.9.2 Bacteriophages as phage display systems 
Bacteriophages offer obvious advantages over animal viruses for foreign epitope 
display. They are well understood at both the structural and genetic levels, and the 
viral particles themselves are highly immunogenic (Greenwood et al., 1991), 
therefore they could lead to cheap and effective vaccine development. In one such 
study a recombinant phage displaying a disease-specific protective B-cell epitope 
was used as a vaccine to confer protection against human respiratory syncytial virus 
infection in mice (Bastien et al., 1997). Also, phage particles displaying recombinant 
anti-idiotypic antibody ScFv (single-chain fragment-variable) polypeptides 
expressed on the phage have been used for maternal immunisation, protecting neo-
natal mice against streptococcal infection (Magliani et al., 1998). 
Greenwood and colleagues (1991) initially used filamentous bacteriophage fd to 
display small peptides of the major surface antigen from the malaria parasite, 
Plasmodium falciparum, as fusion proteins with the phage coat protein. Rabbits 
immunised with the hybrid fd bacteriophage developed specific antibodies against 
malaria epitopes in the fusion proteins and such antibodies predominated over 
antibodies directed against the wild-type coat protein itself. This proved that small 
peptides can elicit a strong and specific immune response. Subsequently, other 
investigators (Felici et al., 1993) used the filamentous bacteriophage fd for 
displaying Bordetella pertussis toxin epitopes, and immunising BALB/c mice. In 
this regard, the use of the phage library technology for vaccine development can be 
extended to any disease for which protective antibodies have been isolated, and 
especially to those cases where the epitope is discontinuous or has not been mapped 
(Felici et al., 1993). 
More recent studies have used the M13 filamentous phage to express foreign gene 
products fused to the phage coat proteins. Antibodies carrying antigenic peptides 
grafted into their complementarity-determining region (CDR) loops at the 
immunoglobulin heavy-chain variable (VH) region have been shown to be highly 
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immunogenic. With respect to this recent finding, Manoutcharian and collaborators 
(1999) have engineered a new type of immunogenic molecule by replacing all three 
CDR loops of the human immunoglobulin heavy-chain variable (VH) domain with 
the Taenia crassiceps epitope PT1 displayed on the surface of M13 bacteriophage. 
When BALB/c mice were immunised with such phage particles, a strong protection 
against challenge infection in very susceptible hosts was obtained, with induction of 
a TH1  response. Also, high levels of phage-specific antibodies were detected. The 
key advantage of this type of immunogen is that no adjuvant is required for its 
application and the proposed strategy for immunogen construction is potentially 
suitable for use in any host-pathogen interaction (Manoutcharian et al., 1999). 
Different immunisation routes have been employed in immunisation protocols using 
recombinant M13. Filamentous M13 phage displaying single epitopes of the 
glycoprotein G (gG2) of HSV-2 have been used as immunogens via the 
subcutaneous route in BALB/c mice without any additional adjuvant (Grabowska et 
al., 2000). The antibody response that developed to gG2 was dependent on the dose 
of phage administered, and mice were protected against a subsequent lethal 
challenge. Because the ability to survive the harsh environment of the stomach in an 
antigenically intact form is an essential requirement for oral vaccines, epitope-
displaying M13 bacteriophages have also been examined as vectors for an 
experimental oral vaccine (Zuercher et al., 2000). These bacteriophage induced anti-
epitope antibodies, whereas oral immunisation with the purified bacteriophage coat-
epitope fusion protein, induced anti-phage antibodies, but no anti-epitope antibodies. 
Therefore, there is evidence that epitope-displaying bacteriophages can be used to 
induce an epitope-specific antibody response via the oral route. All these 
considerations suggest a possible role for phage-displayed peptides as a means for 
inducing protective immunity against pathogens. 
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1.9.3 T7 bacteriophage 
General characteristics 
One of the original Type phages isolated independently by Demerec and Fano in 
1940s, T7 is now considered the prototype of a group of virulent phages that are 
classified as the "T-like phages" within the Podoviridae family. These also include 
coliphage T3, Salmonella phage SP6, and Kiebsiella phage Ku. Members of this 
genus have double stranded DNA genomes, tailed polyhedral capsids and lytic 
replication cycle. They share characteristic features of virion morphology, genome 
organisation and replication strategy (Molineux, 1999). 
T7 structure and assembly 
T7 is an icosahedral phage with a capsid shell composed of 415 copies of the T7 
capsid protein, encoded by gene 10. The capsid proteins are arranged as 60 
hexamers on the faces of the shell and 11 pentamers at the vertices (Steven and Trus, 
1986). Attached at the remaining vertex is the head-tail connector, encoded by gene 
8, a short conical tail, encoded by genes 11 and 12, and 6 tail fibres, encoded by 
gene 17. Linear double stranded DNA is packaged into the capsid and has been 
extensively studied (Dunn and Studier, 1983; Steven and Trus, 1986). Phage 
assembly takes place inside the E. coli cell and mature phages are released by cell 
lysis. 
T7 as a protein display system 
T7 has been modified as a protein display system and is currently available as part of 
a kit from Novagen Inc. T7 has various properties that make it an attractive display 
vector. Unlike the filamentous systems, peptides or proteins displayed on the surface 
of T7 do not need to be capable of secretion through the cell membrane, a necessary 
step in filamentous phage assembly (Russel, 1991). It is very easy to grow, and 
replicates more rapidly than filamentous phages. Plaques form within 3 hours at 
370C and cultures lyse 1-2 hours after infection. The T7 phage is extremely robust 
and is stable to many harsh conditions that inactivate other phage. The phage 
maintains infectivity after treatment with 1% SDS, 4M urea or 2M guanidinium 
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chloride, 10 mM EDTA, 0.1 M dithiothreitol (DTT), and alkaline conditions (pH 
range from 4.0 to 10.0). The phage is not stable at low pH (below pH 4.0) 
(Molineux, 1999). T7 is an excellent general cloning vector. Purified DNA is easy to 
obtain in large amounts, a high efficiency in vitro packaging system is available and 
the DNA is completely sequenced (39,937 bp). 
The capsid protein is normally made in two forms, 1OA (344 amino acids) and lOB 
(397 amino acids). lOB is produced by a translational frameshift at amino acid 341 
of 10A, and makes about 10% of the capsid protein (Condron et al., 1991). 
However, functional capsids can be composed entirely of either IOA or lOB, or of 
various ratios of the proteins (Novagen Inc., USA). This finding provided the initial 
suggestion that the T7 capsid shell could accommodate variation, and that the region 
of the capsid protein unique to lOB might be on the surface of the phage and could 
be used for phage display. The frameshifted C-terminal extension of lOB protein is 
exposed on the outer faces of the icosahedral capsid, but it is not essential for phage 
growth. Cloning sites have been introduced at the 3' end of the modified gene lOB. 
Foreign carboxyl terminal extensions as long as 1,200 residues may replace the 
natural carboxyl terminal extension of lOB, and use of a complementing plasmid 
that supplies 1OA is required for phage assembly. Therefore, foreign proteins are 
displayed on the phage surface at an average copy number of 0.1 to 1.0 per phage 
particle. Note that the large recombinant lOB protein presents a problem for phage 
expression/packaging. For short peptides, different T7 strains are available, which 
express a larger copy number of the recombinant lOB protein. 
1.9.4 Project aims 
It is well known that bacterial GroEL, which belongs to the major Hsp60 family, 
displays a high degree of genotypic and phenotypic homology among various 
microorganisms, and is an immunodominant antigen able to elicit a strong Immoral 
and cellular immune response (Peetermans et al., 1995). GroEL has frequently been 
found to be an immunodominant molecule of intracellular pathogens, such as S. 
enterica. Previous studies have used purified GroEL molecules as immunising 
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agents and it has been found that they were able to induce antibody and cell-
mediated immune responses along with protective immunity against a subsequent 
challenge with the original infectious agent from which they were isolated (Noll and 
Autenrieth, 1996). Also, it has been found that, when mycobacterial GroEL was 
conjugated with synthetic peptides and administered to mice in the absence of any 
adjuvant, high titres of anti-peptide IgG antibodies were induced in mice previously 
primed with live M bovis BCG (Lussow et al., 1991). There is evidence that GroEL 
covalently linked to antigens are potent agents enhancing serum antibodies and 
CD4 T cell proliferative responses when administered by the systemic route, as well 
as secretory IgA and IgG antibodies given by the mucosal route. Therefore, bacterial 
GroEL molecules may function as natural adjuvants generating 13-chemokines in the 
host (Lehner et al., 2000). 
GroEL from S. lyphimurium also has been found to be immunogenic in previous 
studies performed in our laboratory. The development of antibody responses to 
GroEL during the course of infection of mice with S. typhimurium, was determined 
by examining the serum at 14 and 28 days post-infection. The antibody response to 
GroEL was of great magnitude and duration, with substantial antibodies present 
even after 14 days. Moreover, the S. typhimurium-derived GroEL has been shown to 
induce significant DTH responses in mouse footpads 33 and 104 days post-infection, 
suggesting that this protein is recognised in the context of a TH 1 response (Taylor, 
1997). 
Early studies (Inchley, 1969; Inchley and Howard, 1969) showed that bacteriophage 
T4, when administered to mice without any adjuvant, was rapidly cleared from the 
circulation and was capable of inducing an antibody response. The initial 
exponential phase of the normal antibody response to T4 was completed by 7-10 
days after immunisation and thereafter there was a relatively little increase in titre, 
with the antibody level maintained for up to 5-10 weeks in a dose-dependent 
manner. 
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Later, bacteriophages were used as expression vectors in which foreign gene 
products were fused to coat proteins and displayed on the surface of the phage 
particles. Subsequently, the high immunogenicity of these recombinant 
bacteriophages has been proved in different animal systems and production of 
antibodies against the foreign peptide overexpressed onto the phage capsid has been 
reported. Using such an approach, one of the objectives of this study is to clone the 
groEL fragment from S. typhimurium into bacteriophage T7 genome in such a way 
that the protein is expressed on the surface of the phage as a hybrid to coat protein 
lOB. The phage is then infected into an E. coli strain in order to amplify the hybrid 
phage. Subsequently, the purified recombinant phage expressing the S. typhimurium 
GroEL on its surface is used as an immunising agent in mice, without the co-
administration of any adjuvant, to raise antibodies against GroEL from S. 
typhimurium. Using this strategy, the T7 bacteriophage is studied for its potential as 
a vector for immunisation against S. enterica infection in a mouse model. As part of 
this process, the sequence of S. typhimurium groEL gene was undertaken. 
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CHAPTER 2 
Materials and methods 
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2.1 MATERIALS 
2.1.1 Enzymes, chemicals and DNA maninulations 
Chemicals and enzymes were purchased from a range of suppliers. Restriction 
enzymes were used according to manufacturers' instructions. DNA manipulations 
were carried out as described by Sambrook and co-workers (1989) unless otherwise 
stated. Rabbit anti-GroEL antibodies were supplied by Sigma, UK. Anti-mouse, 
anti-rabbit and anti-goat antibodies were provided by SAPU (Lanarkshire, UK). 
Stabilised solutions of [o-32P]-dCTP (3,000 Ci/mmol) and [35S]-methionine  (1,175 
Ci/mmol) were purchased from Amersham International Plc. (Buckinghamshire, 
UK), and ICN Pharmaceuticals Inc. (California, US), respectively. Synthetic 
oligonucleotides were purchased either from PE-Applied Biosystems (Cheshire, 
UK) or Sigma - Genosys Ltd. (Cambridgeshire, UK) and are listed in Table. 2.1. 
Plasmids and bacterial strains and also their sources are shown in Tables 2.2 and 2.3. 
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Table 2.1 - O1igonuceotides used during the course of the present study. 
Numbers shown refer to the position at which each of the primers lay with respect to the published 
sequence; the codes written in parentheses represent GenBank accession numbers; ahpCF (J05478), 
Tartaglia et al., 1990; groEL (U01039) from S. typhi, Liridler and Hayes, 1994; groESL (X07850) 
from E. coli, Hemmingsen et al., 1988; genome of bacteriophage T7 (V01146), Dunn and Studier, 
1983. 
Name Oligonucleotide sequence Comments and usage 
GroEL53 PCR 	of 	the 	S. 
1-18 5 '-CCGAATTCGATGGCAGCTAAAGACGTA3' typhimurium groEL 
(U01039) EcoRI fragment (5'-3') 
PCR 	of 	the 	S. 
GroH3TTA 5 '-TCACAAGCTTACATCATGCCGCCC3' typhimurium groEL 
2117-2102 HindIII fragment (3'-5') 
(X07850)  
GroELI Sequencing 	of 	the 	S. 
893-910 5'- GTACCGTGATCTCTGAAG-3' typhimurium groEL 
(X07850)  fragment (5'-3') 
GroEC17131 Sequencing 	of 	the 	S. 
1062-1044 5'-TCAATCTGCTGACGGATC-3' typhimurium groEL 
(X07850) fragment (3'-5') 
GroELrev Sequencing 	of 	the 	S. 
222-242 5 '-GCTTTAGAGGCAACTTCTTTC-3' typhimurium groEL 
(X07850)  fragment (3'-5') 
T7SelectUP PCR 	of 	the 	region 
21457-21476 5'-GGAGCTGTCGTATTCCAGTC-3' surrounding the multiple 
(V01146) cloning site in T75e!ectl- 
I System (5'-3') 
T7Select PCR 	of 	the 	region 
DOWN 5'-TTGGGGAGTTCTGGGCAAAT-3' surrounding the multiple 
21563-21582 cloning site in T7Selectl- 
(VO1 146)  1 System (3-5') 
SPHI-ANT1739 Sequencing 	of 	the 	S. 
503-479 5 '-ACATGCATGCTGTCGAAGTTACGG-3' typhimurium ahpC 
(J05478) fragment (3'-5') 
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Table 2.2 Table showing all the plasmids and their derivatives mentioned in this 
thesis. 
Shown is a list of plasinids and their derivatives used in this study. Codes written in parentheses are 
GenBank accession numbers. 
Plasmid Relevant features Source! 
Reference 
pBR325 pBR322 derivative, carries the CmIR  gene from phage P1 in which Bolivar, 1978; 
(L08855) the unique EcoRI site is located. Blank and 
Amp',_Tei',_CrnIR Wilson, 1982 
pBR325 derivative containing an EcoRI/HindlIl groEL fragment This study 
pIBi of approximately 1.6 kb, subcloned from S. typhimurium SL1344 (Figure 3.4) 
chromosome by PCR; AmpR, TetS, CmlS  
pAR5615 pAR5615 carries the gene for the T7 capsid protein bA, under the Novagen Inc., 
control of the lacUV5 promoter; AmpR USA 
pUCI8 derivative containing a polylinker/lacZa region flanked by 
pTfQl 8 the Ptac promoter and the rrnB transcription terminator, tarP; Stark, 1987 
Amp' 
pIB2 pTTQ18 derivative containing a EcoRI/HindIII groEL fragment This study 
subcloned_  from _pIB 1;_  Amp R (Figure 3.6) 
Table 2.3 Table showing all the Escherichia coli and Salmonella typhimurium 
strains and their derivatives, used during the course of this study. 
Genotype Source/Reference 
Bacterial strain  
E. coli 
80dlacZAM15, recAl, endAl, gyrA96, thi-1, 
DH5cx hsdRl7 (rK, MK'),  supE44, re/Al, deaR, Hanahan, 1983 
A(1acZYA-argE)U 169  
DH5c (pBR325) AmpR TetR Cml' N. Holden 
DH5rr (pIB 1) Amp' TetS Cm1S This study 
endAl, recA], gyrA96, thi, hsdRI7(rK , MK'), 
JM109 relAl, supE44, A(lac-proAB), [F', traD36, Yanisch-Perron et al., 
proAB, IacPZAM]5] 1985 
JM1O9 (pTTQ18) Al  Stark, 1987 
JM109 (pIB2) Amp  This study 
pAR5615 (AmpR);  pAR5615 carries the gene 
BLT5615 for the T7 	capsid protein 	bA, 	under the Novagen Inc., USA 
control of the lacUV5 promoter 
S. typhimurium 
SL1344 his; highly virulent wild-type mouse pathogen Hoiseth and Stocker, 
1981 
2.1.2 Media 
All media was sterilised by autoclaving unless otherwise stated. 
Luria - Bertani (LB) medium and agar 
LB medium consisted of bacto-tryptone (10 g; Difco Laboratories GmbH, 
Germany), yeast extract (5 g; Difco Laboratories GmbH, Germany) and NaCl (10 g) 
dissolved in 1 litre of dH20. LB agar was formed by adding 15 g/l bacto-agar (Difco 
Laboratories GmbH, Germany) prior to autoclaving. 
Terrific Broth (TB) 
1 litre of TB consisted of bacto-tryptone (12 g; Difco Laboratories GmbH, 
Germany), yeast extract (24 g; Difco Laboratories GmbH, Germany) and 4m1 
glycerol dissolved in deionized water. 
Soc medium 
1 litre of soc broth (pH 7.0) was made from bacto-tryptone (20 g;  Difco 
Laboratories GmbH, Germany), yeast extract (5 g; Difco Laboratories GmbH, 
Germany), NaCl (0.5 g), KC1 (0.186 g), MgCl2 (2.033 g), and glucose (3.6 g). 
YT medium 
YT low-salt medium consisted of bacto-tryptone (10 g;  Difco Laboratories GmbH, 
Germany), yeast extract (5 g; Difco Laboratories GmbH, Germany) and NaCl (5 g) 
dissolved in 1 litre of dH20. 
M9 minimal agar 
300 ml of 15 g/l bacto-agar (Difco Laboratories GmbH, Germany) in dH2O was 
autoclaved for 20 minutes and then allowed to cool down to so°c. It was then 
mixed with 100 ml of 4-fold concentrated M9 salts, 8 ml 20% (w/v) glucose and 0.4 
ml 1M thiamine.HC1. 
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LC top agar 
LC top agar consisted of bacto-tryptone (10 g; Difco Laboratories GmbH, 
Germany), yeast extract (5 g; Difco Laboratories GmbH, Germany), NaCl (5 g) and 
bacto-agar (7 g; Difco Laboratories GmbH, Germany) dissolved in 1 litre of dH2O. 
The pH was adjusted to pH 7.0. 
M9LB medium 
M9LB medium was prepared from 4-fold concentrated M9 salts (25 ml), 20% (wlv) 
glucose (2 ml), 1M MgSO4 (0.1 ml) dissolved in 100 ml LB broth and sterilised by 
autoclaving. It was used to grow T7 lysates. 
2.1.3 Solutions 
All solutions were made up in dH20 (unless otherwise stated) and sterilised by 
autoclaving at 15 pounds per square inch for 20 minutes prior to use. Heat labile 
components were filter-sterilised through 0.45 jtm sterile filters (Pall Gelman 
Laboratory, USA ) and then added to the initial solution after it was autoclaved. 
M9 salts 
4-fold concentrated M9 salts were prepared from NH4C1 (4 g), KH2PO4 (12 g) and 
Na2HPO4 x 71-120 (24 g) dissolved in 1 litre dH20. 
Tris.HC1 
Tris base (tris [hydroxymethyl] aminomethane) was dissolved to the desired 
molarity in dH20 and the pH was adjusted to the required value by addition of 
concentrated HC1. 
PBS 
Phosphate buffered saline (PBS), pH 7.4, was prepared by dissolving 1 tablet of PBS 
(800 mg NaCl, 20 mg KC1, 144 mg Na2HPO4, 24 mg KH2PO4) in 100 ml dH2O. 
TflT A 
EDTA (ethylenediaminetetraacetic acid, di-sodium salt) was dissolved in dH20 to a 
concentration of 0.5 M and was adjusted to p1-I 8.0 by addition of NaOH. 
TE buffer 
1 litre of buffer contained 10 mM Tris.HC1 (pH 8.0) and 1 mM EDTA in dH20. 
lOx TBE buffer 
1 litre of buffer contained 0.9 M Tris.HCI (pH 7.5), 0.9 M boric acid and 0.02 M 
EDTA dissolved in dH20. 
Ethidium bromide 
A stock solution of ethidium bromide was dissolved in dH20 at a concentration of 
10 mg/ml and stored at room temperature in the dark. 
6x DNA loading buffer 
6x loading buffer for nucleic acid gel electrophoresis consisted of a 40% (w/v) 
sucrose solution, with 0.25% (w/v) bromophenol blue, in dH20. 
GTE buffer 
GTE buffer used for preparation of plasmid DNA contained 25 mM Tris.Cl (pH 
8. 0), 50 mM glucose and 10 mM EDTA (pH 8.0). It was stored at 40C. 
STEP solution 
Freshly prepared STEP solution, used for genomic DNA extraction, contained 0.5% 
(w/v) SDS in dH20, 50 mM Tris.HCI (pH 7.5), 0.4 M EDTA and 1 mg/ml 
proteinase K. 
3M sodium acetate 
40.824 g sodium acetate were dissolved in 80 ml dH20, the pH was adjusted to 5.2 
with glacial acetic acid, and then the volume was adjusted to 100 ml with dH20. 
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Potassium acetate (— pH 4.8) 
To 60 ml of 5 M potassium acetate were added 11.5 ml of glacial acetic acid and 
28.5 ml dH20. The resulting solution was 3 M with respect to potassium and 5 M 
with respect to acetate and was used for preparation of plasmid DNA. 
IPTG 
A 0.1 M stock solution was prepared by dissolving 1.2 g isopropyl f3—D-
thiogalactopyranoside (IPTG) in 50 ml dH20. The solution was filtered and then 
stored at 40C in a dark bottle. 
A stock solution of X-Gal was prepared by dissolving 200 mg 5-bromo-4-chloro-
indolyl-3-D-galactoside (X-Gal) in 10 ml dimethylformamide in a dark bottle and 
then stored at —200C. 
RNase A (DNase-free) solution 
A stock solution of 10 mg/ml pancreatic RNase A (from Sigma,UK) in 0.1 M 
Tris.HCI (pH 7.5), 0.015 M NaCl, was prepared by boiling the mixture for 15 
minutes and then cooling it down to room temperature. Aliquots were stored at - 
20°C. 
Tris - buffered phenol 
Tris - buffered phenol was obtained by mixing equal amounts of water-equilibrated 
phenol (from Sigma, UK) and 1 M Tris.HC1 (pH 8.0), agitating vigorously and 
allowing the phases to separate. The process was repeated a further 2 times using 0.1 
M Tris.HC1 (pH 8.0). The buffered phenol was dispensed in 10 ml volumes and 
stored at 40C in light tight bottles for no longer than 2 weeks. 
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Tris buffered saline (TBS) 
Tris buffered saline was prepared by dissolving 4.84 g Tris base and 58.48 g NaCl in 
1.5 L dH20. The pH was adjusted to 7.5 with concentrated HC1 and then the solution 
was made up to 2 L. 
Tween - Tris buffered saline (T-TBS) 
T-TBS was prepared by dissolving 0.5 ml polyoxyethylene sorbitan monolaurate 
(Tween 20) in 1 litre of TBS (pH 7.5). 
I 00 Denhardt's solution 
Ficoll 400 (10 g), polyvinylpyrrolidone (10 g) and bovine serum albumin (10 g) 
were dissolved in a total volume of 500 ml dH20. The solution was stored at —200C 
and used for in situ hybridisation experiments. 
20x SSC solution 
175.3 g NaCl and 88.2 g sodium citrate were dissolved in 80 ml dH20, the pH was 
adjusted to 7.0 with 10 M NaOH and then the volume was made up to 1 litre with 
dH20. The solution was used for in situ hybridisation experiments. 
Antibiotic solutions 
All antibiotic solutions were used as indicated in Table 2.4. Aqueous solutions were 
filter sterilised prior to use and were all stored at —200C. Tetracycline solution was 
covered with foil. 
Table 2.4 Antibiotics used during this investigation. 
Antibiotic Solvent Stock concentration Final concentration 
Ampicillin dH20 10 Mg/Ml 100 .tg/mI 
Carbenicillin dH-,O 100 Mg/Ml 50 tg/mJ 
Tetracycline 70% Ethanol 5 mg/ml 10 p.g/ml 
Chioramphenicol Ethanol 34 mg/ml 25 ig/ml 
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2.1.4 DNA molecular weight markers 
The position of DNA samples in the agarose gel was estimated in relation to DNA 
molecular weight markers. For sizing of a broad range of fragments (from 23,130 bp 
to 564 bp) and for approximate quantitation, the DNA molecular weight marker II 
set (from Boehringer Mannheim, Germany) was used, containing 7 bands of 
bacteriophage lambda (X) DNA digested with Hindlil endonuclease (23,130 bp, 
9,416 bp, 6,557 bp, 4,361 bp, 2,322 bp, 2,027 bp and 564 bp). For sizing of a lower 
range of DNA fragments (from 1,500 bp to 100 bp), the 100 bp DNA ladder from 
New England BioLabs was used (1,500 bp, 1,200 bp, 1,000 bp, 900 bp, 800 bp, 700 
bp, 600 bp, 500 bp, 400 bp, 300 bp, 200 bp, 100 bp). 
2.1.5 Protein molecular size markers 
Molecular weight standard markers (normal and ['4C]-methylated)  for SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) of proteins are indicated below in 
Tables 2.5, 2.6 and 2.7. 
Table 2.5 Molecular weight markers (MW-SDS-70L, Sigma, UK) used for SDS-
PAGE. 
Protein standard Molecular weight (Da) 
Albumin (bovine) 66,000 
Albumin (egg) 45,000 
Glyceraldehide-3-phosphate dehydrogenase (rabbit muscle) 36,000 
Carbonic anhydrase (bovine erythrocytes) 29,000 
Trypsinogen (bovine pancreas) 24,000 
Trypsin inhibitor (soybean) 20,100 
a-Lactalbumin (bovine milk) 14,200 
Table 2.6 - Molecular weight markers (SDS-6H, Sigma, UK) used for SDS-PAGE. 
Protein standard Molecular weight (Da) 
Myosin 205,000 
3-Galactosidase 116,000 
Phosphorylase B 97,000 
Bovine Serum Albumin 66,000 
Ovalbumin 45,000 
Carbonic Anhydrase 29,000 
Table 2.7 - Rainbow [14C]-methylated  (4 /tCi/ml) protein molecular weight markers 
(Amersham, UK) used for SDS-PAGE. 
Protein standard Molecular weight (Da) 
Ovalbumin 46,000 
Carbonic Anhydrase 30,000 
Trypsin Inhibitor 21,500 
Lysozyme 14,300 
Aprotinin 6,500 
Insulin (b) Chain 3,400 
Insulin (a) Chain 2,350 
2.2 METHODS 
2.2.1 Manipulation of bacteria and phage 
Growth of bacterial cultures 
Cultures of S. typhimuriurn and E. coli were grown in LB, with antibiotic when 
appropriate, unless otherwise stated. Cultures were inoculated from a single bacterial 
colony and grown at 370C with shaking (300 rpm). Larger cultures were prepared by 
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diluting an overnight culture 100-fold in conical flasks, with an overall capacity 5-
10-fold that of the culture volume, under the growth conditions stated above. 
Storage of bacterial cultures 
For long-term storage of bacterial cultures, a 1 ml volume of an overnight culture 
was mixed with 75 t1 of dimethyl sulphoxide (DMSO) and stored in a sterile 
cryovial at -800C. For short-term storage (4-6 weeks), bacteria were stored as streaks 
on LB-agar plates at 40C. 
In vitro packaging of T7 recombinant phage 
In vitro packaging of ligation reactions was carried out with the T7 Packaging 
Extract, as described by the suppliers (Novagen , USA). Basically, the T7 Packaging 
Extract (25 j.iI) was thawed on ice and 5 jil ligation reaction was added. The sample 
was mixed gently by stirring with a pipette tip and incubated at room temperature 
(220C) for 2 hours. The reaction was stopped by adding 9 volumes of sterile LB and 
stored at 40C with 20 il chloroform without significant loss in titre, until further use. 
To determine the number of recombinants generated, a plaque assay was performed. 
T7 phage titration 
A plating assay was used with the T7 Select System protocol to determine the 
efficiency of packaging reactions, to determine the number of primary recombinants 
and to determine the titre of amplified phage. For this purpose, the host strain 
BLT5615 was grown overnight at 370C on shaking in LB supplemented with 50 
ig/ml Carbenicillin and then inoculated in fresh medium and incubated in the same 
conditions as above until 0D600 was 0.5. IPTG (1 mlvi final concentration) was 
added and incubation continued for another 30 minutes to induce production of the 
1OA protein. To titre the phage, 0.25 ml culture of BLT5615 and 120 il IPTG (0.1 
M) was added to 3.0 ml of melted LC top agar at 480C. An appropriate dilution of 
phage (100 il in fresh LB) was added and the contents of the tube were immediately 
mixed and then poured in a standard Petri dish containing hardened LB-agar. The 
level of dilution necessary for plating depended on the source of the sample, for 
packaging reactions the dilution range was 10 - 10-7 and for an amplified lysate the 
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dilution range was 10-7 - 10-10. Clear areas (plaques) were observed in the lawn of 
host bacteria following overnight incubation at room temperature, which 
corresponded to individual phage infection events. 
Amplification of the T7 bacteriophage 
After in vitro packaging of T7 phage and plaque assay to determine the T7 titre, a 
plate lysate amplification experiment was carried out. 1 ml from an overnight starter 
culture of BLT5615 in LB (Carbenicillin supplemented) was inoculated into 50 ml 
LB in a conical flask (250 ml) and incubated at 370C with shaking, until 0D600 
reached 0.5. IPTG (to 1 mM final concentration) was added 30 minutes prior to 
infection of cells at a ratio of 105  phage particles per 1 ml cells. This mixture was 
plated with IPTG and molten LC top agar at 480C onto a LB-agar plate containing 
Carbenicillin, and plates were incubated overnight at room temperature. The phage 
was harvested by covering each plate with Phage Extraction Buffer (20 mM 
Tris.HC1 [pH 8.0] containing 100 mM NaCl and 6 mM MgSO4), and incubating the 
plates overnight at 40C. The lysate was gently mixed with 0.5 ml chloroform, then 
clarified by centrifugation at 3,000 g for 5 minutes and the supernatant was 
collected, titred by plaque assay and stored at 40C for several months without a loss 
of titre. 
Growth and storage of T7 lysates 
At an 0D600 of approximately 0.5, IPTG (1 mM final concentration) was added to a 
culture of BLT5615 growing logarithmically in M9LB. After 30 minutes, phage 
were added and the culture was incubated until lysis. NaCl (0.5 M final 
concentration) was added and the culture was centrifuged at approximately 12,000 g 
in a Beckman J2-21 (JA-20 rotor). The clarified lysates could be stored stably for 
months to years at 40C. For long-term storage, samples of the clarified lysate were 
combined with 0.1 volume of sterile 80% glycerol and then frozen at -800C. These 
stocks can be frozen and thawed with little loss of titre. 
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Purification of T7 from lysates 
T7 recombinant phage was purified from different volumes of clarified lysates by 
precipitation with polyethylene glycol (PEG 8,000 from Sigma, UK) followed by 
banding in a CsCI step gradient. In each case, phages were initially extracted from 
the PEG pellet in 10 mI\'I Tris.HCI (pH 8.0) containing 1M NaCl and 1 mM EDTA, 
and the concentrated phage solution was layered on top of a 4-step CsCI gradient. 
The CsC1 layers were made by mixing a stock solution of 62.5% (w/v) CsCI with TE 
buffer (10 mIVl Tris.Cl, pH 8.0, containing 1 mM EDTA) in the following ratios in 
SW41 centrifuge tubes: 2 ml of 1:2 (CsCI:TE), 2 ml 1:1 (CsCl:TE), 2 ml 2:1 
(CsCl:TE) and 1 ml 1:0 (CsCl:TE). Successively denser solutions were gently 
underlayered in the SW41 tube using a pipette. After centrifugation, the tubes 
contained a thick layer of debris and empty phage heads on top of the 1:2 layer, a 
sharp, turbid band of phage particles above the 2:1 layer, and a lower turbid band 
(carbohydrate fraction with no phage particles) above the 1:0 layer. The tube was 
punctured below the desired band which was collected with a syringe needle. 
Purified phage particles were stored in CsC1 solution at 40C after performing a 
plaque assay. 
Purification of T7 from 35 ml-lysates: 0.15 ml of BLT56 15 overnight culture 
grown in LB (Carbenicillin supplemented) was added to 35 ml M9LB medium 
(Carbenicillin supplemented), incubated again at 37°C, with shaking, until the 
0D600 reached 0.5 and then IPTG (1 mM final concentration) was added 30 
minutes before phage infection. An agar plug containing a single T7 plaque was 
added and shaking was continued at 370C until lysis (clearing of the culture) was 
observed. 3.0 ml of 5M NaCl solution was added and the culture was centrifuged 
at approximately 6,000 g in a Beckman J2-21 (JA-20 rotor) for 10 minutes at 
40C. The remaining supernatant was poured into a fresh tube and 1/6 volume of 
sterile 50% (w/v) PEG 8,000 in dH20 was added, followed by thorough mixing 
by vortexing. The lysate-PEG mixture was allowed to stand overnight at 40C, to 
precipitate the phage particles, and then was centrifuged at 6,000 g for 10 
minutes. 1.2 ml of 10 miVi Tris.Cl (pH 8.0) containing 1M NaCl and 1mM 
EDTA, was added to the drained pellet. This was vortexed and then centrifuged 
at 12,000 g for 10 minutes. The supernatant was layered on the CsCl step 
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gradient in an SW41 tube and then ultracentrifuged at 35,000 rpm for 60 minutes 
at 200C in a Beckman ultracentrifuge (SW41 swinging bucket rotor). The phage 
band was removed as described. 
• 	Purification of T7from 2 litre-i ysates: Large amounts of T7 phage were purified 
from 2 litres of lysate as 4 x 500 ml iysates in 2-litre flasks. A fresh overnight 
BLT5615 culture was diluted 1:200 in 500 ml of fresh M9LB (Carbenicillin 
supplemented) and grown at 370C until 0D600 reached 0.5. After 30 minutes 
incubation with JPTG (1 mIVI final concentration), the culture was infected with 
50 p1 of high titre phage lysate and shaken at 370C until lysis. 100 p1 DNase 1(1 
mg/ml) was then added to each flask and incubation was continued for 15 
minutes. 12.5 g solid NaCl was then dissolved in each flask and the suspension 
was centrifuged at 40C for 10 minutes at 9,800 g in a Beckman J2-21 (JA-14 
rotor). 200 g PEG 8,000 was dissolved in the combined supernatants, the 
suspension was left overnight at 40C and then centrifuged at 40C for 10 minutes 
at 9,800 g. The pellets were then resuspended in 40 ml of 10% PEG (10 g PEG 
8,000 in 100 ml of 10 mM Tris.HC1 [pH 8.0] containing 1 mM EDTA) and 
centrifuged at 40C for 10 minutes at 5,900 g in a Beckman J2-21 (JA-20 rotor). 
Pellets were resuspended in 5 ml of 10 mM Tris.HC1 (pH 8.0) containing 1 mM 
EDTA and 1 M NaCl, mixed by vortexing, re-centrifuged as above and the 
supernatants layered on the CsCl step gradient in an SW41 tube, then 
ultracentrifuged and the phage band collected. 
In situ hybridisation of bacteriophage T7 plagues 
Screening of recombinant T7 bacteriophage plaques was promoted by hybridisation 
with a 32P-labelled DNA probe (Benton and Davis, 1977). Bacteriophages were 
plated at an appropriate density (approximately 500 plaques per 90 mm plate) and an 
imprint of the pattern of plaques was obtained by gently layering a nitro-cellulose 
membrane onto the surface of the LC top agar. Bacteriophage particles and DNA 
were transferred to the membrane by capillary action. After denaturation for 5 
minutes with alkali (0.5 N NaOH, 1.5 M NaCl) and neutralisation (1.5 M NaCl, 0.5 
M Tris.HC1, pH 7.4) for another 5 minutes, membranes were rinsed in 2x SSC 
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solution. The membranes were then air-dried for 60 minutes at room temperature, 
and bacteriophage particles and DNA were irreversibly bonded to the membranes by 
baking for 11/2 hours at 800C in a vacuum oven. The membranes were incubated in 
20 ml of a pre-hybridisation buffer composed of 6x SSC, 0.5% (w/v) SDS, 50x 
Denhardt's solution and 100 tg/ml denatured salmon sperm in a hybridisation roller 
in the oven at 680C. After 1 '/2 hours, the pre-hybridisation mixture was replaced with 
an equal volume of fresh buffer, along with 25 tl of probe, which was denatured by 
boiling for 10 minutes. Hybridisation was allowed to proceed overnight at 680C, 
after which the membranes were washed two times with Wash I solution (2x SSC, 
0.1% SDS [w/v] in dH20) at 680C and for two times with Wash II solution (lx SSC, 
0.1% SDS [w/v] in dH20) at 680C, each time for approximately 1'/2 hours, with 
rotation. The membranes were then wrapped in plastic foil and exposed overnight to 
an autoradiographic film at -800C. Hybridising plaques, identified by aligning the 
films with the original agar plates, were picked for further analysis. 
Preparation of T7 DNA 
T7 DNA was prepared from the CsC1-banded phage. 10 volumes of 10 mM EDTA 
(pH 8.0) were added to 1 volume phage. The mixture was heated at 650C for 5 
minutes and then cooled down to room temperature. After addition of 2.5 volumes 
of absolute ethanol and incubation at —200C for 20 minutes, the sample was 
centrifuged for 5 minutes at 10,000 g. The pellet was rinsed twice with 500 t1 70% 
ethanol, dried and then dissolved in TE buffer for 1-2 hours at 370C. 
2.2.2 Nucleic acid manipulation and detection methods 
Agarose gel electrophoresis 
For both preparative and analytical purposes DNA was resolved by electrophoresis 
in 0.8% to 2% (w/v) agarose gels, as appropriate, containing 0.5 jtg/ml ethidium 
bromide. Samples were loaded with 1/6 h volume of 6x loading buffer (40% [w/v] 
sucrose solution in dH20, with 0.25% [w/v] bromophenol blue) and electrophoresed 
at bOy in a 110 mm x 150 mm horizontal gel unless otherwise indicated, until 
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suitable resolution had been obtained. DNA was visualised under UV light (A. 313 
nm) and photographed using a Mitsubishi video copy processor. 
Phenol/chloroform extraction and ethanol precipitation of DNA 
Phenol/chloroform extraction and ethanol precipitation of DNA was performed to 
remove cell debris and proteins associated with DNA, as standardly described by 
Sambrook and co-workers (1989). 
Preparation of plasmid DNA 
Plasmid DNA was prepared by alkaline lysis (Bimboim and Doly, 1979; Sambrook 
et al., 1989). For small-scale preparations, DNA was extracted from 1.5 ml of 
overnight culture. The final DNA pellet was washed with 1 ml 70% ethanol, dried 
under vacuum and then gently resuspended in 50 p1 TE (pH 8.0) containing DNase-
free pancreatic RNase (20 tg/ml) and stored at -200C until use. 
To obtain large amounts of very pure plasmid DNA, the protocols of Bimboim and 
Doly (1979) and Ish-Horowicz and Burke (1981) were employed using 500 ml 
culture and with the following variations. After addition of NaOH (0.2 N) and SDS 
(1% [w/v] in dH20) ice-cold potassium acetate ( pH 4.8) solution was used for 
neutralisation. After centrifugation at 6,000 g for 10 minutes at 40C to pellet the cell 
debris, the supernatant was filtered through a non-absorbent cotton wool plug and 
the filtrate was collected in a clean centrifuge pot where 48 ml isopropanol were 
added to precipitate the DNA. The plasmid DNA was harvested by centrifugation at 
6,000 g for 10 minutes at 4°C, the pellet was rinsed with 70% (v/v) ethanol and was 
air dried by inversion of the centrifuge pot, to remove excess liquid. The dried pellet 
was dissolved in 9 ml TE buffer (pH 7.5) and then 9.2 g of CsCl were added, 
followed by addition of 0.5 ml of ethidium bromide solution (10 mg/ml). At this 
stage, the tube containing the DNA and ethidium bromide mixture was wrapped in 
foil to avoid contact with light. The sample was centrifuged for 10 minutes at 4,000 
g in a MSE Centaur I centrifuge to remove debris. The cleared supernatant was then 
spun in Sorvall TV865 quickseal ultracentrifuge tubes at 200,000 g for 20 hours at 
room temperature, in a Sorvall OTD55B ultracentriftige. Using a sterile needle and 
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syringe, the lower band containing plasmid DNA was removed after visualisation 
under UV light. Extraction of ethidium bromide from the sample was performed 
several times by mixing with TE-saturated butan-1-ol and discarding the upper 
(butanol/ethidium bromide) layer. The aqueous phase was then dialysed overnight 
against TE (pH 8.0) to remove CsCl. The DNA was ethanol precipitated and the 
final pellet was dried under vacuum and resuspended in TE (pH 8.0). As an 
alternative to this protocol, the Qiagen Plasmid Maxi Kit (Qiagen GmbH, Germany) 
was used, following the manufacturers recommendations. This was based on a 
modified alkaline lysis procedure, followed by binding of plasmid DNA to an anion-
exchange resin, elution in a high-salt buffer and isopropanol precipitation. 
Preparation of dialysis tubing: 
Dialysis membrane (Medicell International Ltd.) was prepared by boiling for 10 
minutes in a 2% (w/v) sodium bicarbonate solution in dH20 containing 0.05% (w/v) 
EDTA. This solution was then discarded and the membrane then boiled twice in 
dH20. After this final step, the membrane was transferred to a solution containing 
20% (v/v) ethanol in dH20 and stored at 40C until further use. Prior to dialysis, the 
membrane was rinsed with sterile dH20 to remove the ethanol. 
Preparation of genomic DNA from S. tvphimurium SL1344 
1.5 ml of overnight culture was transferred to a clean tube and cells were harvested 
by centrifugation at 20,000 g for 10 minutes. Cells were resuspended in 0.5 ml of 
solution containing 50 mM Tris.HC1 (pH 8.0) and 50 mM EDTA and frozen at - 
200C for 30 minutes. 0.05 ml fresh 10 mg/ml lysozyme solution in 0.25 M Tris.HC1 
(pH 8.0) was added to the frozen cells which were thawed quickly by hand. When 
just thawed, this suspension was left on ice for 45 minutes, then 0.1 ml STEP 
solution (0.5% [w/v] SDS solution in dH20 containing 50 mM Tris.HC1 (pH 7.5), 
0.4 M EDTA and 1 mg/ml proteinase K) was added, with incubation at 500C for 60 
minutes with occasional mixing. This suspension was then split in half in two micro-
centrifuge tubes and to each tube 2 volumes of Tris-buffered phenol were added. 
The mixture was gently combined by inverting the tubes until an emulsion was 
formed and then centrifuged at 40C in a micro-centrifuge at 10,000 g for 15 minutes. 
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The upper aqueous layer which contains the DNA was then transferred into a new 
tube using a blunt-end pipette tip. The procedure was repeated with 
phenol: chloroform: isoamylalcohol (25 : 24 : 1) until a clear interface was observed. 
The aqueous layer was then transferred into a new tube and the DNA was 
precipitated with 0.1 volumes of 3 M sodium acetate (pH 5.2) and 2 volumes of 95% 
cold ethanol. Precipitated DNA was then spooled out and transferred to a clean tube 
containing 0.5 ml of 200 tg/ml RNase A (DNase free) in 50 mM Tris.HC1 (pH 7.5) 
containing 1 mM EDTA. The tube was rotated gently overnight at 40C. An equal 
volume of chloroform was added, the tube was inverted for 5 minutes to emulsify 
and then centrifuged in a micro-centrifuge at 10,000 g for 15 minutes at 40C. The 
aqueous top layer was then transferred to a clean tube and the DNA was precipitated 
with 0.1 volumes of 3 M sodium acetate (pH 5.2) and 2 volumes of 95% cold 
ethanol. The tube was gently inverted several times until a stringy white precipitate 
of DNA appeared. The DNA was spooled out and added to a solution of 50 mM 
Tris.HC1 (pH 7.5) containing 1mM EDTA. 
Polymerase Chain Reaction 
The polymerase chain reaction (PCR) (Saiki et al., 1988) was employed in order to 
amplify DNA fragments for a variety of applications; the reaction was performed in 
a Techne "Gene E" thermal cycler dry-block. Primers specific for the region of 
DNA of interest were designed as required (Table 2.1). PCR reaction products were 
then analysed by agarose gel electrophoresis. 
The groEL fragment was amplified over 30 cycles consisting of 3 steps: 
denaturation at 940C for 1 minute, annealing at 600C for 1 minute and elongation at 
720C for 2 minutes. A final extension cycle was performed for 10 minutes at 720C. 
Reactions were carried out in 100 j.t1 volumes containing template DNA (10 ng), 2.5 
p1 of each primer (at a concentration of 3.2 pmol/p1 each), 8 p1 of dNTP mix 
(containing 2.5 mM of each dNTP), 2 units of Taq DNA polymerase (Boehringer 
Mannheim), 10 p1 of a lOx PCR reaction buffer (Boehringer Mannheim) and dH20. 
In order to avoid evaporation of sample through the PCR process, sterile mineral oil 
(100 p1) was added to the surface of the PCR mixture. 
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For T7 DNA, a portion of the LC top agar, scraped from an individual plaque, was 
dispersed into a tube containing 100 .xl of 10 mM EDTA (pH 8.0), mixed by 
vortexing and then heated at 650C for 10 minutes. Samples were centrifuged at 
14,000 g for 3 minutes to clarify and the phage lysate was then combined with PCR 
reaction buffer and components in a 50 l total volume. PCR amplification was 
performed by starting with a single denaturation step at 940C for 4 minutes, followed 
by 35 cycles comprising: denaturation at 940C for 1 minute, annealing at 500C for 1 
minute and elongation at 720C for 2 minutes. The final extension consisted of a 
single cycle at 720C for 6 minutes. 
Transformation of E. co/i by electroporation 
An overnight culture was diluted 1/100 in 500 ml fresh LB broth and grown at 370C 
with shaking until the 0D600 had reached 0.5. The flask was chilled on ice for 1 hour 
and then cells were centrifuged at 4,000 g for 10 minutes at 40C in a Beckman JA-21 
(JA-14 rotor). The supernatant was discarded, the cells were resuspended in an 
equivalent volume of ice-cold sterile dH20 and this process was repeated 4 times. 
The cells were centrifuged at 40C for 10 minutes at 4,000 g. After the final spin, the 
cells were resuspended in 0.5 ml dH20 and used immediately for electroporation as 
200 pA aliquots in pre-chilled electroporation cuvettes. Cells kept for further 
transformations were stored as 200 j.tl aliquots at —800C in 10% glycerol for no more 
than 3 weeks. 
Between 5 pg and 10 ng DNA in less than 10 .i1 volume, was added to competent 
cells in electroporation cuvettes and left on ice for 5 minutes. Electroporation was 
performed using the BIORAD "Gene Pulser" apparatus, with the voltage set at 2.5 
kV and the pulse controller set to 200 ohms. After the pulse, 800 p1 of SOC medium 
was added to the cuvettes and the whole contents were transferred to a fresh 
microcentrifuge tube. The cells were then incubated at 370C or 300C for 1 hour, 
prior to plating on selective LB-agar. 
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CaCl2 method for transformation of E. coli 
This protocol was used to prepare JM109 competent cells. The strain was grown on 
M9 minimal plates prior to preparing competent cells and transformation, then a 
single colony was inoculated in 5 ml YT medium (low salt concentration) and 
incubated overnight at 370C with shaking. The overnight culture was diluted 1/100 
in 50 ml fresh warm YT medium and grown in the same conditions (with good 
aeration) until 0D600 was approximately 0.5. The cells were pelleted by 
centrifugation at 40C for 10 minutes at 7,000 g in a Beckman JA-21 (JA-20 rotor), 
the supernatant discarded and then the cells resuspended in approximately 25 ml of 
pre-chilled 10 mM Tris.HC1 (pH 8.0) containing 50 mM CaCl2. After 30 minutes 
incubation on ice, cells were centrifuged at 40C for 10 minutes at 7,000 g, 
resuspended in 2.5 ml pre-chilled CaC12 / Tris mixture and incubated on ice between 
30 minutes and 2 hours prior to transformation. 
A lOOjil aliquot of JM109 competent cells prepared as above was mixed gently by 
swirling with 	10 ng DNA (approximately 5 tl of the ligation reaction) and then 
incubated on ice for 30-40 minutes. The tube was heated at 420C in a water bath for 
50 seconds and then returned to ice for at least 2 minutes. 4 volumes of fresh LB 
was added to the cells and then incubated at 370C for 60 minutes. This suspension 
was then spread in 200t1 aliquots onto LB plates (with 50 tg/ml Carbenicillin) 
containing X-Gal and IPTG and then incubated overnight at 370C. 
DNA sequencing 
DNA sequencing was performed by an automated and non-isotopic method first 
described by Ansorge and colleagues (1986), using fluorescent dye terminators from 
the Big Dye Terminator Kit (Applied Biosystems, USA). 
PCR products and plasmid dsDNAs were used as templates in the Big Dye 
Terminator cycle sequencing reactions. For automated fluorescent DNA sequencing 
purposes, plasmid DNA was obtained with Wizard Plus SV Minipreps DNA 
Purification System kit, as described by the manufacturers (Promega, USA). After 
elution of plasmid DNA from the spin column, an ethanol precipitation step was 
performed to concentrate the DNA. The pellet was resuspended in dH20 and the 
DNA concentration determined by agarose gel/ethidium bromide quantitation. PCR 
products were purified prior to cycle sequencing, by silica-based gel filtration using 
the Qiaquick PCR Purification Kit (Qiagen GmbH, Germany). 30 to 90 ng PCR 
products and between 200 to 500 ng plasmid DNA were used as templates in cycle 
sequencing. DNA sequencing was carried out in 10 l volume containing template 
DNA, 5 pmol primer for sequencing and 4 tl of terminator mix (A-dye terminator, 
T-dye terminator, C-dye terminator, G-dye terminators, dATP, dTTP, dCTP, dGTP, 
Tris.HC1 [pH 9.0], MgCl2, thermostable pyrophosphatase and AmpliTaq DNA 
polymerase), supplied as part of the kit. Reactions were cycle sequenced in a Techne 
"Gene E" thermal cycler dry-block over 25 cycles, each cycle including 30 seconds 
at 960C, 20 seconds at 500C and 4 minutes at 600C. Dye terminators and excess 
nucleotides were removed using Centriflex Gel Filtration Columns (Edge 
BioSystems, Inc.) prior to processing on the automated DNA sequencer. Raw data 
were analysed using GeneJockey (Biosoft) software. 
Radioisotopic labelling of DNA 
Plasmid DNA was labelled by incorporation of labelled deoxynucleotide 
triphosphates using the Nick Translation System (Promega Inc, USA). 
Approximately 1 .tg plasmid DNA was mixed with 5 .il [a-32P]-dCTP (10 tCi/tl 
and 400 Ci/mmole), 5 j.tl of a DNA polymerase I/DNase I mix, 10 il nucleotide mix 
(300 jiM dATP, 300 tM dGTP, 300 j.iM dTTP) and made up to 50 t1 in translation 
buffer (50 mM Tris.HC1, pH 7.2, 10 mM MgSO4, 0.1 mM DTT). The DNA 
polymerase/DNase I mix contained: DNA polymerase I (1 U/il) and DNase I (0.2 
ng/pJ) in a solution containing 50% glycerol, 50 mM Tris.HC1 (pH 7.2), 10 mM 
MgSO4, 0.1 mM DTT and 0.5 mg/mi nuclease-free BSA. The reaction was allowed 
to proceed at 160C for 60 minutes and was then stopped by the addition of 5 jil 0.25 
M EDTA (pH 8.0). The reaction volume was then made up to 200 il and was 
separated through 1 ml of a TE-equilibrated pre-spun Sephadex G 50 column by 
centrifugation at 2,000 g for 4 minutes. Prior to hybridisation the probe was 
denatured by boiling for 5 minutes, cooled immediately on ice and added to the 
hybridisation mix. 
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2.2.3. Protein detection procedures 
Estimation of protein concentration 
The concentration of a protein in solution was estimated using the method of 
Bradford (1976), as adapted by the reagent manufacturers (BIORAD). Standard 
bovine serum albumin (BSA) solutions of 0.2 mg/ml, 0.5 mg/ml, 0.8 mg/ml, 1.0 
mg/mi and 1.25 mg/ml were prepared in the same buffer solution as used to dilute 
the protein sample and 2.5 ml diluted Bradford reagent was added to either 50 jt1 
from each standard or 50 l buffer (used as the blank sample), with gentle mixing. 
Each mixture was incubated at room temperature for 10 minutes and the optical 
density was read at 595 nm (0D595). For each BSA standard, triplicate 
measurements of the 0D595 were obtained and the average reading plotted against 
concentration to give a standard curve (data not shown). The protein concentration 
of the solution of interest was determined from the optical density, by using the OD 
reading in conjunction with the standard curve. 
SDS-polyacrylamide gel electrophoresis of proteins 
SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) was performed 
essentially as described by Laemmli (1970). Proteins were resolved on either a 16 x 
20 cm or a 7 x 8 cm SDS-poiyacrylamide gel, using a PROTEAN II xi Slab Gel or a 
MINI-PROTEAN II Dual Slab Gel apparatus respectively (BIORAD). The 
composition of the resolving gel was dependent upon the protein to be investigated 
and either a 12.5%, 10% or 7.5% (w/v) acrylamide gel was used, with a stacking gel 
at 4% (w/v) polyacrylamide concentration. The composition of the stacking gel was: 
4% (w/v) polyacrylamide, 0.1 % (w/v) SDS (sodium dodecyl sulphate), 0.05 % 
(w/v) APS (ammonium persuiphate) and 0.05% (w/v) TEMED (N, N, N'-
tetramethylethylethylenediamine) in 0.125 M Tris.HC1 buffer (pH 6.8). The 
resolving gels contained either 12.5%, 10% or 7.5% (w/v) polyacrylamide and 0.1 % 
(w/v) SDS, 0.05 % (w/v) APS, 0.05% (w/v) TEMED in 0.125 M Tris.HC1 buffer 
(pH 8.8). 
Samples to be analysed were mixed with an equal volume of 2x Laemmli 
solubilisation buffer (LSB) and boiled for 5 minutes prior to loading. 2x LSB 
contained 100 mIvI Tris.HC1 (pH 6.8), 200 mM dithiothreitol (DTT), 4% (w/v) SDS 
(electrophoresis grade), 0.2% (w/v) bromophenol blue and 20% (w/v) glycerol. 
Boiled samples were loaded (10-30 tl, depending upon the gel used) into individual 
wells and the proteins were electrophoresed in running buffer (0.025 M Tris-base 
[pH 8.3] containing 0.192 M Glycine, 0.1% [w/v] SDS). Molecular size markers 
were used for sizing the polypeptides seen on the gel. Small gels (MIN1PROTEAN 
II) were run at room temperature for 2.5 hours at 15 mA/gel and 250 V and big gels 
(PROTEAN II) were run at 40C for 18 hours at 30 mA/gel and 400 V. 
Staining SDS-polyacrylamide gels with Coomassie Brilliant-Blue-or Silver stain 
Once the polypeptides had been separated by electrophoresis, the gels were 
immersed in a fixing/staining solution (0.1% [w/v] Coomassie Brilliant Blue R250 
(Sigma, UK), 45% [v/v] methanol, 10% [v/v] glacial acetic acid in dH20) and left to 
stain on a shaking platform at room temperature for approximately 4 hours. Excess 
stain was then removed by soaking the gel in a destaining solution (45% [v/v] 
methanol, 10% [v/v] glacial acetic acid in dH20) for 4-8 hours at room temperature 
until polypeptide bands could be seen clearly. After destaining, gels were soaked 
overnight in a pre-dry solution (35% [v/v] ethanol, 0.15% [v/v] glycerol in dH20) 
and then dried at room temperature using a drying kit (Promega Inc., USA). 
Silver staining of proteins resolved by SDS-PAGE was done according to the 
method described by Blum and collaborators (1987). To prevent diffusion of 
separated proteins, gels were soaked overnight in a fixing solution (50% [v/v] 
methanol, 12% [v/v] acetic acid and 0.5 ml 37% [v/v] formaldehyde in dH20) and 
then washed 3 times, each time for 20 minutes, in a solution of 50% (v/v) ethanol in 
dH2O. Gels were then pre-treated for 1 minute in a freshly prepared solution 
containing 0.2 mg/ml Na thiosulphate (Na2S203.5H2O) in dH20, in order to get an 
image enhancement of fixed gels and to prevent background staining from formation 
of soluble silver complexes. After rinsing the gels 3 times with dH20, each time for 
20 seconds, they were impregnated for 20 minutes with a freshly prepared solution 
of AgNO3 (2mg/mi), 1 litre of solution containing 0.75 ml 37% (v/v) formaldehyde. 
For image development, pre-treated gels were rinsed as above and then soaked for 2-
5 minutes in fresh developing solution (60 g Na2CO3, 4 mg Na2S203.5H20 and 0.5 
ml 37% [v/v] formaldehyde in dH20). When the desired contrast was achieved, the 
reaction was stopped by soaking the gels for 10 minutes in an aqueous solution 
containing 50% (v/v) methanol and 12% (v/v) acetic acid. Gels were stored at 40C 
for no longer than 2 weeks in 50% (v/v) methanol in dH20, prior to drying. 
{35Sl-methionine labelling of proteins from the T7 bacteriophage 
T7 proteins were labelled essentially as described previously by Studier (1972). An 
overnight culture of BLT5615 in LB (supplemented with Carbenicillin) was diluted 
1:50 in fresh LB/Carbenicillin medium and grown with shaking at 370C to an 
absorbance of 0.5 at 600 nm (0D600). This corresponded to approximately 2 x 108 
cells/mi. 1 mM IPTG was added 30 minutes prior to T7 infection to induce plasmid 
production of the 10A protein. The culture was dispensed in a Petri dish, was 
irradiated for 6 minutes with U. V. light from a germicidal lamp located 
approximately 60 cm above the sample, as described by Hosoda and Levinthal 
(1968), and was then incubated for 15 minutes at 370C on shaking before infection. 
The cell suspension was then infected with CsC1-purified phage to give 
approximately 10 phage particles per cell and was incubated at 370C. Infection was 
allowed for 8 minutes, and then every 2 minutes, 1 ml-samples of culture were taken 
and pulsed for 2 minutes with 35S-methionine at a final concentration of 15 tCi/ml 
(1175 Ci/mmol). The cells were collected by centrifugation for 2 minutes at 12,000 
g and then resuspended in 1 ml fresh unlabelled LB in order to eliminate further 
incorporation of 35S into proteins, followed by incubation for 4 minutes at 370C. The 
cells were harvested by centrifugation for 5 minutes at 12,000 g, lysed by boiling for 
5 minutes in Laemmli solubilisation buffer (2 x LSB) and then the proteins 
subjected to SDS-PAGE, followed by autoradiography. 
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2.2.4 Immunodetection of polypeptides 
Immunological detection of proteins (Western blotting) was carried out following 
SDS-PAGE and transfer to a solid support (e.g. nitro-cellulose membrane) which 
then could be stained (Towbin et al., 1979). The membrane was subsequently 
exposed to unlabeled antibodies specific for the target protein and finally the bound 
antibody was detected by an anti-immunoglobulin coupled to horseradish peroxidase 
(HRP). Visualisation of the protein band was performed by chemiluminescent 
detection when horseradish peroxidase (HRP) catalyses the oxidation of luminol in 
the presence of hydrogen peroxide (H202). Immediately following the oxidation, the 
luminol is in an excited state, and then decays to the ground state via a light emitting 
pathway (Thorpe and Kricka, 1986). The light signal was captured on X-ray film. 
Transfer of polypeptides to nitro-cellulose membranes by electrophoresis 
Western blotting was carried out by direct electrophoretic transfer of proteins from 
the gel to a nitro-cellulose membrane, using a "TRANS-BLOT CELL" or a 
"TRANS-BLOT SD SEMI-DRY CELL", as described by the manufacturers 
(BIORAD). Nitro-cellulose membrane (Schleicher and Schuell) was used as solid 
support and transfer buffer (48 mM Tris-base, 39 mM Glycine, 20% (v/v) methanol, 
0.0375% (wlv) SDS in dH20) was used for electrotransfer. With the "TRANS-
BLOT CELL", polypeptides were then transferred from the gel to the membrane by 
electrophoresis at 40C for 20 hours at 20 V (250 mA). When the "TRANS-BLOT 
SEMI-DRY CELL" was used, transfer of the polypeptides was carried out at 40C 
and was completed in 30 minutes to 1 hour (depending on the size of the gel) at 15 
V (200 mA). After blotting, the membrane was used immediately for 
immunodetection experiments. 
Immunodetection of polypeptides 
The nitro-cellulose membrane was stained with the reversible dye Ponceau S (0.5 g 
in 100 ml 1% [v/v] acetic acid in dH20) incubating the membrane for 5-10 minutes 
with gentle agitation. When the protein bands were visible, the positions of 
molecular size marker proteins were marked in pencil. After washing in several 
changes of dH20 at room temperature, the blotted membrane carrying the proteins 
was shaken for 1 hour at room temperature in a 5% (w/v) non-fat dry milk solution 
(Sainsbury's own brand) in TBS (Tris buffer saline, pH 7.5). The membrane was 
then rinsed 3 times (each time for 10 minutes) in fresh changes of T-TBS (Tween-
TBS) and primary antibody was added with shaking at room temperature for 1 hour 
in a 1% (w/v) solution of non-fat dry milk in T-TBS. The primary antibody was used 
either as a dilution of anti-GroEL antibody (IgG fraction) raised in rabbit (from 
Sigma, UK), or of mouse antisera from Salmonella lyphimurium (aroN)-immunised 
mice. After this incubation with the first antibody, the membrane was washed 3 
times (each time for 10 minutes) in fresh changes of T-TBS and then the second 
antibody was added and incubation was continued for 1 hour at room temperature in 
a 1% (w/v) non-fat dry milk solution in T-TBS. The second antibody was 
represented by a 1:10,000 dilution of (sheep/donkey) anti-IgG (mouse, rabbit) 
conjugated to horseradish peroxidase (from SAPU, Scotland, UK). After incubation, 
unbound antibodies were removed by washing 3 times in T-TBS, followed by an 
additional washing step in TBS for another 5 minutes. Bound antibodies were 
detected by the addition of a developing mix (1 volume solution B, 100 volumes 
solution A) and allowing the reaction to proceed for 1 minute at room temperature. 
Solution A was prepared by dissolving 50 mg of 5-amino-2,3-dihydro-1,4-
phtalazinedione sodium salt (sodium luminol, Sigma, UK) in 200 ml 0.1 M Tris.HC1 
(pH 8.6) containing 62 tl of 30% (v/v) H202 and was stored in a dark bottle at 40C. 
Solution B was made by dissolving 11 mg of parahydroxycoumaric acid (Sigma, 
UK) in 10 ml dimethyl sulphoxide (DMSO, Sigma, UK) and was stored at 40C as 
0.5 ml aliquots. To visualise the immunoblots, membranes were wrapped in Saran 
Wrap and exposed to X-ray films (AGFA Curix RP1, 100 NIF) for 30 seconds to 2 
minutes. X-ray films were then developed in an X-ray film auto-processor and 
scanned. 
2.2.5 Enzyme-linked immunosorbent assay (ELISA) 
ELISA (enzyme-linked immunosorbent assay) was performed essentially as 
described previously (Engvall and Perlman, 1971). Ninety-six well microtitre plates 
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(Immulon 2, Dynex) were coated with the purified protein at a concentration of 
1tg/m1 (100 ng antigen per well in 100 pA coating buffer [15 mM Na2CO3, 35 mM 
NaHCO3, pH 9.5]), unless otherwise specified, and were incubated overnight at 40C. 
The plates were then washed 3 times with washing buffer (0.05% [vlv] Tween 20 in 
PBS) to remove excess antigen, and unoccupied protein binding sites were blocked 
for 5 hours at room temperature with 200 pA per well blocking buffer (1% [w/v] 
skimmed milk powder in washing buffer). After 3 washes, doubling dilutions of 
serum samples, made up in blocking buffer, were added to duplicate antigen coated 
wells (100 jtl per well) and incubated overnight at 40C. After 3 washes, the wells 
were incubated for 30 minutes at 370C with 100 pi per well of horseradish 
peroxidase-conjugated anti-IgG antibody (SAPU, Scotland, UK) at a dilution of 
1:500 in blocking buffer. The plates were washed further 3 times with washing 
buffer before incubating for 15 minutes at room temperature with 100 tl per well of 
substrate buffer. The substrate buffer (10 ml) contained 2.4 ml of 0.1 M citric acid, 
2.56 ml of 0.2 M Na2HPO4, 4 p1 of 30% (v/v) H202, 5 ml dH20 and 4 mg 0-
phenylenediamine (OPD, from Sigma). The reaction was stopped with 25 pA of 2M 
H2SO4 and the absorbance was read at 492 nm using a Titertek Multiskan Plus plate 
reader and the software ELISA LITE v. 3.01.03 (1986-1991 Meddata Inc.). 
2.2.6 Murine model studies 
The T7 recombinant bacteriophage and purified GroEL from Salmonella 
typhimurium were used as immunogens to produce polyclonal antisera in female 
BALB/c mice (approximately 6 weeks of age). 
Obtaining T7 bacteriophage-specific serum from mice 
20 mice (five per group) were injected by the i.v. route with 100 p1 of PBS 
containing 1011  pfulml CsC1-purified T7 recombinant phage (1010  pfulmouse) on 
day 1 and day 14. Mice were bled prior to infection (day 0), on day 10 after the first 
immunisation, and on days 6 and 12 after the second immunisation (days 20 and 26, 
respectively). Approximately 100 pA of blood was obtained per mouse. The blood 
was allowed to clot at room temperature for 5-6 hours and the serum was then 
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removed from the clot and any remaining insoluble material by spinning the samples 
at 1,800 g in a MSE Centaur bench-top centrifuge for 15 minutes. Serum was 
aliquoted, stored at —800C and then serum samples from individual mice were 
examined. 
Preparation of anti-GroEL (from S. typhimurium) antisera obtained from mice 
Purified GroEL from Salmonella typhimurium prepared by C. Aspinwall as 
previously described (Taylor, 1997), was diluted to 500 jig/ml in sterile PBS. 3.2 ml 
of this solution was mixed with an equal volume of adjuvant (Imject Alum, Pierce, 
USA) added dropwise with stirring for 30 minutes at room temperature. A group of 
6 mice was injected with 200 jil per mouse of the GroEL-Alum mixture (50 jig 
protein per mouse) with each dose being distributed equally between two separate 
subcutaneous sites. 100 jil injection of mouse recombinant interieukin-12 (IL-12, 
R&D Systems, UK) was also given intraperitoneally (2.5 jig/ml IL-12). The other 
groups of mice were injected subcutaneously either with 50 jig GroEL in Alum per 
mouse (as before), or the control groups of mice were injected solely with 100 jil 
PBS or 100 jil IL-12 (2.5 jig/ml) at the appropriate site. After an interval of 14 days, 
each group of mice were given a repeat immunising dose and samples of blood were 
collected under anaesthesia on days 6 and 12 after the second immunisation. The 
blood from each subgroup of mice was pooled and the serum was obtained and 
stored as described above. 
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CHAPTER 3 
Cloning and characterisation of S. typhimurium Gr0EL 
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3.1 INTRODUCTION 
3.1.1 S. typhimurium GroEL - an immunogen used in vaccine design 
When bacteria are subjected to environmental stress they respond by increasing the 
level of various proteins, which in turn help them deal with the detrimental effects of 
exposure to the stress (Mahan et al., 1996). For example, when S. typhimurium 
enters the macrophage, the bacterium responds by inducing around 30-40 proteins 
and repressing around 100 (Buchmeier and Heffron, 1990; Abshire and Neidhardt, 
1993). Stress proteins represent some of the most conserved and abundant proteins 
in nature, and appear to have a variety of important roles in immunity. The elevated 
synthesis of stress proteins in host phagocytes also increases their availability for 
antigen recognition by the host immune system. It has been suggested that such 
stress proteins may be dominant antigens for recognition by both cell-mediated and 
humoral immune responses (Kagaya et al., 1992). 
The GroEL protein is an abundant protein of the bacterial cell. In E.coli, GroEL 
constitutes approximately 1% of the total protein content in unstressed cells, but this 
can be elevated to approximately 10% under stress conditions (Hemmingsen et al., 
1988). It has been estimated that at least half of the soluble proteins of E. coli can 
form complexes with bacterial GroEL while they are in unfolded or partially folded 
states (Viitanen et al., 1992). GroEL has been shown to be an immunodominant 
antigen and a major immunogen of many bacterial pathogens (Kaufmann, 1991), but 
generally it does not act in itself as a protective antigen. For example, mycobacterial 
Hsp60 has been used as an adjuvant (Peterman et al., 1993) and as a carrier molecule 
for conjugated vaccines (Barrios et al., 1992; Perraut et al., 1993). Previous studies 
have shown that mice develop both cell-mediated and humoral immune responses to 
GroEL during the course of infection with S. typhimurium (Brown and Hormaeche, 
1989; Gupta et al., 1996a) and studies performed in our laboratory (Taylor, 1997) 
have demonstrated that S. typhirnurium GroEL is highly immunogenic, producing 
both long-lived T- and B-cell responses. 
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High anti-GroEL antibody levels have been detected long after S. typhimurium 
infection (day 104) and when infected mice were challenged subcutaneously with 
GroEL, a significant DTH reaction developed, even at day 104 post-infection. The 
fact that this protein elicits a significant immune response and induces 
immunological memory, suggests that S. typhimurium GroEL is a potential 
candidate used for vaccine design. 
Phage display 
Phage display consists of a peptide or protein, which is displayed on the surface of a 
phage as a fusion to a protein that is normally found in the phage particle. Most 
phage display work has used filamentous phage strains M13, fd, and ft as vectors 
(reviewed in Smith and Petrenko, 1997), but display systems based on bacteriophage 
T4 (Efimov et al., 1995; Ren et al., 1996) and 2 (Sternberg and Hoess, 1995; 
Mikawa et al., 1996) have also shown promise. The first phage vectors suitable for 
surface display were made by Smith (1985) and consisted in displaying foreign 
peptides or proteins on the surface of filamentous bacteriophage particles via fusion 
to the phage coat proteins. As Smith and Petrenko (1997) have pointed out, the main 
applications of phage display systems are: (1) studies of target receptors for affinity-
selection of phage-displayed peptides, (2) epitope mapping and mimicking, (3) 
identification of new receptors and natural ligands, (4) selection of DNA-binding 
proteins, and (5) epitope and drug discovery. 
The potential of phage T7 for display of peptides was reported initially by 
Houshmand and co-workers (1999). Very recent studies (Sokoloff et al., 2000) have 
used T7 phage as a peptide display system to analyse the interactions of displayed 
peptides with the innate immune system. They used the icosahedral T7 phage, 
displaying random peptides at the carboxi-terminus of the phage coat protein, as a 
model drug and gene delivery vehicle containing peptide ligands. 
In the present study, we explored expression of the S. typhimurium GroEL protein 
on the capsid of the T7 bacteriophage, as a strategy for vaccine design against S. 
enterica. The groEL fragment from the chromosome of S. typhimurium SL1 344 was 
107 
cloned into the T7 genome such that it produced a fusion protein with the lOB 
capsid protein of the phage. The integrity of the overexpressed protein and the use of 
the hybrid phage in immunisation studies are discussed in later chapters of this 
thesis. 
Bacteriophage T7 - structure and assembly 
The T7 bacteriophage, with a diameter of approximately 65 nm, contains double-
stranded linear DNA in a cavity enclosed by the capsid's polygonal outer shell. 
Attached to the outer shell are both an external protein projection (tail) and internal 
proteins (Serwer et al., 1997). The capsid shell on the icosahedral T7 phage is 
composed of 415 copies of the T7 capsid protein (gene 10) arranged as 60 hexamers 
on the faces of the shell and 11 pentamers at the vertices (Steven and Trus, 1986). 
Attached at the remaining vertex are the head-tail connector (gene 8), a short conical 
tail (genes 11 and 12) and six tail fibres (gene 17). The phage assembly process is 
similar to that of other double-stranded DNA phages (Cerritelli and Studier, 1996), 
takes place inside the E. co/i host cell and mature phage are released by cell lysis. 
The bacteriophage packages DNA by first assembling a DNA-free, tail-free capsid 
(procapsid) and then drawing the DNA into this structure (Serwer et al., 1997). The 
procapsid shell is made of scaffolding protein (gene 9), capsid protein (gene 10), the 
head-tail connector and an integral protein structure (genes 13, 14, 15, and 16). The 
DNA is packaged from linear concatemers, and as the DNA enters the procapsid 
shell, the scaffolding protein is released and a conformational change occurs in the 
shell to form the mature particle. Tail and tail fibres attach at the head-tail connector 
vertex. Unlike the filamentous systems, proteins displayed on the surface of T7 do 
not need to be capable of export through the periplasm and the cell membrane 
(Russel, 1991). 
Frameshifting in gene 10 of bacteriophage T7 and protein display 
In the case of a frameshift, a significant proportion of ribosomes switch reading 
frames at a specific site in a coding region, thus entering a new frame. The result is 
that a single mRNA can produce two products, a protein from the normal coding 
frame and a trans-frame fusion protein (Condron et al., 1991). One particular 
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example of frameshifting is gene 10 of bacteriophage T7, encoding the capsid 
protein. This gene has normally two products, a major product of 36 kDa, the 1OA 
protein (344 amino acids), and a minor product of 41 kDa, the lOB protein (397 
amino acids; Dunn and Studier, 1983). From an analysis of both DNA and protein 
sequences, it has been concluded that the minor lOB protein was produced by a 
translational frameshift into the —1 coding frame, at amino acid 341 of 10A, near the 
end of the coding frame for the major product. Thus, lOB contains most of the 
sequence of 10A with 52 extra amino acids from the alternate frame added onto the 
C-terminus (Dunn and Studier, 1983). The frameshift occurs at a frequency of about 
10% of that of normal elongation and both products are incorporated into the capsid 
in about this proportion. In terms of DNA-encoded gene 10 products, with the 
translational start at base 1, the proposed frameshift site is at base 1019, the 1OA 
stop codon is at base 1032, the lOB stop codon is at base 1187, and the 
transcriptional terminator is from base 1198 to 1237 (Condron et al., 1991). 
Functional capsids can be composed entirely of either 1OA or lOB, or of various 
ratios of the proteins. The region of the capsid protein unique to lOB is on the 
surface of the phage and may be used for phage display (Novagen Inc., USA). The 
T7 bacteriophage has been modified as a protein display system for this purpose (T7 
Select Phage Display System). The T7Select 1-lb Phage Display System has been 
used over the course of this study for low-copy number display (0.1-1 copies per 
phage). The vector contains a multiple cloning site between amino acids 348 and 
363 of the lOB gene. The coding sequence for the protein to be displayed can be 
cloned between the EcoRIIHindIII arms of the T7Select 1-lb vector. 
To obtain low-copy number display of the protein, the promoter of the capsid gene 
(10) and the slO translation initiation signal (ribosome binding site) have been 
removed (Figure 3.1). The capsid IIIRNA is produced from phage promoters located 
further upstream of the gene, but production of capsid protein is greatly reduced. 
Target sequence is fused to the C-terminus of the lOB capsid protein near amino 
acid 348. The natural translational frameshift site within the capsid gene has been 
removed, so only a single form of capsid protein is made from this vector, 
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Figure 3.1 
The genetic map of T7 and the phage display vector T7Select 1-lb. 
The T7 capsid gene (gene 10) is located at position 60 in the T7 genome, within the region of 
genes coding for proteins involved in the structure and assembly of 17. Capsid protein expression 
during infection is controlled by a promoter ( 10) and terminator (T4) for T7 RNA polymerase, 
and by translation initiation signals (s 10). A. In wild-type T7, the capsid protein is normally made 
in two forms, 1OA (344 amino acids), and lOB (397 amino acids), the latter being related by a 
translational frame-shift at the amino acid 341 within bA. B. The T7Select 1-lb vector used in 
this study, contains a multiple cloning site, between amino acids 348 and 363 of the lOB gene. The 
natural translational frameshift site within the capsid gene has been removed and therefore only the 
truncated lOB form is made from this vector (adapted from inNovations 6 [1996]; Newsletter of 
Novagen, Inc., USA). 
which is the truncated lOB protein. The hybrid T7 phage is grown on a 
complementing host BLT5615 (Table 2.3) that provides large amounts of the 1OA 
capsid protein from a plasmid, whose expression is controlled by a lacUV5 
promoter. The 1 OA gene in the complementing plasmid and the capsid gene in the 
vector have been engineered to minimise any recombination between the genes. For 
the hybrid T7 phage then, capsids contain mostly IOA protein along with 0.1-1 
copies of the fusion protein (e.g., lOB fused at its C-terminal end with S. 
typhimurium GroEL) per virion. The display number from the T7Select 1-lb vector 
is not strictly fixed, it presumably depends on the ratio of expression of the capsid 
fusion protein from the vector and the 1 OA protein from the complementing host 
(BLT5615), and also on the efficiency of assembly of the fusion protein into the 
capsid shell (Novagen Inc., USA). 
3.1.2 Genetic characterisation of the S. typhimurium jroEL gene 
Previous studies in our laboratory have reported that S. typhimurium contains only 
one homologue of groEL, which exists in an operon with groES, and by Southern 
blot analysis the groESL locus has been mapped to approximately 93-96 genetic 
minutes on the S. typhimurium chromosome (Taylor, 1997). However, very little 
information exists in the databases about the genetic sequence of the S. typhimurium 
homologue of GroEL. With regard to these considerations, the present study offers 
the complete DNA sequence of S. typhimurium groEL, which has been initially PCR 
amplified from S. typhimurium SL1344 chromosome, and then cloned in different 
vectors for overexpression of the protein. Based on the high degree of homology 
among the groEL genes from the related species E. coli and S. typhi (Figure 3.2), 
primers have been designed for PCR amplification of the groEL fragment from the 
S. typhimurium SL1344 chromosome. Furthermore, the integrity of the GroEL 
protein expressed from the cloned gene have been verified by Western blot analysis. 
3.2 RESULTS 
3.2.1 Cloning and overexpression of the S. tvphimurium Rr0EL gene 
Cloning of the groEL gene into pBR325 
As a first step in cloning and overexpression of the groEL gene from S. 
typhimurium, a plasmid pIBi was constructed (see Table 2.2). This plasmid contains 
the groEL gene from S. lyphimurium SL1344, cloned between unique EcoRI and 
Hindlil sites within pBR325 (Bolivar, 1978; Blank and Wilson, 1982). Based on the 
high 93% identity between groEL genes from E. coli (X07850; Hemmingsen et al., 
1988) and S. lyphi (U01039; Lindler and Hayes, 1994), primers were devised to the 
5'- and 3'- ends of the groEL gene, to include nucleotides 1-18 (GroEL5 3; Lindler 
and Hayes, 1994) and 2117-2102 (GroH3TTA; Hemmingsen et al., 1988), 
respectively (Figure 3.2). These primers also incorporated EcoRI or Hindill sites at 
their 5'- ends respectively (see Table 2.1), for directional cloning into pBR325. 
Using these primers, the 1.6 kb groEL fragment was amplified from the genomic 
DNA of S. lyphimurium SL1344 by PCR (Figure 3.3). The product was then 
restricted with EcoPJ and Hindill endonucleases, and cloned into the corresponding 
sites of pBR325 (see Table 2.2) to form pIBi (see Figure 3.4). 
Following electroporation into DH5a cells, the transformants were grown for 12-16 
hours at 370C on LB/Ampicillin plates. 71 colonies out of 75 transformants, were 
found to be Amp R, TetS, Cm1S.  As further proof, the pIBi plasmid was isolated and 
subjected to digestion with endonucleases (Figure 3.5). After agarose gel 
electrophoresis, pIB 1 digested with either EcoRI and Hindill, gave a unique band of 
6.4 kb, and the EcoRJIHindIII restricted pIBi gave two bands, of approximately 4.7 
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kb 	 M 
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Figure 3.3 
PCR amplification of the groEL gene from S. typhimurium SL 1344 
chromosome. 
Shown is the PCR product (1.6 kb) obtained by PCR amplification of the groEL gene 
from S. typhimurium SL 1344 chromosome, using primers to the 5'- (Gr0EL53) and the 
3'- (GroH3TTA) ends of the gene. Figures on the left side of the picture show the size 
of each band of the molecular marker (lane M) and of PCR product (groEL). 
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Cloning of the S. typhimurium groEL gene into pBR325 to generate the 
plasmid pIB 1. 
The groEL gene (1.6 kb) was amplified from S. lyphimurium SL 1344 chromosome by PCR, 
then it was restricted with EcoRT and Hindfll and cloned into the EcoRI and HindIII unique 
sites of pBR325 (5.9 kb) to form piBi (6.4 kb). Key: Amp, gene encoding ampicillin 
resistance; Cml, gene encoding chioramphenicol resistance; Tet, gene encoding tetracycline 
resistance 
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Figure 3.5 - Restriction analysis ofpIBl. 
Transformants were verified for the presence of pIB 1 by restriction with different 
endonucleases. Key: lane M, 2./Hindul molecular weight markers; lane 1, unrestricted pIBI; 
lane 2, piBi restricted with EcoRl (6.4 kb); lane 3, piBi restricted with HindIII (6.4 kb); lane 4, 
pIBI restricted with both EcoRI and HindIII (4.7 kb and 1.6 kb); lane 5, groEL insert as a PCR 
product (1.6 kb); lane 6, pIBl restricted with BamHI (6.4 kb); numbers on the left show the size 
in kilobases of the molecular marker bands. 
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the groEL fragment within pIB 1. Interestingly, BamHI restriction of pIB 1 has given 
one linearised fragment (6.4 kb), whereas it was expected that this restriction might 
give back two fragments. This result will be explained later in terms of the 
sequencing data obtained for the S. lyphimurium groEL fragment. Plasmid pIB 1 was 
used over the course of the experiments performed in this study, to avoid further 
PCR amplifications and the likelihood of inducing point mutations within the groEL 
fragment. 
Cloning of the groEL gene into pTTO 18 
pTTQ 18 (4.56 kb) is an expression vector that has been constructed for the regulated 
expression of genes in E. coli (Stark, 1987). Based on the pUC multi-copy plasmids 
(Vieira and Messing, 1982), the pTTQ 18 vector contains a polylinker/lacZa region 
flanked by the strong hybrid trp-lac (tac) promoter. The promoter comprises the —35 
sequence from the E. coli trp promoter region fused to the —10 sequence from the E. 
coli lacUV5 promoter region (Amann et al., 1983; De Boer et al., 1983). This strong 
promoter allows routinely the accumulation of polypeptides at about 15-30% of the 
total cell protein (Baneyx, 1999). The tac promoter is then followed by the 
ribosome-binding site (RBS) and the translation-initiation codon ATG, followed by 
a set of unique cloning sites within the polylinker region. Foreign genes can be 
inserted into the polylinker, within the lacZa coding region, to give 
transcriptional/translational fusions. The plasmid also carries a strong transcription 
terminator from the E. coli rrnB promoter (Brosius et al., 1981) downstream from 
the polylinker region, together with the laci allele of the lac repressor gene 
(Muller-Hill et al., 1968). The hybrid promoter is subject to tight regulation by the 
laclQ allele, which produces sufficient repressor to prevent expression until addition 
of the inducer, the non-hydrolysable lactose analogue IPTG (Stark, 1987). 
In order to characterise the product of the cloned groEL gene from S. i'yphimurium 
SL1344 chromosome, the groEL fragment was cut from the pIBi vector at its 
Ranking EcoRI and HindIII sites, and cloned within the pTTQ18 polylinker, 
between EcoRI and HindIll unique sites, downstream of the strong tac promoter. 
This translational in-frame fusion of the groEL fragment allowed the production 
Rue 
within the E. coli JM109 cells, of large amounts of S. typhiinuriuin GroEL protein 
for studies of the expected size of the product (60 kDa) and of specificity of 
interaction with anti-GroEL antibodies. The new plasmid was named pIB2 (see 
Figure 3.6 for pIB2 construction). 
Plasmid pIB2 was isolated from the transformants (white colonies) on 
LB/Ampicillin plates containing X-Gal and IPTG, and then subjected to restriction 
analysis with various restriction endonucleases, as shown in Figure 3.7. 
Overexpression of S. typhimuriurn GroEL from JM109 (pIB2) cells 
Before proceeding any further with cloning of the groEL fragment into the T7 
genome, overexpression of the GroEL protein was examined in E. coli JM109 
(pIB2). Cells were grown at 370C in LB/Ampicillin (100 ig/m1) until an 0D600 of 
0.4. The production of the S. typhimuriurn GroEL protein was then induced by 
addition of 1 ruM IPTG. Induced and non-induced protein samples were solubilised 
in Laemmli solubilisation buffer (LSB; Laemmli, 1970) by boiling for 5 minutes, 
and then electrophoresed in a 10% (v/v) polyacrylamide resolving gel (SDS-PAGE), 
as shown in Figure 3.8A. Subsequently, the S. typhirnuriurn GroEL protein was 
characterised by Western blotting with polyclonal antibodies (1/10,000 dilution) 
raised against recombinant GroEL from E. coli (Sigma, UK). Horseradish 
peroxidase-conjugated donkey anti-rabbit IgG (SAPU, Scotland), at a dilution 
1/10,000, were used as secondary antibodies. Visualisation was performed using the 
chemi luminescent detection reaction catalysed by horseradish peroxidase (Figure 
The immunological reactivity with a protein of apparent molecular mass of 60 kDa, 
indicated that the S. typhirnurium GroEL protein was overexpressed, following 
addition of IPTG. These preliminary cloning and overexpression experiments, 
proved useful in demonstrating the integrity of the insert at both genetic and protein 
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Cloning of the S. lyphimurium groEL gene from pIBi into pTTQ18 to generate 
the plasmid pIB2. 
The groEL gene (1.6 kb) was excised from the pIB 1 plasmid with EcoRI and Hindlil and then 
inserted into the plasmid pTTQI8 (4.5 kb), between the EcoRI/HindIII sites within the multiple 
cloning site to form pIB2 (6.2 kb). Key: bla, gene encoding Ampicillin resistance (13-lactamase); 
MCS, multiple cloning site containing the unique sites, EcoRI and HindIIlI, within the lacZa 
coding region; Ptac, the hybrid trp-lac promoter; rrnB, transcription terminator; lad 2 allele of 
the lac repressor gene. 
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Figure 3.7 - Restriction analysis of pIB2. 
JM109 transformants were verified for the presence of the pIB2 plasmid by restriction with different 
endonucleases. Shown is an 0.8% agarose gel in which restricted and unrestricted DNA samples 
were resolved and then photographed under UV light. Key: lane M, X/HindIII molecular weight 
markers; lane 1, unrestricted pIB2; lane 2, pIB2 restricted with EcoRI (6.2 kb); lane 3, pIB2 
restricted with HindIll (6.2 kb); lane 4, pIB2 restricted with both EcoRI and HindIII simultaneously, 
which gave rise to a 4.5-kb fragment (pl1Q18), and to the groEL insert (1.6 kb); lane 5, groEL PCR 
product (1.6 kb); lane 6, pIB2 restricted with EcoRV ( as shown in Figure 3.6, pIB2 contains one 
EcoRV site which is located within pTTQ18 inside the lacP gene, and a second putative EcoRV site 
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Figure 3.8 
Overexpression of S. typhimuri urn GroEL protein from induced 
TM 109 (pIB2) cells. 
The S. typhimurium GroEL protein was induced in E. coil from the Ptac promoter of pIB2, 
by addition of 1mM 1PTG. Panel A: un-induced and induced samples were solubilised in 
100 p1 LSB by boiling for 5 minutes, and then 15 p1 from each solubilised sample were 
resolved on a 10% (v/v) polyacrylamide resolving gel and stained with Coomassie Brilliant 
Blue. Panel B shows a Western blot of a parallel protein gel, using polyclonal anti-GroEL 
antibodies for detection. Key: lane M, molecular size marker SDS-70L (Sigma); lane 1, un-
induced JM109 (pIB2); lanes 2, 3 and 4, JM109 (pIB2) induced for 30 minutes, 60 minutes 
and 90 minutes, respectively. The position of GroEL is shown by the arrowheads. 
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Cloning of S. tyhimurium groEL fragment into the T7 genome 
The procedure for cloning into the T7 vector (Novagen Inc., USA) consists in 
ligation of the insert between the vector arms provided in the kit, and incubation 
with an in vitro packaging extract. The phage product is subsequently infected into a 
suitable E. coli host (e.g., BLT5615). T7Select 1-lb vector dephosphorylated 
EcoRl/HindIII arms were therefore used for directional cloning of the S. 
typhimurium groEL fragment. To provide compatibility with the vector arms and 
obtain expression in-frame with the 1 OB protein, the groEL insert was cut from its 
flanking EcoRIIHindIII sites within the pIBi plasmid (see Figure 3.9). Ligation 
reactions (5.0 l) were incubated at 160C for 16-20 hours and then added directly to 
T7 Packaging Extracts for in vitro packaging of the phage. After incubation at room 
temperature for 2 hours, packaging reactions were stopped by adding sterile LB 
medium, and then stored at 40C with 20 .tl chloroform, until further use. 
Approximately 5x 104  pfulml was obtained when the mixture contained insert whilst 
in contrast, no plaques were observed in the absence of insert. 
Amplification of the T7 hybrid phage was then performed (see Chapter 2), to allow 
display of GroEL on the surface of the phage particles. This also was performed for 
positive control T7 phage, which expressed an S.tag peptide on the capsid shell. 
After plate lysate amplification, the titre of the recombinant phage was calculated to 
be 4.5 x 106  pfulml whilst 2 x 109  pfu/ml were obtained for the positive control. 
Identification and analysis of the recombinant T7 bacteriophage 
After the T7 recombinant phage had been constructed and amplified, screening of 
the T7 bacteriophage plaques for the groEL insert was performed by in situ 
hybridisation with a 32P-labelled DNA probe. Plasmid pIBi, which contains the S. 
typhimurium groEL insert, was labelled by incorporation of 32P-dCTP into duplex 
DNA by nick translation, using a Promega kit. The recombinant T7 bacteriophage 
was plated at approximately 400-500 plaques per 90-mm plate (corresponding to a 
10-3 dilution of the amplified T7 phage), and an imprint of the pattern of plaques was 
obtained by layering a nitro-cellulose filter onto the surface of the LC top agar. After 
denaturation with alkali, the phage DNA was bonded irreversibly to the filter by 
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T7Select 1-lb (36,219 bp) 
Figure 3.9 
The reading frame of the groEL insert cloned into EcoRI/HindIII T7Select 
1-lb vector arms. 
Shown is the insertion of the groEL fragment (1.6 kb) between EcoRI/HindIII T7Select I-
lb arms. The approximate position of gene 10 is marked on the T7Select 1-lb genome 
(36,219 bp). The position of the groEL insert fused at the carboxyl-terminus of the lOB 
protein-encoding fragment is shown. The EcoPJ and Hindill restriction sites are 
underlined. Asp and Pro are encoded on the left arm of the T7 vector, followed by the 
amino acids Asn and Ser created by an in-frame insertion of the EcoRI-cleaved groEL 
fragment. 
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baking at 800C, and then hybridised to the 32P-labelled pIBi plasmid by overnight 
incubation at 680C in 20 ml of a buffer that contained 6x SSC, 0.5% (w/v) SDS, 50x 
Denhardt's solution and 25 j.xl of denatured probe. Excess probe was removed by 
washing two times in Wash I solution (2x SSC, 0.1% SDS [w/v] in dH20) at 680C 
and another two times in Wash II solution (lx SSC, 0.1% SDS [w/v] in dH20) at 
680C, each time for approximately 1 'A hours, with rotation. The filters were exposed 
to an autoradiographic film and hybridising T7 plaques were identified by aligning 
the film with the original agar plate, as shown in Figure 3.10. As a control for the 
hybridisation protocol performed in this study, the amplified T7 bacteriophage 
containing the S.tag peptide was plated on a 90-mm plate at a dilution of 
approximately 10-5  (corresponding to 200 plaques per plate). However, these phage 
gave virtually no autoradiography, following the same protocol and using the same 
32P-labelled pIB 1 plasmid. 
Positive T7 recombinant plaques were analysed for the presence of the groEL insert, 
by performing a PCR amplification using a scrape from an individual plaque and 
primers which flank the multiple cloning site (T7SelectUP and T7SelectDOWN; 
Table 2.1). Approximately 35 T7 recombinant plaques out of - 450, were identified 
as positive by hybridisation with the 32P-labelled pIB 1 plasmid. Following PCR, 10 
plaques out of 35, proved positive for the presence of the 1.6 kb S. typhimurium 
groEL insert (Figure 3.11). PCR was also performed for the T7 positive control 
plaques as above, and the expected 152 bp fragment was obtained (data not shown). 
Plaques which were positive for both tests, were purified from 35-ml lysates, as 
described earlier (see Chapter 2). Essentially, a plug containing a single T7 positive 
recombinant plaque taken from the agar plate, was added to 35 ml M9LB medium 
containing Carbenicillin. The T7 were propagated in a BLT5615 host strain at an 
0D600 of 0.5. IPTG (1 mM) was added 30 minutes prior to infection of the T7 
phage, to allow expression of the 10A protein from the plasmid. Incubation at 370C 
with shaking was continued until lysis was observed. The clarified lysate was then 
treated with 5M NaCl to precipitate bacterial proteins, centrifuged, and then the 
supernatant was mixed with a 50% PEG 8,000 solution to precipitate T7 phage. 
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Figure 3.10 
In situ hybridisation of the recombinant T7 plaques with 32P-labelled pIB 1 
plasmid containing the S. lyphimurium groEL fragment. 
Shown is an autoradiographic film, after a 5-hour exposure, of an 90 mm-agar plate 
containing a 10-3  dilution of the amplified T7 recombinant phage after hybridisation with 32p_ 
labelled pIB 1. Numbers shown on the film indicate positive and negative plaques 
subsequently used for PCR amplification of the insert (1.6 kb groEL fragment) as shown in 
Figure 3.11. 
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Figure 3.11 - PCR amplification of T7 recombinant plaques. 
PCR amplification of the T7 recombinant phage was performed using a scrape from 
individual plaques. Following PCR with primers T7UP and T71DOWN (see Table 2.1) 10 
plaques proved to be positive for the presence of the groEL fragment (1.6 kb). Sample 
numbers correspond to plaques, as shown in Figure 3.10. Key: lane M, molecular weight 
marker II (Boehringer Mannheim, Germany); lanes 1, 4, 5, 6, 8, 12, 14, 16 are PCR products 
of negative plaques for in situ hybridisation; lanes 2, 3, 7, 9, 10, 11, 13, 15 are PCR products 
of positive plaques. Only lanes 2, 10, 11, 15 were found to contain a clean PCR product (1.6 


















M 	1 	2 
	
M 	1 	2 	3 
A. 
Figure 3.12 - PCR amplification of the T7 recombinant DNA. 
A. Recombinant 17 DNA (-.. 39,937 bp) was examined before being used as a 
template in PCR amplification. Key: lane M, X/HindIII molecular weight markers; 
lanes 1, 2, 17 recombinant DNA (100 ng) from the CsCl-purified phage. B. PCR 
products of the 17 recombinant DNA. Key: lane M, X/HindIII molecular weight 
markers; lane 1, PCR product using the primers T7UP and T7DOWN; lane 2, PCR 
product using the primers T7UP and GroH3TTA; lane 3, PCR product using the 
primers GroEL53 and T7DOWN. 
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After centrifugation, phage were resuspended in 10 mM Tris.HC1 (pH 8.0) 
containing 1M NaCl and 1mM EDTA, and the concentrated phage solution was 
purified by banding in a CsC1 step gradient. CsC1 layers were made by mixing a 
stock solution of 62.5% (w/v) CsCl with TE buffer (10 mM Tris.Cl, pH 8.0, 
containing 1 mM EDTA), and successively denser solutions were underlayered in a 
SW41 tube using a pipette. The phage solution was layered on top of the 4-step CsC1 
step gradient, centrifuged and the band containing phage particles was collected with 
a syringe needle. Purified recombinant T7 phage particles (-j 0.2 ml) were stored 
stably in the CsC1 solution at 40C. A plaque assay established their titre as 5x 1012 
pfulml. 
The T7 phage were then heat-treated (5 minutes at 650C) and ethanol precipitated 
(see Chapter 2). The DNA was resuspended in 20 il TE (pH 7.5) and was used for 
PCR amplification of the groEL insert. Figure 3.12A shows the recombinant T7 
DNA ( 40.0 kb) on a 0.5% agarose gel. The amplified fragment from the T7 
recombinant DNA prepared previously produced a band of approximatly 1.7 kb 
fragment (Figure 3.12B). 
Sequencing of the S. typhimurium groEL fragment cloned into the T7 genome 
Purification of large amounts of recombinant T7 phage containing the groEL 
fragment was performed from a 2 litre-lysate (grown as 4 x 500 ml in M9LB 
medium), as previously described (see Chapter 2). Briefly, 1 mM IPTG was added 
to four flasks containing 500 ml BLT5615 host cells at an 0D600 0.5 for 30 minutes 
at 370C with shaking, to induce 10A protein. Immediately after 1 OA induction, the 
host cells were infected with purified recombinant T7 phage containing the S. 
typhimurium groEL fragment (5x 1012 pfulml; 50 p1 per 500 ml culture) and allowed 
to lyse at 37°C for 1.5 hours. DNase I was added to each flask at 37°C for 15 
minutes. Bacterial proteins precipitation was facilitated by addition of NaCl and 
centrifugation. PEG 8,000 was then dissolved in the pooled supernatants to 
precipitate phage (at 40C for 12-16 hours), and was followed by centrifugation. The 
pellet was washed with 10% PEG 8,000 solution, and the phage were resuspended in 






banding in a CsC1 gradient (see Chapter 2). Approximately 4 ml purified 
recombinant T7 phage were obtained with a titre of 5 x 1013  pfulml. T7 DNA was 
then prepared from the purified recombinant phage by heat treatment (5 minutes at 
650C), phenol extraction and ethanol precipitation, and stored as 5 il-aliquots at - 
200C until used for PCR or sequencing purposes. 
The cloned groEL gene was amplified by PCR with primers T7SelectUP and 
T7Se1ectDOWN (Table 2.1), which flank the multiple cloning site within the 
T7Select 1-lb genome. A fragment of approximately 1.7 kb was amplified. This 
PCR product was purified using the QlAquick PCR Purification Kit (Qiagen GmbH, 
Germany), and quantified by running 1 1 of the product on a 0.8% (w/v) agarose 
minigel and comparing the intensity of the band with a control of known 
concentration (DNA molecular weight marker II, Boehringer Mannheim). 30-90 ng 
of PCR product was then used as template in cycle sequencing, using a Big Dye 
Terminator Kit (PE Applied Biosystems, USA). 
Figure 3.13 shows a diagram of the strategy followed in order to sequencing the 
amplified groEL gene. Primers used in sequencing (see Table 2.1) are shown 
relative to the organisation of the E. coil groEL gene, upon which they were 
designed (GenBank accession number X07850). The information generated by the 
sequencer was collected and analysed using GeneJockeyll (Biosoft) software. 
The complete DNA sequence of the entire coding region of S. typhimurium groEL 
gene is shown in Fig. 3.14. The data revealed the absence of a unique BamHI site 
within the S. typhimurium groEL gene, whereas the E. coii groEL gene sequence 
shows the presence of a unique BamHI site at bases 1482-1488 (base pairs 
numbering relates to the ATG start codon of the groEL gene; GenBank accession 
number X07850). This was confirmed by restriction analysis of the plasmid pIBi 
(Table 2.2) with the endonuclease BamHI, which shows one linearised fragment (6.4 
kb) after the BamHI restriction (see Figure 3.5) - there is a unique BamHI restriction 
site within the pBR325 vector. The sequencing data also confirmed that the S. 
typhimurium groEL gene was fused in-frame with the T7 phage lOB protein. 
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Expression of this fusion protein will be investigated and discussed later in this 
study. 
Figure 3.14 - The nucleotide sequence of the groEL gene from S. lyphimurium 
SL1344. 
Shown is the sequence of the groEL gene from S. typhimurium, and its corresponding amino acid 
sequence. The numbers at the left indicate nucleotide position and the numbers at the right indicate 
amino acid positions in the predicted protein sequence. The nucleotide sequences in bold letters 
represent the ATG start codon, the TAA stop codon, and, at location 1482, the absence of the BamHI 
site, found at the same location within the E. coli groEL gene (see GenBank accession number 
X07850). 
1 	 20 
atggcagctaaagacgtaaaattcggtaacgacgCtCgtgtgaaaatgCtgCgCggcgta 
MA A K DV KEG ND AR V K ML R G V 
61 	 40 
aacgtactggcagatgcagtgaaagttaccctcggtccgaaaggCcgtaaCgtggttctg 
N V LAD A V K VT L G P KG RN V V L 
121 	 60 
gataaatctttcggtgcgccgactatcactaaagatggtgtttCcgtagcgcgtgaaatC 
D KS F GA P TI T K D G VS VAR RI 
181 	 80 
gaactggaagacaagtttgaaaacatgggcgcgcaaatggtgaaagaagttgcctctaaa 
SLED KEEN MG A Q MV K E V A S K 
241 	 100 
gcgaacgatgctgcaggcgacggcaccaccaccgcgaccgtactggcgcagtccatcatt 
AND A A G 	G T T TAT V LA Q SIl 
301 	 120 
accgaaggcttgaaagccgttgctgcgggcatgaacccgatggacctgaaacgtggtatc 
T S G L K A V A A GM N P M D L KR G I 
361 	 140 
gacaaagcggttgctgcggcggttgaagagctgaaagCcCtgtCCgtaccgtgCtCCgac 
D K A V A A A V EEL K AL S V POS D 
421 	 160 
tctaaagcgattgctcaggtaggtactatctccgctaactccgacgaaacCgtaggtaaa 
SK A IA Q V G TI SANS D S TV G K 
481 	 180 
ctgatcgcggaagcgatggataaagt cggtaaagaaggcgt catcaccgttgaagacggt 
L 	A E A MD K V G KEG V IT V ED G 
541 	 200 
accggt ctgcaggacgaactggacgtggttgaaggtatgcagtttgaccgcggctacctg 
T G L Q DEL DV V E GM Q F ORGY L 
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601 	 220 
tctccttacttcatcaacaagCCggaaaCtggCgCagtagagCtggaaagcccgttcatc 
SPY F INK PET GAVEL ES P Fl 
661 	 240 
ctgctggctgataagaaaatCtCCaaCatCCgCgaaatgCtgCCggttCtggaagccgtt 
L LAD K K IS N IRE ML P V LEA V 
721 	 260 
gcaaaagcaggcaaaCCgCtgCtgatCatCgCtgaagatgttgaaggCgaagCgCtggct 
A K AG K P L L I I A ED V E GE ALA 
781 	 280 
accctggttgttaaC&CCatgCgtggCatCgtgaaagtggCtgCtgttaaggcacctggc 
T L 	V NT MR G IV K VA A V K A PG 
841 	 300 
ttcggcgatcgt cgtaaggcgatgctgcaggatatcgctacCCtgaCcggCggtaCCgta 
PG DR R K A ML Q DI AT L T G G TV 
901 	 320 
atctctgaagagatCggtatggagCtggaaaaagCaaCCctggaagaCCtgggtcaggcg 
IS E El GM EL E K AT LED L G Q A 
961 	 340 
aaacgtgttgtgatcaacaaagacaccaCCaCCatCatCgatggCgtgggcgaagaagct 
KR V VI N K OTT TI ID G V GEE A 
1021 	 360 
gccatccagggccgtgttgctcagatccgtcagcagattgaagaagCgaCCtCCgaCtaC 
Al Q G R V A Q I R Q Q I E EATS D  
1081 	 380 
gatcgtgaaaaactgcaggagcgcgtagcgaaactggCaggCggcgttgCggttatCaaa 
D R E K L Q ER VA K LAG G VA VI K 
1141 	 400 
gttggcgctgcgaccgaagttgaaatgaaagagaagaaagcccgcgttgaagatgCCCtg 
VGA AT EVE M K E K K AR V ED AL 
1201 	 420 
cacgcgacccgtgctgcggtagaagaaggcgtggttgCtggtggtggCgttgCgCtgatc 
HAT R A AVE E G V V AG G G V A L  
1261 	 440 
cgcgttgcttctaaaattgCtgaCCtgaaaggCCagaaCgaagaCCagaaCgtgggtatC 
R V A SKI A DL KG Q N E D Q N V G I 
1321 	 460 
aaagttgcgctgcgcgcaatggaagCtcCgCtgCgtCagatcgtgctgaaCtgCggCgaa 
K V AL RAM E A P L R Q IV L N C GE 
1381 	 480 
gagccgtctgttgtcgctaacaccgttaaaggCggcgacggtaaCtaCggttaCaaCgCa 
E PS V V A N TV KG G 	G NY G Y N A 
1441 	 500 
gcaactgaagaatacggcaacatgatcgatatgggtatcctggaCcCaaCCaaagttaCC 
A TEE Y G N MID M G I L D PT K VT 
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1501 	 520 
cgttctgcgctgcagtacgctgcttctgtggctggtctgatgatcactaccgagtgcatg 
R SAL Q Y A A S V AG L MITT E CM 
1561 	 540 
gtgaccgacctgccgaaaagcgatgctcctgatttaggcgCtgC ggcggcatgggtggt 
VT DL P K SD A PD L GA AG GM G G 
1621 	 548 
atgggtggtatgggcggcatgatgtaa 
MG GM G GM M * 
3.3 DISCUSSION 
The groEL gene from S. typhimurium SL1344 chromosome was successfully 
amplified from the genomic DNA and then cloned within a variety of vectors for 
different purposes. This allowed verification of protein expression from the 
amplified and cloned fragment, using plasmid pIB2. Before cloning into the T7 
bacteriophage genome, GroEL expression was also confirmed by performing a 
Western Blot with rabbit anti-GroEL (E. coli) antibodies (Sigma, UK). This showed 
induction of a 60-kDa band corresponding to the S. typhimurium GroEL protein, 
following IPTG induction. The theoretical molecular weight of the S. typhimurium 
GroEL is of approximately 60 kDa. 
Purified T7 DNA is easy to obtain in large amounts and has been completely 
sequenced (GenBank accession number VOl 146). By cloning of the S. typhimurium 
groEL fragment within the T7Select 1-lb genome, the hybrid T7 phage has been 
obtained. This phage has the GroEL protein fused in-frame with the lOB protein of 
the T7 bacteriophage and so should be expressed onto its shell. This will be used in 
experiments described in the forthcoming chapters. 
Very little information exists about the S. typhimurium homologue of GroEL. 
Previous studies in our laboratory have reported that S. typhimurium contains only 
one homologue of groEL, which exists in an operon with groES (Taylor, 1997). In 
the present study, the S. typhirnurium groEL gene has been sequenced. The S. 
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typhirnuriurn SL1344 groEL sequence has not been reported previously. The DNA 
sequence of the open reading frame has revealed 98% identity with the S. typhi 
groEL gene and 93% identity with the E. coli gene. Exploration of GenBank for 
homologues of the predicted protein has identified many members of the Hsp60 
family of stress proteins, with a high degree of similarity to GroEL. The amino acid 
identity range includes 100% for S. typhi GroEL, 98% for E. coli GroEL and 50% 
for the human mitochondrial gene product (see Figure 3.15 for an alignment). It 
cannot be excluded that point mutations may have arisen during the PCR 
amplification. However, the likelihood of this seems low since no frame-shift errors 
were identified by sequencing. 
As observed elsewhere (Hemmingsen et al., 1988), there is a high level of amino 
acid sequence identity between the prokaryotic and eukaryotic GroEL molecules. 
With the introduction of only a few gaps, 50% of the residues are identical and many 
of the differences represent conservative substitutions. However, the eukaryotic 
GroEL molecules contain an amino terminal sequence of 24-25 amino acids, which 
is not present in their prokaryotic counterparts. 
Based largely on studies of E. coli GroEL and mitochondrial Hsp60 in 
Saccharomyces cerevisiae, Hsp60s are believed to reside in the cytoplasm, either in 
the matrix or stroma of organelles (Craig et al., 1993; Soltys and Gupta, 1996). 
Furthermore, no member of the prokaryotic GroEL family possesses a leader 
sequence or other recognisable motifs that would suggest a secretory role (Garduno 
et al., 1998), and no such sequence appears within the putative amino acid sequence 
of S. typhimuriurn GroEL (see Figure 3.14 and Figure 3.15). However, a number of 
reports indicate an extra-cytoplasmatic location for the GroEL chaperonin. There are 
studies that report that surface-located Hsp60 mediates adherence of H. pylon 
(Huesca et al., 1996), C. difficile (Hennequin et al., 2001) and S. typhirnurium 
(Ensgraber and Loos, 1992) to host cells. Garduno and collaborators (1998) have 
shown that Hsp60 is surface-exposed during intracellular survival of L. pneumophila 
within host cells and that this molecule also mediates adherence of L. pneumophila 
to HeLa cells. In this respect it has been previously observed that during the early 
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infection of macrophages by L. pneurnophila, Hsp60 appears to be released into 
newly formed phagosomes (Fernandez et al., 1996). McLennan and co-workers 
(1993) have shown that the amino acid sequence of E. coli GroEL and other 
members of the Hsp60 family, share a carboxyl terminal motif, namely the GMR 
tail, variable in length and which consists mainly of glycine and methionine 
residues. They have demonstrated that this conserved carboxyl terminal sequence, 
present also within the putative amino acid sequence of GroEL from S. typhiinurium 
(see Figure 3.14 and Figure 3.15), is not required for normal growth and does not 
extend to adjacent sequences. Moreover, it has been experimentally demonstrated 
that the carboxyl terminus mediates an interaction of GroEL with lipid layers, and 
also suggested a lipochaperonin activity for GroEL (Torok et al., 1997). 
Regarding the three-dimensional structure of prokaryotic and eukaryotic 
chaperonins, they share a common design in which the substrate is enclosed in a 
central cavity. Their general structure reveals a radial symmetry, consisting of two 
rings assembled back to back (Gutsche et al., 1999). According to their sequence 
homologies, chaperonins have been classified into two groups: type I, which exist in 
bacteria and eukaryotic cellular organelles, that have seven-fold symmetry, and type 
II, comprising the eukaryotic cytosolic chaperonins, that have eight-folded 
symmetry (Gutsche et al., 1999). Consistent with this remarkable structural 
similarity, sequences of types I and II chaperonins have significant homologies, 
especially in the regions corresponding to the equatorial domain. Larger differences 
appear in the central region of the sequence, corresponding to the GroEL apical 
domain (Gutsche et al., 1999). 
Since Buchmeier and Heffron (1990) have observed that mice which are immune to 
virulent S. typhimuriurn infection mount a strong humoral response to GroEL after 
they are vaccinated with a live attenuated strain, research has focussed on the 
requirement for the recognition of GroEL in immunity to Salmonella infection. The 
derived protein sequence of S. typhimurium GroEL reported here may facilitate 
future studies of immune recognition of GroEL by an intracellular pathogen and also 
help identify epitopes which are recognised during infection. 
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Evidence for co-purification of cellular Gr0EL with bacteriophage T7 
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4.1 INTRODUCTION 
4.1.1 The T7 particle 
Bacteriophages are among the simplest biological entities known, and yet they carry 
out basic biological processes that occur even in the most complex organisms. 
Among phages that contain double-stranded DNA, T4 and 2 and their relatives have 
been favoured objects of study. Phage T7 appears to be less complex than T4, and 
along with its relative T3, is the smallest of the seven T phages originally described. 
It has a polyhedral head, a small, simple tail, and contains a single piece of double-
stranded DNA of molecular weight 25 x 106,  about one-fourth the size of the DNA 
from T even phages (Dubin et al, 1970). After infection, T7 specifies approximately 
30 proteins, which account for virtually all of the coding capacity of T7 DNA 
(Studier and Maizel, 1969). 
4.1.2 Infection cycle of T7 bacteriophage 
Initially, T7 was isolated as a phage that grows on E. coli B, but T7 and its close 
relatives grow equally well on E. coli K-12 and C strains and on some of the 
Shigellae. A number of E. coli strains, as well as other enterobacterial hosts, are 
nonpermissive for T7. It does not form plaques on fresh natural isolates of E. coli 
because it does not adsorb well to smooth or capsule-containing bacteria, and it can 
be propagated on S. typhimurium strains only if the latter are rough and lack the 
hsdLT restriction system (Molineux, 1999). 
The infection cycle of T7 has been described as beginning with the attachment of the 
tail fibers to the lipopolysaccharide of the E. coli outer membrane to initiate 
adsorption. Following adsorption, the infection process is made irreversible by 
proteolysis of the internal head proteins, which in turn allows disaggregation and 
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passage of the internal core structure into the cell. The core proteins enter the 
periplasm from where they insert into the cytoplasmic membrane, thereby 
completing a protein channel across the cell envelope for DNA translocation. Only 
when the transmembrane channel has been formed does DNA leave the phage head, 
but even then only - 850 bp enter the cell immediately. The remainder of the 40-kb 
genome is normally translocated into the cell as a result of transcription, initially by 
E. coli RNA polymerase and then by T7 RNA polymerase (Molineux, 1999). 
4.1.3 T7 proteins 
Purified T7 phage particles, when disrupted and electrophoresed on SDS-
polyacrylamide gels, give a distinctive pattern of protein bands, which can be 
visualised by staining or by autoradiography (Studier and Maizel, 1969), and at least 
11 different protein chains can be resolved when purified T7 particles are subjected 
to electrophoresis on SDS-PAGE gels (Studier, 1972). These account for almost half 
of the coding capacity of T7 DNA. Genes 7, 8, and 10 to 17 specify 10 proteins, and 
gene 9 specifies a protein found in empty head structures (Studier, 1972). 
Gene 10 of bacteriophage T7 specifies the major subunit 10A of the T7 head, a 
protein having a molecular weight of approximately 36 kDa, which accounts for 
more than 60% of the mass of the phage particle (Studier and Maizel, 1969), where 
the T7 phage mass is 7.4 x 10 14 grams (Mazzone, 1998). The second product of this 
gene, lOB (41 kDa), is produced by frameshifting into the —1 frame near the end of 
the 1OA coding frame (Condron et al., 1991). 1 O is approximately 10% that of the 
major subunit 1OA (Studier, 1972). Together 1OA and lOB represent 415 molecules 
on the phage capsid. Phages making only 1OA or lOB are also viable. 1OA-only 
phages grow like the wild type, but 1 OB-only phages produce distinctly smaller 
plaques (Steven and Trus, 1986). This frameshift event appears to be conserved in 
bacteriophage T3, a divergent relative of T7 (Condreay et al., 1989). The gene 10 
homologues of other T7-like phages are also thought to make two products; lOB 
may therefore be important under some conditions of infection (Molineux, 1999). 
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4.1.4 Time course of T7 protein synthesis 
Studier and Maizel (1969) have established patterns of protein synthesis during the 
growth cycle of wild-type T7 by pulse labelling with radioactive amino acids and 
SDS-PAGE. They have shown that 80-90% of the phage particles adsorb to their 
host within 1 minute. Synthesis of most T7-directed proteins begins between 7.5 and 
10 minutes after infection and continues until lysis, which begins approximately 25 
minutes after infection. Although T4, T5, and SPO1 bacteriophages seem to have 
complex mechanisms of control over protein synthesis, with T7 the pattern of 
synthesis seems relatively simple, by comparison (Studier and Maizel, 1969). T7 
proteins can be divided into three classes, which are called earliest, early, and late. 
The late proteins appear approximately 10 minutes after infection and are 
synthesised until lysis. This class includes proteins of the phage shell, i.e. capsid 
proteins 10A and 10B (Studier and Maizel, 1969), which have been used over the 
course of this study. 
This chapter describes different purification protocols for recombinant T7Select 1-
lb bacteriophage (Novagen, Inc., USA), in which the lOB protein of the phage was 
fused in-frame at its carboxyl terminus with S. typhimurium GroEL. In the T7 Select 
vectors, the natural translational frameshift site within the capsid gene was removed 
so only the truncated lOB protein is produced. The 10A capsid protein is produced 
from a plasmid by the E. coil BLT5615 host (Table 2.3), in which the recombinant 
T7 phage is grown (more details have been provided in Chapter2). This recombinant 
T7 bacteriophage incorporates onto its capsid 0.1-1 copies per virion of the lOB 
fusion protein. Purification of this hybrid T7 phage was performed prior to 
immunisation studies on BALB/c mice. 
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4.2 RESULTS 
Analysis of GroEL display on T7 bacteriophage 
In Chapter 3, the construction and purification of the recombinant T7 phage, 
encoding a 10B-GroEL fusion protein, was described. In order to confirm that the 
fusion protein was displayed on the phage, we purified the phage and examined it by 
immuno-blotting with anti-GroEL antiserum. For this purpose, recombinant T7 
bacteriophage was purified from clarified lysates by precipitation with polyethylene 
glycol (PEG 8,000) followed by extraction of phage from the PEG pellet in a 
solution of 10mM Tris.HC1, pH 8.0, containing IN NaCl and 1 mM EDTA. The 
concentrated phage solution was subsequently layered on top of four steps of 
different CsC1 density solutions and then banded in the CsC1 step gradient, as 
previously described in Chapters 2 and 3. DNA from a sample of recombinant T7 
phage (5 x 1013 pfulml from 2 litres of cells) was sequenced (see Chapter 3) and 
proved to have an in-frame fusion of the S. typhimurium groEL fragment to the lOB 
gene of T7. A T7 positive control, containing the S.tag peptide (2 x 109 pfu/ml) was 
also purified as above and yielded approximately 4 ml of phage, with a titre of 2 x 
iO13 pfu/ml. 
The recombinant T7 phage containing the S. lyphirnurium groEL fragment was used 
to perform a Western blot in order to verify the expression of the 1OB-GroEL fusion 
protein onto the phage capsid. The purified T7 S.tag phage (T7 positive control) was 
included as a control. Both purified T7 phages were initially solubilised in sample 
buffer by boiling for 5 minutes and then electrophoresed on a 7.5% (vlv) 
polyacrylamide resolving gel (SDS-PAGE) as previously described (Laemmli, 
1970). Subsequently, proteins were transferred to a nitro-cellulose membrane 
(Scleicher and Schuell) and then the non-specific binding sites were blocked (see 
Chapter 2). Polyclonal antibodies raised in rabbit against recombinant E. coli GroEL 
(Sigma, UK) were diluted in a 1% (wlv) solution of non-fat dry milk in T-TBS, and 
incubated with the membrane for 1 hour at room temperature. After washing, the 
membrane was incubated with 1% (wlv) milk solution in T-TBS, containing 
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horseradish-conjugated donkey anti-rabbit IgG (SAPU, Scotland) and binding was 
visualised using the chemiluminescent detection reaction catalysed by horseradish 
peroxidase. 
As can be seen in Figure 4. 1, the purified recombinant T7 phage containing S. 
typhimurium groEL fused with the 1013 minor capsid protein of the phage, shows 
two bands on the Western blot (lane 1): one upper band of approximately 100 kDa, 
and a lower 60-kDa band corresponding to the size of the purified GroEL protein 
from E. coli. It has been expected that the 1 OB-GroEL fusion protein would have the 
size of around 100 kDa, as lOB is 41 kDa in size and S. lyphimurium GroEL has a 
predicted size of approximately 60 kDa. The lower band in lane 1 could be 
explained perhaps, by cleavage of the fusion protein to release GroEL, or by co-
association of cellular GroEL as a complex with the fusion protein. However, the 
presence of the lower band of around 60 kDa in lane 2, which contains S.tag T7 
phage (positive control), was not expected and complicated the interpretation. 
GroES/EL chaperonins were found to take part in the assembly of the bacteriophage 
X, T4, T5, and 186 (Zeilstra-Ryalls et al., 1991). GroEL protein from the E. coli was 
shown to act in early steps of phage morphogenesis (Hendrix, 1979) and thus, it may 
remain attached to the mature T7 phage in the presence or absence of a GroEL 
fusion protein, through the CsCl purification (lanes 1 and 2, respectively). 
Conversely, the inability to separate the host GroEL from the T7 groEL-containing 
phage may suggest also that a specific protein-protein interaction may occur due to 
the natural affinity of GroEL monomers, which normally associate in a multimeric 
ring. 
Pulse chasing of the recombinant T7 phage proteins 
In order to help clarify the situation, we decided to examine the de novo synthesis of 
T7 proteins from recombinant T7. When bacteriophage T7 infects E. coli, the T7 
genes are expressed in an orderly progression (Studier and Maizel, 1969; Studier, 
1972). In a normal infection, T7 DNA is transcribed first by the host RNA 
polymerase (the early region), and then by a T7-encoded RNA polymerase (the late 
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Figure 4.1 
Purification and immunoblot analysis of recombinant T7 bacteriophage. 
The T7 GroEL-containing bacteriophage were purified using a CsC1 step gradient, as 
described in the text. After purification, phage were solubilised by boiling for 5 minutes in 
sample loading buffer (lx LSB), then 30 pA was loaded onto a 7.5% (v/v) polyacrylamide 
resolving gel (16 x 20 cm) and electrophoresed. Shown is a Western blot of the protein gel 
using polyclonal anti-GroEL antibodies (from Sigma). Key: lane 1, 17 GroEL-containing 
phage; lane 2, control T7-S.tag phage; lane 3, purified S. typhimurium GroEL (0.075 pig); 
molecular size markers (see Table 2.6) are shown on the left. 
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region). The class I genes are transcribed by E. coil RNA polymerase and include 
functions to overcome host restriction and to convert the metabolism of the host cell 
to the production of T7 proteins, the class II genes are the next to be expressed and 
include functions involved in DNA metabolism, and the class III genes are the last to 
be expressed (late genes) and include genes for proteins which form part of the 
phage particle (i.e., gene 10), or function in maturation and packaging of the DNA 
(Dunn and Studier, 1983). Pulse labelling of T7 phage proteins has been reported 
previously (Studier and Maize!, 1969; Studier, 1972). We adopted a similar strategy 
in this study, in order to examine expression of the recombinant 1 OB-GroEL (-100 
kDa) fusion protein from the T7 phage. 
An overnight culture of E. coil BLT5 615 carrying a plasmid from which 10A 
expression is controlled by a iacUV5 promoter (see Table 2.3), was diluted 
approximately 50-fold into LB (with Carbenicillin) and grown with shaking at 370C 
to an absorbance of 0.5 at 600 nm (approximately 4-6 x 108  cells/ml). The 
production of the 10A capsid protein was induced for 30 minutes by addition of 1 
mM IPTG. The culture (approximately 10 ml) was then irradiated in an open plastic 
Petri dish, for 6 minutes with ultraviolet light using a germicidal ultraviolet lamp 
located at approximately 40 cm above the sample. The cells were returned to a clean 
flask at 370C and shaken for 15 minutes, before infecting with T7. Approximately 5x 
1010 pfu of T7 phage were added to 1-ml cultures to give a multiplicity of infection 
of approximately 10 phage particles/cell. The same procedure was performed with a 
similar number of T7 S.tag phage, as a positive control, and the T7 phage were 
allowed to infect the E. coil cells for 8, 10, 12, 14, and 16 minutes, respectively. 
Then, each infected (1-ml) culture was mixed briefly with [3 S]-methionine (at a 
final concentration of 15 iCi/ml), and incubated for 2 minutes at 370C. The samples 
were centrifuged for 2 minutes at 12,000 g in a microcentrifuge and then the pellets 
were resuspended each in 1 ml fresh (cold) LB medium to provide excess unlabelled 
methionine, and samples were incubated for a further 4 minutes at 370C. Samples 
were pelleted by centrifugation for 5 minutes at 12,000 g, resuspended in LSB, 
boiled and then loaded onto a 7.5% SDS-PAGE resolving gel. The autoradiogram of 
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Pulse chasing of late T7 proteins from the GroEL-containing bacteriophage. 
A culture of E. coil BLT5615 grown in LB medium (Carbenicillin supplemented) was 
irradiated under U.V. light (6 minutes) and then infected with the GroEL-containing hybrid 
T7 bacteriophage at 370C for 8, 10, 12, 14, and 16 minutes, respectively. Then, each culture 
was pulsed for 2 minutes with [32S]-methionine. Cells were briefly incubated in fresh LB 
medium, harvested and subjected to electrophoresis on a 7.5% (vlv) polyacrylamide gel (16 x 
20 cm) followed by autoradiography, essentially as described by Studier and Maizel (1969). 
Shown is an autoradiogram of such a 7.5% SDS- polyacrylamide gel through which pulse 
labelled samples of the GroEL-containing T7 bacteriophage were electrophoresed. Key: lane 
M, [14C]-methylated protein molecular size markers (from Amersham; see Table 2.7); 
numbers on top of each lane show the time in minutes at the beginning of each 2-minute 
pulse. The same protocol was performed for the T7-S.tag control bacteriophage and the 
autoradiogram showed no difference (data not shown). 
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the electrophoresed samples was visualised after 2-day exposure to film at —800C 
(Figure 4.2). 
As the 1013 phage protein is a late protein of the T7 bacteriophage, it was expected 
that the fusion protein 1 OB-GroEL would be visualised after the 10-minute period in 
which T7 was allowed to infect the host cells. The absence from the autoradiogram 
of a distinct band, of approximately 100 kDa, may be a consequence of the low 
display level of the fusion protein per virion, expected to be 0.1-1.0 molecules per 
phage (Novagen Inc., USA). Pulse labelling experiment under different conditions 
(using concentrations of 8, 10, and 15 jiCi/ml [355]-methionine), were no more 
revealing (data not shown). As a result of the initial lack of autoradiographic signals, 
we decided to try longer exposure periods (from 2 days to 5 days) at —800C, and 
shorter U.V. irradiation periods (from 2 to 4 minutes), in case the ultraviolet light 
excessively damaged the bacterial cell, such that the phage infection was limited. 
Longer recovery periods for host cells at 370C, after U.V. irradiation, were also 
examined (15, 25, 35, 45, 55 minutes), but the 15-minute period gave the best result. 
As a control, radiolabelled T7 phage harvested from the supernatant was assessed 
for retaining infectivity and proved positive (data not provided). 
Extra-purification of the recombinant T7 bacteriophage 
The presence of the 60-kDa band on the previously discussed Western blot, namely 
in lane 1 (see Figure 4. 1), may have arisen as a result of association of cellular 
GroEL. Novagen Inc. describe a further purification for the CsC1-banded T7 phage, 
which involves adding CsCl 62.6% (wlv) to make the phage solution more dense 
than is used with the 2:1 CsC1:TE mixture, then floating it up to an interface with an 
10-ml upper layer of 1 M NaCl, and centrifuging at 35,000 rpm for 60 minutes in an 
ultracentrifuge (SW41 rotor). We attempted this procedure in order to determine if 
the 60-kDa protein would remain associated. 
1 ml CsC1-banded T7 phage suspension was subjected to the extra-purification and 
approximately 0.5 ml of T7 was obtained. This protocol was performed for both the 
GroEL-containing T7 and for the S .tag-T7 control. Initially, these lysates had titres 
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of 5 x 1013  pfulml, and 2 x 1013 pfulml, respectively and these increased to 5 x 10'7 
pfulml following further purification. 
The CsC1-banded and further purified phage, were denatured by boiling for 5 
minutes in Laemmli solubilisation buffer, and then electrophoresed on a 7.5% (wlv) 
polyacrylamide gel. After electrophoresis, the proteins from the gel were blotted 
overnight onto a nitro-cellulose membrane and a Western blot was performed as 
previously described (see Chapter 2). Figure 4.3 shows the Western blot following 
exposure to anti-GroEL polyclonal antibodies, anti-immunoglobulin antibodies 
conjugated to horseradish peroxidase and chemiluminescent detection. For the 
recombinant CsC1-purified T7, both the upper and lower bands of approximately 
100 kDa and 60 kDa were observed, but for the extra-purified phage, the upper band 
was missing. Moreover, the lower band was less intense, suggesting a possible 
contamination of the phage with cellular GroEL via direct adhesion to the phage. 
Therefore, another attempt was made in order to purify the groEL-containing T7 
bacteriophage. 
Purification of recombinant T7 bacteriophage under various conditions 
Purification in the presence of a protease inhibitor: 
Western blot analysis of CsC1-purified recombinant T7 showed the presence of a 60-
kDa band, in addition to the expected 100-kDa band, which represented 1 OB-GroEL 
fusion protein (Figure 4.1). In order to address whether the 60-kDa band arose as a 
result of proteolysis of the 1 OB-GroEL fusion protein, purification of the phage was 
carried out in the presence of the protease inhibitor 4-(2-aminoethyl) 
benzenesulphonylfluoride (AEBSF), a strong serine-protease inhibitor. The 
polypeptide fused to the bacteriophage 1 OB capsid protein and exposed on the phage 
surface, is known to have considerable structural flexibility (Houshmand et al., 
1999) and may be a target for degradation by proteases. Therefore, the protease 
inhibitor AEBSF was added to the phage lysate at a final concentration of 0.5 mM, 
at the stage of purification when the cell lysis occurred, concomitantly with DNase I 
addition (see Chapter 2), and also to all buffers used throughout the remainder of the 
purification. The recombinant T7 CsC1-purification in the presence of AEBSF was 
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Figure 4.3 
Extra-purification of the GroEL-containing T7 bacteriophage. 
The GroEL-containing T7 bacteriophage was initially banded through a CsCl step gradient and 
then further purified through an additional CsCl gradient, as described in the text. 50 .il of purified 
phage was electrophoresed on a 7.5% (vlv) polyacrylamide gel (7 x 8 cm). Shown is a Western 
blot of the protein gel using polyclonal anti-GroEL antibodies (Sigma). Key: lane 1, purified S. 
typhimurium GroEL (0.037 fig); lane 2, T7-S.tag positive control; lane 3, T7-GroEL after the 
second CsCl purification step; lane 4, GroEL-containing T7 bacteriophage after one CsCl 
purification; numbers shown on the left side correspond to size of protein markers (SDS-6H from 
Sigma; see Table 2.6). 
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performed using the single gradient purification, as previously described (2 litre-
scale; see Chapter 2). The purified phage (approximately 4 ml) exhibited a titre of 1 
x 10 3 pfulml. 
Purification in the presence ofaprotease inhibitor and various other conditions. 
Apart from degradation by proteases of the fusion protein, the 60-kDa band on the 
Western blot may be produced by co-purification of cellular GroEL with the T7 
phage. GroEL is known to affect protein folding (Horwich et al., 1993; Gaitanaris et 
al., 1994) and to be involved in early stages of phage morphogenesis (Georgopoulos 
et al., 1972; Hendrix, 1979; Tilly and Georgopoulos, 1982; Friedman et al., 1984). It 
has been demonstrated that at least 50% of the soluble proteins in E. coil form 
complexes with GroEL when diluted from denaturant into GroEL-containing 
solution (Viitanen et al., 1992), and that approximately 300 newly translated 
polypeptides strongly interact with E. coil GroEL (Houry et al., 1999). The inability 
to separate the cellular GroEL from the recombinant T7 phage through the CsCl-step 
gradient purification may suggest a protein-protein interaction, either to the T7 
phage itself or/and to the GroEL moiety from the 1 OB-GroEL fusion protein. It has 
been demonstrated that GroEL recognises and binds to polypeptides predominantly 
by hydrophobic interactions (Fenton et al., 1994), and that interactions between 
polypeptides and GroEL are nucleotide dependent: ATP binding and hydrolysis in 
GroEL control the binding of polypeptide/GroES and the folding/release of the 
polypeptide (Rye et al., 1997). Therefore, for the removal of the co-purifying 
cellular GroEL, an alternative method described by Thain and co-workers (1996) 
was employed, which used the addition of ATP and MgCl2 upon phage 
precipitation. 
In order to remove the cellular GroEL attached to the recombinant T7 phage, which 
gave the 60-kDa band on the Western blot, 1% SDS was added upon phage 
precipitation. SDS is an anionic detergent, which allows for efficient disruption of 
most expressed proteins and their ligands, and is included in the T7 Elution Buffer 
(Novagen Inc., USA) used for biopanning of the recombinant phage. 
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It is known that the T7 phage is stable to a broad range of harsh treatments, 
including a solubilising agent such as urea, or a protein denaturant such as the 
chaotropic agent guanidinium hydrochloride (Novagen Inc., USA). Therefore, 
proteins that attach to the recombinant T7 phage, such as the cellular GroEL, may be 
partially denatured with a water-soluble chaotropic agent such as a solution of 4M 
urea, added upon phage precipitation. Removal of the cellular GroEL attached to the 
recombinant T7 phage was also tried by addition of 2M guanidinium hydrochloride 
solution upon phage precipitation with 10% PEG in TE. 
The recombinant T7 phage was purified through a CsCl-step gradient from 2 litres 
of lysate, following the same steps as previously described (see Chapter 2). The 
entire purification was performed in the presence of the protease inhibitor AEBSF 
(at a final concentration of 0.5 mM), which was added to the phage lysate and then 
to all buffers used throughout the purification protocol, as described above. Thus, 
the 2-litre lysate was split in four after the addition of AEBSF and DNase I, and each 
500-ml recombinant T7 lysate followed the same steps for the purification through 
CsC1 gradient, each under different conditions. This experiment was performed for 
looking at the effect of several factors on purification of the GroEL-expressing T7 
phage. 
The removal of the putative cellular GroEL was performed by addition of ATP and 
MgCl2  (each at a final concentration of 5 mM) upon phage precipitation with 10% 
solution of PEG in TE, based on the concept that binding of ATP by GroEL triggers 
a conformational shift from a tight binding to a weak binding form of the protein 
(Badcoe et al., 1991; Thain et al., 1996). Additionally, AEBSF was added to the 
phage lysate and to all buffers used, as in the protocol described for the phage 
purification in the presence of AEBSF. Therefore, from the 2-litre phage lysate, 
which was split in four 500-ml samples, the 500-ml lysate purified in the presence of 
0.5 mM AEBSF, 5 mM ATP and 5 mM MgC12, approximately 1 ml pure phage was 
obtained, with a titre of 0.9 x 1013  pfulml. 
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Apart from adding AEBSF (at a final concentration of 0.5 mM) to the T7 phage 
lysate and to all buffers used throughout the CsC1 purification, the recombinant T7 
phage was purified in the presence of 1% SDS, added upon phage precipitation with 
10% solution of PEG in TE. Therefore, after the 2-litre T7 lysate was split in four, 
one of the 500-ml lysate was purified in the presence of 0.5 mM AEBSF and 1% 
SDS. Approximately 1 ml pure recombinant T7 phage was obtained, with a titre of 
0.8 x i013 pfulml. 
The third 500-ml sample of recombinant T7 lysate, from the 2-litre lysate initially 
split in four, was purified through CsCI step gradient in the presence of AEBSF, as 
previously indicated. Urea was added to a final concentration of 4M upon phage 
precipitation with 10% PEG in TB. After pulling out the putative phage-containing 
band present above the 2:1 layer in the CsC1 step gradient, the phage proved not to 
be viable and no titre could be established. 
The last 500-ml sample from the 2-litre recombinant T7 lysate split in four, was 
purified through CsC1 step gradient in the presence of AEBSF as previously 
described, and guanidinium hydrochloride was added upon phage precipitation, at a 
final concentration of 2M. After the ultracentrifugation step, no phage band was 
observed and after pulling out approximately 1 ml from where the phage band was 
expected to be situated, no plaques were obtained, which is contradictory to the 
Novagen technical recommendations. 
The T7 recombinant phage purified under the conditions described above were 
solubilised by boiling in LSB, electrophoresed on a 7.5 % (v/v) polyacrylamide gel, 
blotted overnight onto a nitro-cellulose membrane, and Western blotted, as 
previously indicated (see Chapter 2). Figure 4.4 illustrates the Coomassie-stained 
protein gel (Panel A), and the Western blot (Panel B) performed using polyclonal 
anti-GroEL antibodies and horseradish peroxidase/ECL detection, as previously 
described. Figure 4.4A shows faint patterns of the T7 proteins (lanes 3, 4, 5, 6, 7), 
and of S. typhimurium GroEL (lanes 1 and 2) purified using a sucrose density 
gradient protocol. Use of a Silver stain protocol may circumvent this limitation by 
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Purification of GroEL-containing T7 phage under various conditions. 
A. The recombinant T7 bacteriophage was purified through a CsCI step gradient (2L-scale) as 
previously described. A protease inhibitor (AEBSF) was added at a final concentration of 0.5 mM 
into the cell lysate and in all buffers used to resuspend the phage throughout the course of 
purification. After each purification, 50 p1 purified phage was loaded onto a 7.5% (v/v) 
polyacrylamide resolving gel (16 x 20 cm) and stained with Coomassie Brilliant Blue. B. Shown 
is a Western blot of an equivalent gel, using polyclonal anti-GroEL antibodies and 
peroxidase/ECL detection, as described previously (see Chapter 2). Key: lane M, molecular size 
markers (SDS-6H; see Table 2.6); lane 1, purified S. typhimurium GroEL (0.37 .tg); lane 2, 
purified S. typhimurium (iroEL (0.075 pg); lane 3, 
purified recombinant T7 in the presence of 
AEBSF; lane 4, purified recombinant T7 in the presence of AEBSF and precipitated in the 
presence of 5 mM ATP and 5 mM MgCl2; lane 5, purified recombinant T7 in the presence of 
AEBSF and precipitated in the presence of 1% SDS; lane 6, purified recombinant T7 in the 
presence of AEBSF and precipitated in the presence of 4M urea; lane 7, purified recombinant T7 
in the presence of AEBSF and precipitated in the presence of 2M guanidmium hydrochloride. 
providing higher resolution and by detecting nanogram quantities of proteins (Blum 
et al., 1987). The intense band visible on the Coomassie-stained gel (lanes 3, 4, 5) is 
thought to represent the major capsid protein (1 OA), with a size of 36 kDa (Dunn 
and Studier, 1983). On the gel, this band is not visible for the recombinant T7 phage 
purified in the presence of 0.5 mM AEBSF and 4M urea, or 0.5 mM AEBSF and 
2M guanidinium hydrochloride (lanes 6 and 7), and may indicate that the T7 phage 
is not stable when purified under these conditions, finding confirmed by the lack of 
viability for these purified phage. From Figure 4.4B, it can be seen that the Western 
blot in which the recombinant T7 phage was purified in the presence of the protease 
inhibitor AEBSF showed a very intense 60-kDa band and also a faint 1 00-kDa band 
(lane 3). This suggests that the treatment with a strong protease inhibitor, such as 
AEBSF, does not eliminate the presence of the 60-kDa protein shown on the 
Western blot, and therefore this protein is unlikely to result from cleavage of the 
10B-GroEL fusion protein by proteases. This suggests that cellular GroEL remains 
attached to the recombinant T7 phage and co-purifies with it. The action of 
proteases which are insensitive to AEBSF cannot be ruled out, however. Lane 4, 
which contains the recombinant T7 phage purified in the presence of AEBSF, ATP 
and Mg 2+' showed two distinct bands (60-kDa and 100-kDa) on the Western blot, 
suggesting that the ATP/Mg2  treatment does not remove the contaminating GroEL 
efficiently. However, lane 5, which contains the recombinant T7 phage purified in 
the presence of AEBSF and 1% SDS, showed a single 1 00-kDa band, suggesting 
that the 1% SDS treatment introduced upon phage precipitation with 10% PEG 
solution, can eliminate association of phage with the 60-kDa GroEL from cellular 
sources or from degradation. 
Purification of the recombinant T7phage in the presence ofaprotease inhibitor and 
1%SDS: 
As a further test for co-association of the 60-kDa band, purification of T7 phage was 
also examined in the presence and absence of 1% SDS and the alternative protease 
inhibitor phenylmethyl-sulphonyl fluoride (PMSF). Purification and Western blot 
analysis was carried out as before. 
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The T7 recombinant phage (GroEL-containing) was purified through the CsC1 step 
gradient from 2 litres of lysate (see Chapter 2) obtained by infection of E. coli 
BLT56 15 cells with the previously amplified T7 phage (with a titre of 15 x 1010 
pfu/ml). The T7 lysate was split in four 500-ml lysates and each 500-ml lysate was 
purified under the following conditions: in the presence of 0.5 mM PMSF, in the 
presence of 0.5 mM PMSF and 1% SDS, in the absence of PMSF, and in the 
presence of 1%SDS and absence of PMSF. The protease inhibitor was added upon 
lysis and was incorporated in all buffers used throughout the purification protocol, 
and the SDS was added only upon phage precipitation, as described above. 
Approximately 0.8 ml purified phage were obtained in each case. Their titres were 
established as follows: the recombinant T7 phage purified in the presence of 0.5 mM 
PMSF and 1% SDS had a titre of 0.7 x 1013 pfu/ml, the T7 phage purified in the 
presence of 0.5 mM PMSF (without addition of 1% SDS) had a titre of 0.94 x 10 3  
pfu/ml, the T7 phage purified in the absence of 0.5 mM PMSF and 1% SDS had a 
titre of 0.95 x 1013  pfu/ml, and the T7 phage purified in the presence of 1% SDS and 
with no addition of 0.5 mM PMSF had a titre of 1 x 10' pfu/ml. In parallel, the T7 
positive control phage (S.tag-containing), with a titre of 2 x 109 pfu/ml, was used to 
infect host cells and was then purified from a 1 litre of lysate, through the CsC1 step 
gradient. The lysate was split in two 500-ml samples which were processed as 
described above, in the presence and absence of the protease inhibitor PMSF (added 
at a final concentration of 0.5 mM). Approximately 1 ml purified phage were 
obtained in each case. The T7 positive control phage purified in the absence of 
PMSF had a titre of 2 x 1013  pfu/ml and the T7 positive control phage purified in the 
presence of 0.5 mM PMSF had atitre of 1.5 x 10 3 pfu/ml. 
The purified T7 phage were boiled for 5 minutes in LSB, loaded on a 7.5% (v/v) 
polyacrylamide gel, and then electrophoresed. After blotting onto a nitro-cellulose 
membrane, a Western blot was performed with polyclonal anti-GroEL antibodies, as 
previously described (see Chapter 2). Figure 4.5 shows the Silver-stained protein gel 
(Panel A) and the Western blot (Panel B). The T7 GroEL-containing phage purified 
in the presence of 0.5 mM PMSF, but without addition of 1% SDS upon phage 
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Figure 4.5 
Purification of the GroEL-containing and positive control T7 phage. 
A. The T7 GroEL-containing and the T7 positive control (Stag-containing) bacteriophage were 
purified through a CsCI step gradient (2L-scale), as described in the text. After each purification, 
30 i1 from each phage were loaded on a 7.5% (v/v) polyacrylamide gel (16 x 20 cm), 
electrophoresed and the gel was stained  using the Silver stain protocol. B. Shown is a Western blot 
of an equivalent gel using polyclonal anti-GroEL antibodies and peroxidase/ECL detection, as 
described previously (see Chapter 2). Key: lanes 1, 2, and 3 contain purified T7 phage in the 
absence of any protease inhibitor, as follows: lane 1, T7-S.tag phage; lane 2, T7-GroEL phage 
precipitated in the presence of 1% SDS; lane 3, T7-GroEL phage precipitated in the absence of 
SDS; lane 4, purified S. typhimurium GroEL (0.075 fig); lanes 5, 6, and 7 contain T7 phage 
purified in the presence of the protease inhibitor PMSF, as follows: lane 5, T7-S.tag phage; lane 6, 
T7-GroEL phage precipitated in the presence of 1% SDS; lane 7, T7-GroEL phage precipitated in 
the absence of SDS; numbers shown on the left side correspond to size of protein markers (SDS-
6H from Sigma; see Table 2.6). 
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100 kDa, suggesting that the 60-kDa band corresponded to cellular GroEL attached 
to the phage, rather than to the action of proteases. However, the recombinant phage 
purified in the absence of both the protease inhibitor and SDS (Panel B, lane 3) gave 
a single 60-kDa band, suggesting that the presence of the protease inhibitor 
prevented the action of proteases on the fusion protein displayed on the phage 
capsid. The same recombinant T7 phage purified in the presence of 0.5 mM PMSF 
and precipitated with 10% PEG solution containing 1% SDS (lane 6), gave a single 
1 00-kDa band on the Western blot, corresponding to the 1 OB-GroEL fusion protein, 
indicating that the contaminating cellular GroEL was disrupted efficiently from the 
phage through the SDS treatment, and also that the addition of the protease inhibitor 
preserved the integrity of the fusion protein. The absence of bands for the S.tag-
containing T7 phage purified in the absence and presence of PMSF (Panel B, lanes 1 
and 5) strengthens the conclusion that the 60-kDa band present on Western blot is 
mainly the result of cellular GroEL associated to the 1 OB-GroEL fusion protein 
displayed on the recombinant T7 phage, and not only to T7 proteins. 
Purification of the AhpC-containing T7 bacteriophage 
Previous studies performed in our laboratory (Francis et al., 1997; Taylor et al., 
1998) established that the ahp locus of S. typhimurium is a macrophage-induced 
locus, is not essential for S. typhimurium virulence, and that an immune response is 
elicited against the AhpC polypeptide by both humoral and cellular arms of the 
immune system during the course of Salmonella infection. The ahp locus from S. 
typhimurium is a bicistronic locus, which encodes ahpC and ahpF (Tartaglia et al., 
1990). Work performed in our laboratory produced a hybrid T7 bacteriophage by 
cloning a 505-bp fragment from the S. typhimurium ahpC gene (166-729 bp; 
GenBank accession number J05478) between the EcoRJIHindIII arms of the 
T7Select 1-2a phage (Novagen Inc., USA). The value of the AhpC-containing T7 
bacteriophage in this study was to establish the mechanism through which GroEL 
co-purified with the T7 bacteriophage. This allowed distinguishing between cellular 
GroEL that stuck to the 1 OB-GroEL fusion protein, and GroEL which bound to other 
phage proteins. This AhpC-containing T7 phage was also used in immunisation 
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studies on BALB/c mice, in parallel with the S. typhimurium GroEL-containing T7 
phage. 
In order to undertake analysis of GroEL binding to the AhpC-containing T7 
bacteriophage, it was first of all necessary to validate the DNA sequence of the 
insert. For this purpose, the fragment was amplified using primers T7UP and 
T7DOWN (see Table 2.1), and DNA from the T7-AhpC phage (following 
phenol/chloroform extraction of CsC1-purified phage). Primers T7UP, T7DOWN 
and SPHI-ANT1739 (Table 2.1) were used for sequencing (see Figure 4.6). The 
sequencing data confirmed that the ahpC fragment, inserted into the T7Select 1-2a 
genome, is fused in-frame with the lOB gene and that no point mutations were 
introduced by performing the PCR amplification (see GenBank J05478 for the S. 
typhimurium ahpC sequence). 
Having validated the insert sequence, the T7-AhpC bacteriophage was purified 
through a CsC1 step gradient, as previously described (see Chapter 2). The 2-litre 
clarified lysate was split in four 500-ml lysates and separately processed through the 
CsC1 step gradient purification as follows: in the presence of 0.5 mM PMSF and 1% 
SDS, in the presence of 0.5 mM PMSF and without addition of 1% SDS, in the 
absence of both 0.5 mM PMSF and 1% SDS, and in the absence of 0.5 mM PMSF 
but under addition of 1% SDS. Approximately 0.8 ml purified phage were obtained 
in each case. The titres of the resulting phage were: 0.5 x 1013 pfulml for the phage 
purified in the presence of 0.5 mM PMSF and 1% SDS, 0.5 x 10' pfulml for the 
phage purified in the presence of 0.5 mM PMSF and without addition of 1% SDS, 
0.5 x 10 3  pfulml for the phage purified without addition of 0.5 mM PMSF or 1% 
SDS, and 0.5 x 10'3  pfulml for the phage purified in the presence of 1% SDS 
(without addition of 0.5 mM PMSF), respectively. 
The recombinant AhpC-containing T7 phage was used as a control system to 
compare with the GroEL-containing T7 bacteriophage. The presence of cellular 
GroEL was tested by purifying the AhpC-containing T7 phage under various 






















































Purification of the AhpC-containing and GroEL-containing T7 phage under various 
conditions prior to being used in immunisation studies on BALB/c mice. 
A. The AhpCcofltaifl1flg and GroEL-containing T7 bacteriophage were purified through a CsC1 step 
gradient (2L-scale), as described in the text. After each purification, purified phage were loaded on a 
7.5% (v/v) polyacrylamide resolving gel (16 x 20 cm), electrophoresed and stained using the Silver 
stain protocol. B. Shown is a Western blot of an equivalent protein gel analysed using polyclonal anti-
GroEL antibodies and peroxidase/ECL detection, as previously described (see Chapter 2). Key: lanes 1, 
2, 3, and 4 contain purified T7 phage in the absence of a protease inhibitor (PMSF), as follows: lane I, 
T7-Gr0EL phage precipitated with 1% SDS; lane 2, T7-GroEL phage precipitated in the absence of 
SDS; lane 3, T7-AhpC phage precipitated in the absence of SDS; lane 4, T7-AhpC phage precipitated 
with 1% SDS; lane 5, purified S. yphimurium 
GroEL (0.37 .ig); lanes 6, 7, and 8 contain purified T7 
phage in the presence of the protease inhibitor PMSF, as follows: lane 6, T7-GroEL phage precipitated 
with 1% SDS; lane 7, T7-GroEL phage precipitated in the absence of SDS; lane 8, T7-AhpC phage 
precipitated in the absence of SDS; lane 9, T7-AhpC phage precipitated with 1% SDS; numbers shown 
on the sides correspond to size of protein markers (SDS-6H; see Table 2.6). 
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described previously. The purified phage were boiled for 5 minutes in LSB, loaded 
on a 7.5% (v/v) polyacrylamide gel, electrophoresed, and then blotted onto a nitro-
cellulose membrane. Figure 4.7 shows the Silver-stained protein gel (Panel A) and 
the corresponding Western blot (Panel B). As expected, the CsC1-purified GroEL-
containing T7 phage (lane 7) showed two distinct bands (60-kDa and 100-kDa) on 
the Western blot, whereas the same hybrid bacteriophage precipitated with 1% SDS 
(lane 6), showed a single 1 OO-kDa band, corresponding to the 1013-GroEL fusion 
protein. The AhpC-containing T7 bacteriophage, precipitated with 1% SDS in the 
absence or presence of PMSF (lanes 4 and 9), showed no 60-kDa bands in either 
case, whereas the absence of SDS correlates with the appearance of very faint 
GroEL bands. This finding indicates that GroEL co-purifies with the T7 phage 
independently of the nature of the displayed fusion protein, but can be removed by 
precipitation of phage with 1% SDS prior to the CsC1 density gradient 
centrifugation. 
4.3 DISCUSSION 
In the 1970s, a number of laboratories reported the isolation of E. coli mutants that 
blocked growth of either bacteriophage 2 or T4, specifically at the level of head 
assembly, and bacteriophage T5 at the level of tail assembly (Georgopoulos et al., 
1973; Sternberg, 1973; Zweig and Cummings, 1973). The groE mutants were so 
named because they blocked bacteriophage 2 growth (gm), and the first 
bacteriophage X mutants able to propagate on these mutant bacteria were shown to 
have amber mutations in gene E, whose product is the major capsid protein of 
bacteriophage X, hence the designation groE (Georgopoulos et al., 1973; Sternberg, 
1973). The previous genetic experiments of Fayet and collaborators (1989) 
demonstrated that both the groES and groEL genes are absolutely essential for E. 
coli viability under all growth conditions tested. This type of approach has been very 
recently extended to show that the groES gene can be deleted in the presence of the 
31 gene of bacteriophage T4 or the cocO gene of bacteriophage RB49 (Ang et al., 
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2000). Not only can the bacteriophage-encoded genes completely substitute for 
groES in E. coli growth, but also can replace groES for both bacteriophage 2c and T5 
growth as well. These genetic studies were substantiated by in vitro experiments that 
demonstrate that these bacteriophage-encoded polypeptides can replace GroES in 
the folding of all tested protein substrates of GroEL (Ang et al., 2000). 
In this chapter, we explored whether CsCI-purified T7 bacteriophage, containing the 
S. typhimurium GroEL protein fused in-frame with the lOB minor capsid protein of 
the phage, and expressed onto the phage surface, contained co-purifying cellular 
GroEL. GroEL from the E. coli BLT5615 T7 host appeared on Western blots of 
CsCI-banded recombinant T7 phage as a 60-kDa band along with the anticipated 
100-kDa band, which corresponds to the fusion protein. The S.tag-T7 phage purified 
through a CsC1 step gradient gave also a 60-kDa band on the Western blot (see 
Figure 4.1). 
Previous studies have shown that patterns of T7 proteins synthesis can be 
established using SDS-PAGE and pulse labelling with [35S]-methionine (Studier and 
Maizel, 1969). Using this approach, a protein appears on an autoradiogram only if it 
is being synthesised during the period of the pulse, but disappearance of a band does 
not necessarily relate to the physical loss of that protein and can be explained by 
abolition of further synthesis. In the present study, we explored whether a 100-kDa 
fusion protein was synthesised, using this strategy. The 1013-GroEL fusion protein 
from the recombinant T7 phage was expected to be visualised after 10 minutes of 
incubation of the hybrid phage with the host cells, as a late T7 protein. However, the 
autoradiogram (see Figure 4.2) showed the lack of autoradiographic signal for the 
100-kDa band corresponding to the fusion protein, and there was no difference to 
the autoradiogram for the T7-S.tag control phage. Thus, the inability to detect the 
presence of the 100-kDa band corresponding to the 1013-GroEL fusion protein on 
the autoradiogram of the radio-labelled late proteins from the hybrid T7 
bacteriophage may be explained by the small proportion (less than 10% of the total 
capsid protein) represented by the fusion protein. Other factors may also have had an 
influence. For example, the infection of irradiated E. coli BLT5615 host by the 
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hybrid T7 phage, under the conditions used, may be anomalous. It has been reported 
that, using this approach, DNA synthesis is delayed and greatly reduced, with the 
maximum rate being less than 15% of normal and the total incorporation less than 
10%. Moreover, the onset of lysis is delayed approximately 5 minutes and the period 
of lysis is prolonged thereby diluting the signal. In addition, the final burst size is 
known to be very low using this approach and probably produces less than one 
infective particle per cell (Studier and Maizel, 1969). 
Removal of GroEL from the purified T7 phage was initially examined by a second 
CsC1-centrifugation, but this method proved unsuccessful (see Figure 4.3). Addition 
of serine-protease inhibitors throughout the T7 purification protocol improved the 
general outcome by protecting the expressed 1OB-GroEL fusion protein from action 
of cellular proteases, yet the presence of the 60-kDa band on Western blots is still 
visible. This also supports the view that the 60-kDa band on Western blots of T7 
purified bacteriophage, is not the result of 1OB-GroEL degradation by cellular 
proteases, but the result of co-purification of bacterial GroEL with the T7 phage. 
However, this would not exclude the action of non-serine protease activity. 
As a further attempt to remove GroEL from the purified T7 phage, the addition of 
ATP and Mg2  during phage precipitation was explored. It is known that interactions 
between polypeptides and GroEL are nucleotide-dependent: ATP binding and 
hydrolysis by GroEL control the binding of polypeptide/GroES and the 
folding/release of the polypeptide (Rye et al., 1997). In the present study, 
precipitation of the hybrid T7 phage with ATP did not completely remove the 
GroEL chaperonin, possibly indicating a strong interaction between GroEL and the 
phage. The addition of GroES in addition to ATP and Mg 2+  upon phage precipitation 
with 10% PEG, may well have been sufficient, as GroES can induce the release of 
GroEL from the phage or the surface-exposed fusion protein (Thain et al., 1996), but 
this possibility was not explored. Very recently, Rohman and Harrison-Lavoie 
(2000) developed an ingenious method for the complete removal of the 
contaminating GroEL based on addition of urea-denatured proteins to compete with 
the expressed protein for binding to GroEL. However, the protein denaturants urea 
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and guanidine greatly affect phage viability and so, cannot be used in the present 
situation. This study did find that addition of 1% SDS upon phage precipitation with 
10% PEG successfully removed the co-purifying bacterial GroEL, possibly through 
disruption by the anionic detergent SDS, of the protein complex between the phage 
and bacterial GroEL. This provides an efficient method for removing associated 
GroEL from CsC1-banded T7 bacteriophage. 
The hybrid T7 bacteriophage which expressed onto its capsid a fragment of the 
AhpC protein from S. typhimurium, fused in-frame with the capsid protein 1013 of 
the phage, was used in this study as a control system for the T7-GroEL 
bacteriophage. A Western blot of the T7-AhpC phage (see Figure 4.7) purified in the 
presence of 1% SDS, either in the presence or absence of a protease inhibitor 
(PMSF), showed the lack of the 60-kDa band, and a faint 60-kDa signal for the 
phage purified in the absence of PMSF. These findings may suggest that cellular 
GroEL co-purifies with the T7 phage regardless of the protein expressed on the 
capsid, can be removed by precipitation with 1% SDS, and addition of a protease 
inhibitor throughout the purification protocol prevents contamination of phage with 
this chaperonin. 
Because the GroEL-containing T7 phage was used over the course of this 
investigation in immunisation studies on mice, it was important to avoid any 
contamination of the T7 bacteriophage with bacterial proteins. In case of co-
purification of GroEL protein from E. coli with the recombinant T7 phage, which 
exposes on its surface S. typhimurium GroEL fused to the lOB phage protein, 
immunisation with this product could induce immune responses in mice, directed 
not only to the S. typhimurium GroEL, but also to E. co/i GroEL. In this case, the 
levels of anti-GroEL antibodies in the immunised mice could be monitored 
incorrectly. 
The evidence provided by this study supports the fact that cellular GroEL co-purifies 
with the T7 bacteriophage and also that, this bacterial chaperonin attaches to the T7 
phage capsid. The primary function of GroEL is to ensure that polypeptides fold 
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properly in the cell and this chaperone acts primarily by binding to reactive surfaces 
of polypeptides, which are hydrophobic (Fenton et al., 1994), thus preventing 
aggregation and promoting proper folding. Thus, attachment of cellular GroEL to 
the hybrid T7 phage, regardless of which polypeptide is expressed on its capsid, may 
relate to the primary function of GroEL as a chaperonin. However, the formation of 
stable interactions between the expressed GroEL-10B fusion protein and the 
molecular chaperone GroEL may result in the co-purification of the cellular protein 
with the T7 phage. This cannot be discerned from the present data, however. 
Moreover, binding of cellular GroEL to the GroEL-containing T7 hybrid 
bacteriophage may well be tighter than to the other hybrid bacteriophages, since 
GroEL naturally forms a barrel-shaped multimer. Early genetic studies identified the 
E. coli groES and groEL genes whose mutations blocked the growth of 
bacteriophage ?c, T4, T5 and 186 (Zeilstra-Ryalls et al., 1991), their encoded 
polypeptides being involved in the phage assembly process. Moreover, the host co-
expression of GroEL and GroES chaperonins was shown to increase the titre of the 
packaged M13 bacteriophage (Soderlind et al., 1995). Additionally, based on the 
very recent findings (Ang et al., 2000) that some phage capsid proteins may 
substitute for GroES in folding of protein substrates of GroEL, the attachment of 
cellular GroEL to the T7 phage is further emphasised. However, unlike several other 
phages, T7 was shown to be able to propagate in groE mutants (Molineux, 1999), 
but such mutants may not have been completely devoid of GroEL function. 
CHAPTER 5 
Study of the T7 bacteriophage as a vector to deliver bacterial proteins 
to the immune system of the host 
5.1 INTRODUCTION 
Infection by both typhoidal and non-typhoidal serovars of S. enterica remains a 
considerable global health problem (see Chapter 1). The emergence of multiple 
antibiotic-resistance among S. typhi strains and hence, the increased incidence of 
typhoidal mortality (Gupta, 1994), have increased the need of developing effective 
vaccine strategies to minimise or eliminate S. enterica-related diseases. In addition, 
S. enterica infection in animals is a common occurrence and has economic 
importance in agriculture and animal husbandry (Coynault et al., 1996). A vaccine 
against S. enterica infection in animals, may also limit the spread of S. enterica 
infection to humans via the food chain (Maurice, 1994). 
Early studies on vaccines against S. enterica employed whole cell preparations 
(reviewed in Plotkin and Orenstein, 1999). However, apart from the inconvenience 
of using a multiple dose regimen, which may be difficult to implement in developing 
countries (Bloom, 1989), these vaccines induced minimal production of secretory 
IgA antibodies (Forrest et al., 1991; Nisini et al., 1993), a weak cell-mediated 
immune response (D'Amelio et al., 1988), and short-lived protection (Collins, 1974; 
Chatfield et al., 1992). The low efficacy of these vaccines prompted the search for 
improved immunisation procedures. Attenuated live salmonellae have played a 
major role in recent vaccine development, as they generate effective long-term 
protection due to their ability to elicit both humoral and cell-mediated immunity. 
The greater degree of immunity induced by live attenuated organisms has been 
attributed to their ability to persist in the host (Chatfield et al., 1992; Dougan, 1994; 
Ivanoff et al., 1994; Mastroeni et al., 1996). However, field trials demonstrated that 
live attenuated vaccines may produce symptoms of typhoid fever in vaccinees 
(Miller et al., 1993; Ivanoff et al., 1994) and may need multiple doses to sustain 
protective immunity (Ivanoff et al., 1994; Plotkin and Bouveretlecam, 1995). 
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Attenuated S. typhimurium cells produce stronger cell-mediated immunity and 
greater immunological protection in mice than killed cells (Collins, 1974; Mastroeni 
et al., 1993). This protection was attributed to the production and recognition of 
bacterial proteins induced in response to the host environment (Kagaya et al., 1992). 
Preliminary work on other bacterial species, such as M tuberculosis, has 
investigated the use of mycobacterial proteins in the development of a subunit 
vaccine (Andersen and Heron, 1993; Andersen, 1994; Gelber et al., 1994; Horwitz et 
al., 1995; Silva et al., 1996; Tascon et al., 1996). It was shown that proteins which 
are selectively secreted by replicating bacteria, and which are also believed to be 
released when the bacteria reside within the macrophages, generate strong cell- 
mediated responses and are thought to be an important factor in the elimination of 
Mycobacteria from the host. Vaccination of mice with M tuberculosis culture 
filtrates was found to prime T cells against a broad spectrum of these proteins 
(Andersen and Heron, 1993; Andersen, 1994; Horwitz et al., 1995), and produce 
protection at a level equivalent to that produced by the BCG vaccine (Andersen and 
Heron, 1993). 
Other studies have employed the intracellular pathogen L. pneumophila, which 
produces a fatal form of pneumonia. It has been demonstrated that guinea pigs 
injected with the Major Secretory Protein (MSP), a heat shock protein homologue of 
GroEL, showed 80-85% survival three weeks after virulent bacterial challenge, and 
the preparation was more effective than dead cells (Blander et al., 1990; Blander and 
Horwitz, 1991, 1993). However, MSP itself is not directly involved in virulence, 
thus, protection does not always correlate to the immune recognition of virulence 
determinants. Such studies showed that any polypeptide that has the potential to 
initiate an immune response in the presence of a pathogen may be effective in 
inducing protective immunity, and can be seen as a candidate for a subunit vaccine 
(Blander and Horwitz, 1991). The most important property of these polypeptides is 
that, when suitably administered, they are capable of inducing a TO type of immune 
response (Galdiero et al., 1990, 1993, 1995, 1997; Kagaya et al., 1992; Gupta et al., 
1996a). 
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Very few S. enterica-derived polypeptides capable of inducing protection against a 
virulent bacterial challenge have been identified so far. When BALB/c mice were 
injected intra-peritoneally with KatG, a stress-induced catalase, 50% protection 
against a virulent strain of S. typhimurium was achieved after three weeks. In a 
separate study, S. typhimurium outer membrane proteins (OMPs) have been 
subcutaneously injected into BALB/c mice and proved to induce protective 
immunity against a lethal bacterial challenge (Udhayakumar and Muthukkaruppan, 
1987). However, while proteins associated with pili and flagella, and the KatE 
protein from S. typhimurium, have been shown to induce a DTH reaction, they have 
not been found to be protective (Kagaya etal., 1992; Gupta et al., 1996a). 
For practical use, subunit vaccines are usually preferred over live vaccines, as live 
vaccines present a greater risk of vaccine-induced complications. However, live 
vaccines are easier to produce and can elicit long-lasting immunity after only a 
single immunisation. In addition to being less reactogenic than live vaccines, 
recombinant subunit vaccines have a tendency to be less immunogenic than their 
conventional counterparts, particularly when highly purified. The contaminants 
found in some subunit vaccines may aid the inflammatory process, and thus boost 
immune response. This problem might be overcome by employing one of the many 
new types of adjuvants that are becoming available (Dertzbaugh, 1998), to improve 
immunogenicity and regulate the balance between TO (mostly cellular) and TH2 
(mostly humoral) immune responses (Gupta and Siber, 1995; Vogel, 1995; Gupta et 
al., 1996). 
Many recent studies have attempted to use novel adjuvants, such as native or 
recombinant cytokines, in combination with subunit vaccines to induce TO 
immunity (see Chapter 1). IL-12 is normally produced by macrophages and B cells 
upon stimulation by microorganisms or their products, and is believed to influence 
the formation of a TH 1 type of response (Hendrzak and Brunda, 1995; Trinchieri, 
1995; Abbas et al., 1997) and promote macrophage activation through IFN-y 
(Hendrzak and Brunda, 1995; Trinchieri, 1995). Native or recombinant IL-12 has 
been used as an adjuvant with soluble protein antigens, and proved efficient in 
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sustaining memory and effector TH1 cells in vivo (Bliss et al., 1996; Mountford et 
al., 1996; Noll and Autenrieth, 1996; Jankovic et al., 1997; Arulandam et al., 1999; 
Park et al., 2000; Stobie et al., 2000). Treatment of mice with recombinant IL-12 has 
been shown to increase resistance against salmonellosis (Kincy-Cain et al., 1996). 
5.1.1 GroEL as major component of a Salmonella enterica vaccine 
Heat shock proteins are widely distributed and highly immunogenic molecules. 
Hsp60 has been shown to be an immunodominant antigen of Mycobacteria and 
other microorganisms (Kaufmann, 1991; Jones et al., 1993a). Mycobacterial Hsp60 
has been used as a carrier molecule for conjugated vaccines (Barrios et al., 1992; 
Perraut et al., 1993) and as an adjuvant (Peterman et al., 1993). The ATP-treated 
molecule can be covalently linked or loaded with peptides, which will elicit specific 
immunity without the need for another adjuvant (Barrios et al., 1992; Perraut et al., 
1993; Ciupitu et al., 1998). This effect may be explained by Hsp60-induced 
stimulation of 13-chemokine production from dendritic cells, macrophages, and CD4 
and CD8 T cells (Lehner et al., 2000). 
The importance of GroEL in generation of immune responses during infection by S. 
typhimurium has been demonstrated initially by Buchmeier and Heffron (1990a), 
and later, antibodies specific to S. lyphi GroEL have been found in sera from 
patients with typhoid fever (Tang et al., 1997). Even though the predominant 
antibody response to S. enterica is directed towards the surface of bacteria, specific 
immune responses to GroEL as well as other intracellular proteins have been 
recorded (Brown and Hormaeche, 1989; Buchmeier and Heffron, 1990a; Tang et al., 
1997). Taylor (1997) assessed the immunogenicity of S. typhimurium GroEL and 
AhpC during infection in mice. Both GroEL and AhpC induced specific cell-
mediated and humoral immunity. When mice were challenged subcutaneously with 
purified GroEL or AhpC at days 33 and 104 post-infection, a significant increase in 
footpad swelling was observed, suggesting the presence of memory T cells (Taylor, 
1997). In contrast to the results with AhpC, the antibody response to GroEL, 
although it developed less rapidly, was of a greater magnitude and duration, with 
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substantial antibody levels present at days 28 to 114 post-infection. This suggested 
that the kinetics of a humoral response to these two proteins could be different. The 
immunogenicity of GroEL has been confirmed by the appearance of antibodies after 
injection of the protein into uninfected mice (C. J. Inchley, personal 
communication). 
Genetically modified bacteriophage offer an alternative method of immunisation 
with proteins such as GroEL. They are highly immunogenic, and specific anti-phage 
antibodies are rapidly induced (Inchley, 1969; Inchley and Howard, 1969; 
Greenwood et al., 1991; Meola et al., 1995; Manoutcharian et al., 1999; Grabowska 
et al., 2000; Zuercher et al., 2000). As previously shown, the key advantage of this 
type of immunogen is that no adjuvant is required for its application (Manoutcharian 
et al., 1999). In the present study, the hybrid T7 bacteriophage expressing S. 
typhimurium GroEL protein fused to the lOB capsid protein of the phage (Chapter 
3), has been employed as a vehicle to deliver GroEL to the immune system of 
BALB/c mice, to investigate the ability of this construct to induce anti-GroEL 
immunity. 
5.1.2 AhpC as a candidate in Salmonella-vaccine design 
Oxidative stress is known to widely damage the bacterial cell (reviewed in Farr and 
Kogoma, 1991), and the ability of S. enterica to withstand the oxidative killing 
mechanisms of macrophages was demonstrated by the derepression of multigenic 
responses (Demple, 1991). For example, hydrogen peroxide stress induces at least 
30 proteins, of which 9 are under OxyR regulatory control. The OxyR regulon 
includes alkyl hydroperoxide reductase (Ahp), as well as catalase (KatG), 
glutathione reductase (GorA), and a non-specific DNA-binding protein (Dps) 
involved in protection of DNA against oxidative damage (Christman et al., 1985). 
The biochemical characterisation of S. typhimurium alkyl hydroperoxide reductase 
(Ahp) showed that this enzyme consists of two subunits, a small (26-kDa) subunit, 
AhpC, with peroxidase activity, and a larger (56-kDa) subunit, the flavoprotein 
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AhpF (Jacobson et al., 1989). In living cells, elimination of alkyl hydroperoxides is 
particularly important since they can initiate lipid peroxidation chain reaction and 
consequently propagate free radicals, leading to DNA and membrane damage 
(Halliwell and Gutteridge, 1984). In S. typhimurium, loss of the specific regulator 
OxyR, or the genes it regulates, makes the cells extremely susceptible to peroxide 
stress (Christman et al., 1985; Almiron et al., 1992; Buchmeier et al., 1995). Using 
the Mudlux reporter system, it has been shown that the ahpC gene is transcribed 
during the interaction of S. typhimurium with macrophages (Francis and Gallagher, 
1993; Francis et al., 1997). Similarly, it has been reported that ahpC is expressed by 
Mycobacterium species during their interaction with macrophages 
(Dhandayuthapani et al., 1994). Very recently, it has been demonstrated that AhpC 
is a major antigen constitutively and highly expressed in M avium, without the 
bacteria being submitted to oxidative stress. Infection of goats with M avium 
induced production of antibodies against AhpC and strong IFN-y responses (Olsen et 
al., 2000). Previous studies have shown that the S. typhimurium AhpC protein is 
antigenic in rabbits (Storz et al., 1989). More recently, it has been shown that while 
the AhpC polypeptide is not essential for the virulence of S. typhimurium in BALB/c 
mice, it is recognised as an antigen during infection (Taylor et al., 1998), resulting in 
positive antibody responses at 14 and 28 days post-infection. Purified AhpC was 
also found to elicit a significant inflammatory reaction (DTH) in infected mice at 33 
days and 104 days post-infection, a time at which the bacteria have been cleared 
from the host (Mastroeni et al., 1993). AhpC is expressed by S. typhimurium during 
infection of BALB/c mice and constitutes a target for the immune system. 
In order to further investigate its immunogenicity, this study has employed the 
hybrid T7 bacteriophage expressing a large fragment of S. typhimurium AhpC 
protein on its capsid, as a delivery vehicle of this protein to the immune system of 
BALB/c mice. By virtue of the presence of E. coli GroEL from the phage host 
attached to the hybrid T7 bacteriophage through the purification protocol, regardless 
of the protein expressed (Chapter 4), the AhpC-containing recombinant T7 phage 
has been used as a control in immunisation studies on mice, compared to the GroEL-
containing T7 bacteriophage. Levels of antibodies mainly against GroEL, but also 
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against AhpC, have been monitored after a two-dose regimen for intravenous 
immunisation of BALB/c mice with purified hybrid T7 bacteriophages. 
Induction of a significant antibody response directed towards the protein expressed 
on the T7 phage capsid (i.e., S. typhimuriurn GroEL or AhpC) would give a clear 
indication, in terms of future vaccine design, about the use of the T7 bacteriophage 
as an efficient vector able to deliver bacterial immunogenic proteins to the immune 
system of the host. Moreover, it would provide information about the 
immunogenicity of the T7 bacteriophage compared to other immunogens previously 
used, such as the purified proteins administered in the presence of alum as an 
adjuvant, and attenuated bacterial strains (i.e., S. typhiinurium aroN 1344 
[MPG479]; Taylor, 1997). 
5.2 RESULTS 
5.2.1 Elaboration of an ELISA test 
The ELISA protocol initially described by Cavanagh and McBride, (1997), was 
optimised in the present study in order to determine serum antibody levels to GroEL 
and AhpC induced after immunisation of mice with hybrid T7 bacteriophages (see 
Chapters 3 and 4). All washes and other general procedures were carried out as 
described in Chapter 2. Initially, in a preliminary test (Assay 1), a 96-well plate was 
coated with purified S. typhin1uriurn GroEL for 4 hours at 370C, at a concentration of 
1 jig/ml in coating buffer (Lauritzen et al., 1994). Blocking was performed by 
addition of blocking buffer (1% [w/v] skimmed milk in washing buffer) at 370C for 
1 hour. Subsequently, the plate was incubated overnight at 40C with doubling 
dilutions of mouse serum samples, assayed in duplicate. Dilutions of rabbit 
polyclonal anti-GroEL antibodies (Sigma, UK) were included as a positive control. 
HRP-conjugated anti -immunoglobulin antibody with specificity for either mouse or 
rabbit immunoglobulins (SAPU, Scotland, UK), was added at a dilution of 1:500 in 
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blocking buffer. After incubation for 30 minutes at 370C, the wells were washed, 
and then incubated for 15 minutes at 37°C with 0.1 mg/ml O-phenylenediamine and 
0.012% H202 in development buffer (24.5 mM citric acid monohydrate and 52 mM 
Na2HPO4, pH 5.0). The reaction was stopped with 2M H2SO4  and absorbance was 
measured at 492 nm. 
Negative controls (blocking buffer instead of both antibodies) and second step 
controls (no first antibody) were routinely included. Also included as standards to 
confirm the effectiveness of the assay, were pooled normal BALB/c serum and 
pooled day 28 serum from mice immunised with the attenuated S. typhimurium 
strain MPG 479 (Taylor, 1997). Positive wells were identified as those having an 
OD greater than the mean of the second step control plus three standard deviations. 
Assuming a normal distribution, the probability of a negative result falling above 
this value is less than 0.01%. This method was preferred to the regression analysis of 
Crowther (2001). Results are given in Table 5.1. 
Subsequently, an optimised ELISA (Table 5.1) was developed from preliminary 
protocol, to increase its sensitivity. Previously, Taylor (1997) concluded that 
uninfected mice may have been exposed to GroEL or a related antigen prior to 
infection. Thus, a dilution of 1:100 of pooled normal mouse sera gives a positive 
reaction (un-published data) in a Western blot against GroEL, while at a dilution of 
1:200 a positive reaction is also occasionally seen (Taylor, 1997). Based on these 
findings, it was expected that the titre of anti-GroEL antibodies for normal mouse 
sera would be in the region of 100 to 200. Thus, the anti-GroEL antibody titre of 
normal sera obtained in the preliminary test at a value below 8 (2 3)  suggests that the 
protocol was not sufficiently sensitive. As a consequence, conditions employed in 
the preliminary ELISA test were modified in order to provide the test with a higher 
sensitivity (Chapter 2). Briefly, after coating the plate overnight at 40C with 1 .1g/ml 
purified S. typhimurium GroEL, and washing as before, blocking was performed for 
5 hours at room temperature (220C). Mouse sera were applied and incubated 
overnight at 40C. After a further wash, HRP-coupled anti-immunoglobulin 
antibodies were added and incubated for 30 minutes at 3 70C. Incubation with the 
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Figure 5.1 
Anti-GroEL antibodies measured by an optimised ELISA. 
The optimised ELISA has been performed as described in the text. The absorbance readings 
(O.D.) corresponding to each sample dilution (expressed as log2) are plotted. The endpoints 
for each mouse serum sample (tested in duplicate) can be assessed from this graph using the 
method described in the text. They correspond to the values given in Table 5.1. The buffer 
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HRP substrate was for 15 minutes at room temperature, in a dark chamber. Results 
from this optimised test relating anti-GroEL antibodies levels in tested samples, are 
plotted as a 1092  of the serum dilution against the measured absorbance (O.D.) (see 
Figure 5.1). 
According to the optimised test, the titre of anti-GroEL antibodies for normal mouse 
serum falls between 26  (64) and 2 (128) (Table 5.1), a level which corresponds to 
the predicted value. Further, the titre of anti-GroEL antibodies for the mouse anti-
aroA serum (at day 28 post-infection) was found to fall beyond 211, a level which 
better supports the previous studies (Taylor, 1997). 
The coating antigen must be titrated to obtain an optimal assay (Crowther, 2001). 
Therefore, the coating S. lyphimurium GroEL antigen was applied in dilutions of 1 
jig/ml, 0.5 jg/ml, 0.1 i.g/ml, 0.05 jtg/ml, and the test carried out as described for the 
optimised ELISA (Assay 2, Table 5.1). Results are illustrated in Figure 5.2 and 
confirm that the optimal coating concentration for GroEL remains 1 jtg/ml, as lower 
concentrations do not increase the sensitivity of the test. Based on the results 
obtained from the optimised test (Assay 2), the procedure described for this ELISA 
test is used throughout the present study, mainly for determination of antibody levels 
induced in mice after injection with hybrid T7 bacteriophages. 
5.2.2 Examination of antibody responses of mice infected with the hybrid T7 
bacteriophage 
The aim of this section was to determine whether the T7 bacteriophage could be 
used as a vector for immunisation of mice with bacterial proteins. This was 
addressed by using recombinant T7 bacteriophage which express on their capsid 
either GroEL or AhpC from S. typhimurium fused in-frame with the lOB minor 
protein of the phage (see Chapter 3 and Chapter 4 of this thesis). 
After an initial pre-bleed, four groups of five female BALB/c mice, aged 4-6 weeks 
(15-20 g) were injected intravenously (i.v.) with 1010 pfu of CsC1-purified hybrid T7 
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phage in 100 1.11 of phosphate buffered saline (PBS) from the stock preserved at 4°C. 
Groups A and B were injected with T7-GroEL and groups C and D with T7-AhpC 
(Table 5.2). The immunising dose for the hybrid T7 phage was chosen because it 
had been previously shown (Inchley, 1969; Inchley and Howard, 1969) that a single 
intravenous injection with 108  pfu of T4 bacteriophage induced a rapid antibody 
response against the phage. Because the T7Select System (Novagen Inc., U.S.A.) 
used in this study provides only 1-0.1 copies of the bacterial protein expressed on 
each capsid, the immunising dose was increased one hundred times, to 1010  pfu 
hybrid T7 per mouse. The T7 hybrid bacteriophage was administered in two separate 
intravenous injections 14 days apart. After infection with the hybrid T7 
bacteriophage, mice were supplied with a commercial pellet diet and water ad 
libitum. Ten days after the first phage injection (day 10), and six and twelve days 
after the second phage injection (days 20 and 26), mice were bled and individual 
mouse sera were tested for antibodies by ELISA. 
It has been shown in Chapter 4 of this thesis that cellular GroEL from the E. coil 
host attaches to the phage and co-purifies with it. Mice were therefore immunised 
both with a normal phage preparation (groups B and D) or a preparation from which 
bacterial GroEL had been removed (groups A and Q. Removal of the contaminating 
GroEL from the hybrid T7 phage was performed by precipitation of phage with 10% 
PEG solution containing 1% SDS, and CsCl-purification in the presence of 0.5 mM 
PMSF (see Chapter 4). The experimental details are summarised in Table 5.2. 
Background antibody levels to GroEL in normal mouse sera 
Previous studies have suggested a level of background immunity to S. typhimurium 
proteins in normal laboratory mice (Brown and Hormaeche, 1989). More recently, 
Taylor (1997) showed that purified GroEL, injected subcutaneously (s.c) into 
footpads of uninfected mice, induces a transient increase in footpad thickness, 
suggesting previous immunological recognition of GroEL, or previous encounter 
with cross-reacting antigens. Taylor (1997) also showed the presence of anti-GroEL 
antibodies in pooled normal mouse sera (pre-immune sera) by Western blot analysis. 
An occasional weak positive response was reported for the presence of anti-GroEL 
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Treatment 
Mouse (Schedule of T7 immunisation) 
Group  Comments 
Day  Day 14 
T7/GroEL/PMSF/SDS (*) T7/GroEL/PMSF/SDS  (*) T7 	from 	which 	the 
A (1010 pfulmouse; i.v.) (10 10 pfu!mouse; i.v.) exogenous GroEL was 
removed 
T7/GroEL/PMSF (**) T7/GroEL/PMSF (**) T7 	containing 	the 
B (1010 pfulmouse; i.v.) (10 10 pfulmouse; i.v.) cellular 	GroEL 
attached to the phage 
T7/AhpC/PMSF/SDS T7/AhpC/PMSF/SDS (***) T7 	from 	which 	the 
C(***1 (1010  pfulmouse; i.v.) exogenous GroEL was 
(101 	pfulmouse; i.v.)  removed 
T7/AhpC/PMSF (****) T7/AhpC/PMSF (****) T7 	containing 	the 
D (10'° pfulmouse; i.v.) (1010 pfulmouse; i.v.) cellular 	GroEL 
attached to the phage 
Table 5.2 
A summary of the experimental protocol for examining the generation of an 
antibody response specific to either GroEL or AhpC, after immunisation of mice 
with the hybrid T7 bacteriophage. 
Key: (*) T7 hybrid phage containing S. typhimurium GroEL, purified in the presence of 0.5 mM 
PMSF and precipitated with 1% SDS (T7/GroEL/PMSF/SDS); (**) T7 hybrid phage containing S. 
typhimurium GroEL, purified in the presence of 0.5 mM PMSF (T7/GroEL/PMSF); (***) 17 
hybrid phage containing a fragment from S. typhimurium AhpC, purified in the presence of 0.5 mM 
PMSF and precipitated with 1% SDS (T7/AhpC/PMSF/SDS); (****) T7 hybrid phage containing a 









GroA 	GroupB 	GroC 	GroupD 
Figure 5.3 
Background anti-GroEL antibody levels in all groups of mice used in 
the hybrid T7 immunisation study. 
Mice (five per group) were bled prior to being injected with the hybrid T7 
bacteriophage and the titre of anti-GroEL antibodies in pre-immune (normal) mouse 
individual sera was determined by an ELISA test, as previously described. Groups A, 
B, C, and D of mice were given different immunising hybrid T7 bacteriophages, as 
specified in Table 5.2. Error bars represent standard deviations. 
184 
antibodies using a dilution of 1:200 of normal mouse sera. This result has been more 
recently confirmed by experiments in our laboratory, which found a positive result 
for the presence of anti-GroEL antibodies, by performing a Western blot with a 
dilution of 1:100 from pooled normal mouse sera (unpublished data). 
Prior to starting the experiments outlined in this chapter, all the mice (groups A, B, 
C, D) were bled and the sera analysed for the presence of antibody specific to 
GroEL by ELISA. This would determine whether the mice had previous exposure to 
GroEL or a cross-reacting antigen. Anti-GroEL antibody titres in normal mouse sera 
were found to fall near to 2 and 28,  and were plotted as shown in Figure 5.3. there 
are no significant differences (p<0.05) regarding the titre of anti-GroEL antibodies 
in pre-immune sera, between the four groups tested in this study, as shown by 
analysis of variance (p = 0.14). 
Anti-GroEL antibody responses in mice immunised with the hybrid T7 
bacteriophage 
Mice were given two intravenous injections 14 days apart, of the hybrid T7 
bacteriophage (Table 5.2). Primary anti-GroEL antibody responses were analysed by 
ELISA 10 days after the first injection, and secondary responses were analysed on 
days 20 and 26. The ELISAs followed the optimised protocol, and the cutoff value 
specific to each plate, was calculated as before. Multiple tests were performed for 
each individual antiserum, in order to verify the reproducibility of the assay. 
Assuming a normal distribution of data, the paired Student's t-test was employed to 
analyse the different treatments. Group A mice, immunised with the S. typhimurium 
GroEL-containing hybrid T7 phage, from which the contaminating GroEL from the 
E. coli T7 host was removed, showed a very small increase in levels of specific 
antibody 10 days after initial immunisation (p = 0.024), and 6 and 12 days after 
challenge (p = 0.003, p = 0.014, respectively), when compared with the background 
(day 0) levels (see Figure 5.4, Panel A). Group B mice was immunised with the S. 
typhimurium GroEL-containing T7, contaminated with the cellular E. coli GroEL. 
By immunisation with this T7, the anti-GroEL antibody response monitored did not 
show a difference between the humoral response directed towards the expressed 
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Humoral immune responses directed towards GroEL, after immunisation 
of different groups of mice with the hybrid T7 bacteriophage. 
Key: panel A, shows the anti-GroEL antibody titre in group A mice after immunisation 
with the hybrid 17 bacteriophage T7/GroEL/PMSF/SDS (Table 5.2); panel B, shows the 
anti-GroEL antibody titre in group B mice after immunisation with the hybrid T7 
bacteriophage T7/GroEL/PMSF (Table 5.2); panel C, shows the anti-GroEL antibody titre 
in group C mice after immunisation with the hybrid T7 bacteriophage 
T7/AhpC/PMSF/SDS (Table 5.2); panel D, shows the anti-GroEL antibody titre in group 
D mice after immunisation with the hybrid T7 bacteriophage T7/AhpCIPMSF (Table 5.2). 
Anti-GroEL antibody titres are represented as the mean 1092 value for each group at day 0 
(pre-immunisation), day 10 after the first injection, and days 20 and 26 (6 and 12 days 
after challenge, respectively). Error bars represent standard deviations. 
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protein on the phage capsid (S. typhimurium GroEL), and the response directed 
towards the cellular E. coli GroEL co-purified with the phage, but rather the overall 
anti-GroEL antibody response induced by this hybrid T7 phage. The anti-GroEL 
antibody response induced in the group B mice showed no increase after 
immunisation, as calculated by a paired t-test (see Figure 5.4, Panel B). 
Group C was immunised with the S. typhimurium AhpC-containing T7 
bacteriophage (Table 5.2), which were not contaminated with cellular GroEL from 
the T7 phage host, due to the SIDS precipitation of the phage. Therefore, this group 
of mice provides a control for monitoring the anti-GroEL antibody responses in this 
experiment. However, the anti-GroEL antibody titres determined for the individual 
antisera collected from group C show a significant increase between day 0 and day 
26 (p = 0.044; paired t-test). Figure 5.4 (Panel C) illustrates the kinetics of anti-
GroEL antibodies induced in this group of mice. Group D was immunised with the 
S. typhimurium AhpC-containing hybrid T7 phage which contained traces of E. coli 
GroEL co-purified with the hybrid T7 phage (Table 5.2). However, there was no 
significant anti-GroEL antibody response induced in this group of mice after 
immunisation, as calculated by the paired t-test (see Figure 5.4, Panel D). 
Examination of the background antibody levels to AhpC in normal mouse sera 
Pre-immune (day 0) sera from mice in groups C and D were assayed for background 
levels of anti-AhpC antibody. The ELISA test performed for measurement of anti-
AhpC antibody in these mice followed the optimised protocol described for the anti-
GroEL antibody ELISA, with the modification that the coating antigen used was S. 
typhimurium AhpC purified by C. Aspinwall.. Because Taylor (1997) has previously 
demonstrated, by performing a Western blot analysis, that a dilution of 1:200 of 
pooled mouse antisera collected 28 days post-infection by an attenuated S. 
typhimurium strain (MPG479), gave a positive result for detection of anti-AhpC 
antibodies, these sera were used as a positive control for the test. 
The results show that there is a detectable amount of background anti-AhpC 
antibody in the normal mice sera (see Figure 5.5). Additionally to the results 
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presented here it must be noted that previous work performed in our laboratory 
(Taylor, 1997) has shown that pooled pre-immune mice sera diluted 1:200, failed to 
give a positive result for the detection of anti-AhpC antibodies in a Western blot 
analysis. Since pooled sera were analysed in this experiment, it was impossible to 
evaluate whether the antibody responses investigated were true for all the mice in 
the studied group, or if the results reflected cage- or even mouse-specific 
phenomena. As such, the results provided by this present study should be more 
accurate for the groups of mice under investigation. 
Anti-AhpC antibody responses in mice immunised with the hybrid AhpC-containing 
T7 bacteriophage 
Mice immunised with the hybrid T7 bacteriophage expressing a large fragment (18.6 
kDa) from S. typhirnuriurn AhpC fused in-frame with the lOB capsid protein of the 
phage (Chapter 4), were analysed for increases of anti-AhpC antibody in primary 
(day 10) and secondary (days 6 and 12 after challenge) immune responses (Figure 
5.5). Each individual serum was analysed in duplicates. Figure 5.5 (Panel A) shows 
the anti-AhpC humoral immune responses determined for group C after injection 
with the hybrid T7 phage purified through a CsC1 step gradient and precipitated with 
1% SDS. This phage is not contaminated with the cellular GroEL protein, and 
therefore provides a control system for the entire experiment, regarding the 
immunogenicity of hybrid T7 bacteriophage, and its potential as a vector for the 
delivery of bacterial immunogenic proteins to the immune system of the host. By 
performing a paired t-test between the collected groups of data, it has been found 
that there is a significant statistical difference between the mean 1092  anti-AhpC 
antibody titres on days 0 and 20 (p = 0.0092), and days 0 and 26 (p = 0.0094), 
showing that two injections of AhpC-T7 can induce a measurable anti-AhpC 
response. There is also a significant difference for the levels of anti-AhpC antibody 
between days 10 and 20 (p = 0.0042), and between days 10 and 26 (p  0.0015), 
suggesting that the initial injection served to prime the mice and that a secondary 
response was initiated after challenge. However, there is only an eight-fold increase 
in antibody between days 0 and 20, and a four-fold increase between days 10 and 20. 
There is no significant increase between days 20 and 26 (p = 0.186). 
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Figure 5.5 
Anti-AhpC antibody responses in mice immunised with the hybrid 
AhpC-containing T7 bacteriophage. 
Key: panel A, shows the anti-AhpC antibody titre in group C mice after immunisation 
with the hybrid T7 bacteriophage T7/AhpCIPMSF/SDS (see Table 5.2); panel B, 
shows the anti-AhpC antibody titre in group D mice after immunisation with the hybrid 
T7 bacteriophage T7/AhpC/PMSF (see Table 5.2). Data are expressed as the mean 1092 
titre for each group. Vertical bars represent the standard deviation. Mice were bled at 
days 0, 10, 20 (6 days post-challenge), and 26 (12 days post-challenge). 
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Group D, immunised with the hybrid T7 phage expressing the fragment of S. 
typhimurium AhpC, and contaminated with the cellular E. coil chaperone GroEL 
(purified without SDS precipitation), showed an eight-fold increase in anti-AhpC 
antibody titre after challenge (Figure 5.5, Panel B). Overall, there were significant 
differences between the mean 1092 titres determined on days 0 and 20 (p < 0.00 1), 
between days 0 and 26 (p < 0.001), and between days 10 and 26 (p  <0.001) (paired 
t-test). These findings confirm that two injections of T7 bacteriophage expressing S. 
typhimurium AhpC are able to induce a detectable antibody response directed 
towards AhpC, although the size of the response, even after challenge, is relatively 
small. 
The humoral immune response directed towards the T7 phage particle and induced 
after immunisation with the hybrid T7 bacteriophage 
The development of an antibody response directed towards the T7 phage particle 
following the immunisation schedule previously described (Table 5.2), was 
determined by examining the pooled sera collected from mice at day 0 (pre-immune 
sera), day 10 after the first injection, and days 6 and 12 after the second injection 
(days 20 and 26), through a Western blot analysis. This gave an indication about 
antibody responses specific for components of the T7 phage particle, after this was 
utilised as a vector for the delivery of bacterial proteins to the immune system of the 
host. 
An SDS-polyacrylamide gel (7.5% [v/v]) (Figure 5.6, Panel A) was loaded with 
approximately 0.25 ig purified S. typhimurium GroEL (lane 1) and with 
approximately 0.24 ..tg purified S. typhimurium AhpC (lane 3), in order to detect any 
immune response directed towards these proteins after immunisation with the hybrid 
T7 bacteriophage. Lanes 2 and 4 were loaded with purified T7 hybrid bacteriophage, 
as follows: lane 2 with purified hybrid T7 phage expressing S. typhimurium GroEL 
and precipitated with 1% SDS (approximately 0.35 x 1011  pfulwell of 
T7/GroEL/PMSF/SDS), which therefore is not contaminated with the cellular E. coil 
GroEL, and lane 4 with purified hybrid T7 bacteriophage expressing S. typhimurium 
AhpC and precipitated with 1% SDS (approximately 0.25 x 1011  pfu!well of 
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T7/AhpC/PMSF/SDS), from which the cellular GroEL was removed after SDS 
precipitation. Molecular mass markers (SDS-6H, Sigma, UK) of 205, 116, 97, 66, 
45, and 29 kDa were included on the gel as a guide to the protein size (lane M), and 
then the gel was subjected to electrophoresis. This gel template was used throughout 
the Western blot analysis. 
Equivalent gels were blotted onto nitro-cellulose and the filters were incubated in 
the presence of 1:200 dilutions of pooled antisera from group A mice, at day 0 (pre-
immune), day 10 after the first injection, or days 6 or 12 after the second injection 
with the hybrid T7 bacteriophage (T7/GroEL/PMSF/SDS). The presence of 
specifically bound antibody was then determined by incubation with rabbit anti-
mouse horseradish peroxidase-conjugated antibody. The sera for each time point 
showed a negative response with GroEL and AhpC. However, after a negative 
response directed towards components of the T7 bacteriophage at day 0 (pre-
immune) and day 10, a strong positive response was detected with a T7 protein of 
about 36 kDa at days 6 and 12 after the second injection (Figure 5.6, Panels B and 
Q. It must be noted that the secondary immune response specific for the T7 protein 
is stronger at day 6 than at day 12, suggesting that this anti-T7 humoral immune 
response peaks around 6 days after the second boost with the phage, and begins to 
decline by day 12. The result for this T7 protein suggests that the T7 bacteriophage 
itself is immunogenic when delivered intravenously (i.v.) into BALB/c mice. 
The 36-kDa protein band for which the Western blot gives a positive reaction 
corresponds to the iDA major capsid protein of the phage (see Figure 5.6), which 
accounts for more than 60% of the mass of the phage particle. Because of the 
frameshifting at gene 10 of the T7 bacteriophage (Condron et al., 1991), the iDA and 
lOB T7 proteins share high structural homology, therefore it would have been 
expected to get a humoral immune response directed not only to bA, but also to the 
lOB protein of the phage, revealed by the presence of a second band in each track 
(Figure 5.6, panels B and C, lanes 2 and 4). However, each T7 phage particle 
contains 415 molecules of iDA protein, and the lOB protein represents only 10% of 
this. The low copy number of the lOB protein onto the T7 bacteriophage versus the 
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Figure 5.6 - Humoral immune responses specific to the T7 bacteriophage. 
Western blot analysis of the pooled sera from group A mice (immunised with 
T7/GroEL/PMSF/SDS; see Table 5.2), taken on day 6 after the second injection with the T7 
phage (Panel B), and day 12 after the second injection with the T7 phage (Panel Q. Panel 
A represents a corresponding 7.5% (v/v) polyacrylamide resolving gel (7 x 8 cm) stained 
using the Silver stain protocol. The gel was loaded with: 0.25 tg purified S. lyphimurium 
GroEL (lane 1), 0.35 x 1011 pfulwell of T7/GroEL/PMSF/SDS (lane 2), 0.24 p.g purified S. 
typhimurium AhpC (lane 3), and 0.25 x 1011 pfulwell of T7/AhpC/PMSF/SDS (lane 4). 
Key: lane M, molecular size marker SDS-6H (Sigma). Identical gels to that described above 
were electrophoresed and blotted onto nitro-cellulose. Each blot was then exposed to a 
1:200 dilution of the pooled sera from group A mice. The arrangement of the lanes in 
panels B and C is identical to that described for the Silver-stained gel. 
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Anti-GroEL antibody titres 
Bleeding 
days 0 14 28 49 
Assay 1 256 128 4,096 16,384 
Assay 2 256 512 4,096 16,384 
Table 5.3 
Humoral immune responses directed toward the GroEL protein, detected 
in BALB/c mice antisera after immunisation with an attenuated strain of 
S. typhimurium [MPG479]. 
The anti-GroEL antibody titre is represented as log2 from the value determined by the 
ELISA test, performed for pooled mice sera at day 0 (pre-immunisation), and then at 
day 14, day 28 and day 49 after the i.p. injection of BALB/c mice with the attenuated 
aroA S. lyphimurium strain, as described by Taylor (1997). Each antiserum was tested 
in duplicates (Assay 1, Assay 2). 
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high copy number of the 1 OA protein, may explain why at the dilution used in the 
Western blot, it was impossible to get a detectable positive response with the pooled 
mice antisera (at days 20 and 26). Moreover, based on the high homology between 
1 OA and lOB proteins, the recombinant proteins expressed by each T7 
bacteriophage, the S. lyphimurium GroEL fused in-frame with the lOB protein 
(approximately 100 kDa in total), and the fragment of S. lyphimurium AhpC protein 
fused in-frame with the lOB protein (approximately 63.6 kDa in total), would have 
been expected to give a positive result in the Western blot analysis. Thus, these two 
recombinant proteins, which both share the 1 OB moiety, would share homology with 
the 1 OA protein and therefore, a positive band at approximately 100 kDa would have 
been expected to appear in lane 2 for both days 20 and 26, and also a positive band 
of approximately 63.6 kDa would have been expected to appear in lane 4 for both 
days 20 and 26 of mice antisera (Figure 5.6). However, these hybrid T7 
bacteriophages constructed in this study (see Chapter 4 for details) express only 0.1-
1.0 copies per virion of the bacterial protein fused with the 1 OB protein, a level of 
expression which may not be very efficient in triggering a detectable humoral 
immune response. 
Anti-GroEL antibody responses in mice immunised with attenuated S. tvphimurium 
Previous work performed in our laboratory (Taylor, 1997) has analysed by Western 
blotting the immune responses directed towards the immunogenic proteins GroEL 
and AhpC from S. lyphimurium, after immunisation of BALB/c mice with an 
attenuated strain of S. typhimurium (MPG479). However, ELISA tests for the 
detection and titration of anti-GroEL antibodies in mice antisera were not 
performed. As a comparison for mice immunised with T7-GroEL, BALB/c mice, 
immunised intra-peritoneally (i.p.) with 1.78 x 105 c.f.u. MPG479 (Taylor, 1997), 
were bled at intervals after infection. Pooled serum samples were assayed in 
duplicate for antibodies to GroEL using the optimised ELISA. The results are shown 
in Table 5.3, from which it can be seen that antibody titres to GroEL increased 64-
fold by day 49. Although the anti-GroEL antibody levels are higher in the pre-
immune (day 0) pooled mice sera than in individual sera tested in the T7 experiment, 
the response was greater and maintained at higher levels for a long period of time, 
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even at day 49 after immunisation, despite the two immunising doses used with the 
T7 phage. 
5.3 DISCUSSION 
In summary, the results presented in this chapter point out that the T7 bacteriophage 
can be used as an immunogen per se, inducing a detectable humoral immune 
response specific to the 1OA major protein of the phage, after two intravenous doses. 
This response peaks six days after the second boost with the phage, and begins to 
decline twelve days after this. The low copy number per virion of the bacterial 
proteins fused with 10B, seems to make the T7 bacteriophage have a low efficiency 
as a delivery vector for the immunogenic bacterial proteins to the immune system of 
the host, being able to induce a low but detectable humoral immune response 
directed towards these bacterial proteins. This might contribute to subsequent 
protection against a pathogenic agent, such as S. enterica. 
Protective efficacy was reported for an experimental vaccine based on secreted 
proteins of M tuberculosis (Andersen, 1994), results that confirmed the hypothesis 
that a subunit vaccine based on a selection of bacterial products may provide a 
feasible alternative to a live recombinant carrier. Because microbial heat shock 
proteins are dominant antigens for the host immune responses, they may be 
promising candidates for the design of subunit vaccines. Noll and Autenrieth (1996) 
have previously shown that parenteral administration of Yersinia Hsp60 protein 
induced high anti-Hsp60-specific serum antibody responses as well as T-cell 
responses. Experiments subsequently performed in our laboratory (unpublished 
work) analysed the level of anti-GroEL antibodies induced in mice immunised with 
purified S. typhimurium GroEL protein. These experiments are outlined here. 
Groups of six BALB/c female mice, aged 6 weeks, were given two i.p. injections of 
GroEL in alum, with/without the addition of recombinant IL-12, on day 0 and day 
14 (Table 5.4). Mice were bled on days 0 (pre-immune), 6 and 26, and their sera 
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were pooled in subgroups of 3 mice (Al, A2, BI, B2, Cl, C2, Dl, D2). Anti-GroEL 
antibodies in each serum pool were measured by the optimised ELISA, and the 
results are presented in Figure 5.7. 
As can be observed from Figure 5.7, group A mice immunised i.p. with the purified 
GroEL protein in alum developed high levels of anti-GroEL antibodies after the 
initial injection (day 6). Titres on day 26, 12 days post challenge, were not further 
increased. The primary anti-GroEL antibody titres determined at day 6 after the first 
injection represented a 65,000-fold increase over pre-immune antibody levels. This 
response to protein in alum was therefore very much greater than the responses 
induced by immunisation with hybrid T7 bacteriophage. An explanation for these 
findings may be that the T7 bacteriophage used in the present study, has a very low 
copy number (0.1-1 copies per virion) of the immunogenic S. typhimurium GroEL 
displayed onto the phage capsid, and therefore there is a poor antigen presentation 
on the T7 particle. From this point of view, the T7 bacteriophage is a poor 
immunogen, although detectable anti-T7 antibodies are present as a secondary 
immune response directed toward the phage particle. The induction of high levels of 
antibodies specific to GroEL after immunisation with the purified protein compared 
to the barely detectable increase in anti-GroEL antibody titres following 
immunisation of mice with the hybrid T7 bacteriophage may be explained by the co-
administration of alum as an adjuvant. However, T7 appears capable, at this copy 
level, of only inducing weak responses against inserted peptides. 
By comparing antibody levels to GroEL measured after immunisation with the 
purified protein, to those induced after the inoculation of mice with the attenuated S. 
typhimurium strain MPG479 (Table 5.3), it can be concluded that immunisation of 
mice with purified GroEL, in the presence of alum, induces a higher and more rapid 
response. However, the level of anti-GroEL antibodies in mice infected with the 
attenuated Salmonella strain tends to persist longer, a possible consequence of the 
persistence of the intracellular pathogen. 
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Treatment 
Mouse (Schedule of S. typhimurium GroEL immunisation) 
Group 
Day  Day 14 
50 	jig 	GroEL 	per 	mouse 50 jig GroEL per mouse 
A precipitated 1:1 with alum, and precipitated 1:1 with alum, and 
administrated 	in 	two 	i.p. administrated in two i.p. 
injections, injections. 
50 	jig 	GroEL 	per 	mouse 50 jig GroEL per mouse 
B precipitated 1:1 with alum, and precipitated 1:1 with alum, and 
administrated 	in 	two 	i.p. administrated in two i.p. 
injections; injections; 
0.25 jig recombinant IL-12 per 0.25 jig recombinant IL-12 per 
mouse administered i.p. in one mouse administered i.p. in one 
injection, injection. 
0.25 jig recombinant IL-12 per 0.25 jig recombinant IL-12 per 
C mouse administered i.p. in one mouse administered i.p. in one 
injection, injection. 
100 	p.1 	PBS 	per 	mouse 100 	p.1 	PBS 	per 	mouse 
D administered i.p. administered i.p. 
Table 5.4 
A summary of the experimental protocol for examining the generation of an 
antibody response specific to GroEL, after immunisation of mice with purified S. 
typhimurium GroEL protein. 
Each group of mice consisted of six female BALB/c mice, 6 weeks of age. Antisera collected from 
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Humoral immune responses directed toward the GroEL protein, detected in 
BALB/c mice antisera after immunisation with the purified GroEL protein 
from S. typhimurium. 
The anti-GroEL antibody titre is represented as 1092 from the value determined by the ELISA 
test, performed for pooled mice sera at day 0 (pre-immunisation), and then at day 6 after the 
first injection and day 12 after the second injection (see Table 5.4 for immunisation 
schedule). Each group of mice (A, B, C, D) was split in two subgroups containing three mice 
each, and pooled sera were collected from each subgroup (Al, A2, Bl, B2, Cl, C2, Dl, 132). 
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IL-12 is a potent stimulator of TH1 responses and various studies have previously 
investigated the potential of native or recombinant IL-12 as an adjuvant in the 
administration of soluble protein antigens (Bliss et al., 1996; Mountford et al., 1996; 
Jankovic et al., 1997; Arulandam et al., 1999; Park et al., 2000; Stobie et al., 2000). 
However, different authors used different doses/routes of IL-12. For example, No!! 
and Autenrieth, (1996) focused on the use of IL-12 as an adjuvant in the parenteral 
administration of purified Y. enterocolitica Hsp60 protein. When IL-12 was 
included, significant Hsp60-specific T-cell responses were induced, together with 
protection against subsequent challenge with yersiniae. Therefore, the potential of 
IL-12 as an adjuvant in the i.p. administration of the purified S. lyphimurium GroEL 
protein was also investigated (Table 5.4, Figure 5.7), as a preliminary experiment. 
However, no significant difference in the anti-GroEL antibody titres at day 6 after 
the first injection and day 12 after the second injection was found between groups A 
(no IL-12) and B (with IL-12). Therefore, in mice immunised i.p. with the purified 
S. typhimurium GroEL protein, with alum as an adjuvant, the recombinant IL-12 did 
not induce any increase in the primary or secondary humoral responses to GroEL. 
However, the cellular immune responses in these mice were not studied. It may be 
that IL-12 induced additional cell-mediated immunity due to its effects on TH 1 cells. 
It is well known that both humoral and cellular immune responses must be taken 
into account for the design of an efficient vaccine. 
The icosahedral T7 phage displaying on its capsid peptides or proteins fused to the 
carboxyl-terminus of phage coat proteins has been used in recent studies as a model 
peptide delivery system. Sokoloff and collaborators (2000) reported that displayed 
peptides were recognised by natural antibodies and induced complement activation. 
Moreover, initial studies on the fate of phagocytosed T4 (Inchley, 1969) indicated 
that this is rapidly inactivated and broken down during first few hours after 
injection, but part of the constituent antigens are then localised in cytoplasmic 
organelles and protected from catabolism. After intravenous injection, the T4 
antigen is phagocytosed by splenic macrophages, its immunogenicity persists longer 
than, and is not proportional to the rate of phage destruction. 
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The immunisation of mice with a hybrid T7 bacteriophage as a vector for the 
delivery of immunogenic proteins to the host immune system, such as GroEL from 
S. typhimurium, has been analysed in this study. Compared to other methods of 
immunisation described above, which also investigated the production of anti-
GroEL antibodies, the T7 system proves to be ineffective. However, two aspects of 
the T7 system are promising. Firstly, the anti-AhpC responses induced by T7-AhpC, 
even at low copy number, were stronger than those against GroEL, though not 
strikingly so. Secondly, modified T7 kits are available which will allow for 
expression of high copy number of inserted peptide genes. These should be tested, 
not only for their ability to induce antibody, but also for their ability to stimulate 
cell-mediated immunity. An efficient vaccine to intracellular pathogens involves the 
participation of both humoral and cellular immunity and therefore, the next step in 
analysing the efficiency of a T7-based vaccine against Salmonella infection, would 
be to investigate whether the cellular immunity against S. typhimurium GroEL is 
triggered by the hybrid T7 phage, when expressed at a higher copy number on the 
phage capsid. By challenging the mice footpads with purified S. typhimurium GroEL 
protein and then at 24 and 48 hours measuring the footpad enlargement from these 
mice initially immunised with the hybrid T7 phage, would determine whether 
cellular immunity is induced. In case of positive results for the participation of both 
humoral and cellular arms of the immune responses directed toward S. typhimurium 
GroEL, then the level of protection against a subsequent Salmonella infection of 
mice would be interesting to examine, by performing an LD50 test for mice 





6.1 CONCLUDING DISCUSSION 
S. enterica infection contributes to the massive incidence of diarrhoeal disease 
recorded in the world each year (Pang et al., 1995, 1998). Although antibiotics have 
proved useful in the treatment of S. enterica-related illness, the emergence of 
antibiotic resistance makes antibiotic therapy practically useless. Therefore, a major 
objective is to devise suitable prophylactic therapies, such as vaccines, to reduce the 
incidence of a S. enterica infection. Of relevance to this thesis is the antigenicity and 
immunogenicity of the GroEL protein from S. typhimurium, which can therefore be 
used as a base-component in the construction of a Salmonella vaccine studied in a 
mouse model. 
Much of the recent work into developing an effective vaccine to S. enterica has 
focused on the use of attenuated bacterial strains (Chatfield et al., 1992; Ivanoff et 
al., 1994; Ivanoff and Levine, 1997). Live attenuated bacteria provide much greater 
protective immunity than killed cells, but this ability has been attributed to the fact 
that the live bacteria express immunogenic proteins in response to the host 
environment (Kagaya et al., 1992). A polypeptide-based vaccine is more likely to 
have wide-scale use in humans and animals and be safer, less reactogenic, and may 
induce stronger protective immunity than whole-cell vaccines. The immunological 
relevance of S. lyphimurium GroEL was initially demonstrated by Buchmeier and 
Heffron (1990a) and later on, high titres of antibodies specific to S. typhi GroEL 
were detected by Tang and collaborators (1997) in sera from patients with typhoid 
fever. It is now well known that the successful elimination of S. enterica from its 
host involves the generation of a TO response (Kagaya etal., 1992; Mastroeni et al., 
1993), and therefore, any form of a polypeptide-based vaccine would have to 
stimulate the TH 1 -type of immune response to be effective. Moreover, recent work 
performed in our laboratory by Taylor (1997) has shown that the S. typhimurium-
derived GroEL protein is able to induce significant humoral and DTH responses, 
suggesting that this protein is recognised in the context of a TH1 response. 
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Bacteria, such as S. typhimurium, are capable of persisting within the host, and 
therefore there is greater probability for the antigens derived from bacteria to be 
displayed over a long period. Moreover, factors associated with the bacterium are 
likely to stimulate the immune system and therefore, bacteria have natural adjuvant 
properties. Thus, bacterial components such as LPS are known to up-regulate 
immune responses by stimulating B cells to undergo isotype switching, such that 
they produce complement fixing antibodies, or by activating macrophages 
(Baldridge and Wood, 1997). Much of the work into the ability of polypeptides to 
generate protective immunity showed that protection is most effective in the 
presence of an adjuvant (Kagaya et al., 1992; Andersen, 1994; Gelber et al., 1994; 
Noll and Autenrieth, 1996). For example, the TH1 response-associated cytokines, 
such as IL-12, were successfully used as adjuvants to skew the immune responses to 
the desired phenotype (Noll and Autenrieth, 1996). However, data from a 
preliminary experiment reported in this study, reveal no significant difference in 
levels of anti-GroEL antibody titres between sera from BALB/c mice immunised i.p. 
with the purified S. typhimurium GroEL protein, and sera from mice administered 
the same protein and recombinant IL-12, concomitantly. Analysis of antibody 
isotypes might have characterised the responses more precisely and shown changes 
which were not revealed by the basic ELISA. As opposed to the studies involving 
immanogenicity of proteins administered in association with various adjuvants, this 
study focuses mostly on the ability of a protein, such as S. typhimurium GroEL, 
when expressed onto a phage vector, such as the T7 bacteriophage, to induce a 
humoral response in BALB/c mice. 
During this study, BALB/c mice were immunised intravenously with the hybrid T7 
bacteriophage, which expresses on its capsid the GroEL protein from S. typhimurium 
fused in-frame with the 1 OB capsid protein of the phage, and humoral immune 
responses directed toward this GroEL protein were monitored. Due probably to the 
low copy number estimated at less than 10% of the total capsid protein, this 
immunising agent stimulated barely detectable levels of antibody against GroEL. 
These responses were significantly weaker than the anti-GroEL antibody levels 
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induced in mice injected i.p., either with the purified GroEL protein from S. 
typhimurium in the presence of alum, or with the aroA attenuated S. typhimurium 
strain (MPG479). Levels of antibody in mice immunised with purified GroEL were 
approximately 4 orders of magnitude greater than the maximum detected in mice 
immunised with T7-GroEL, probably because of insufficient antigen presentation by 
the hybrid T7 bacteriophage, and also because the purified protein was administered 
in the presence of alum as an adjuvant. Although the anti-GroEL antibody response 
determined in mice immunised with the purified protein precipitated with alum 
showed higher levels than the anti-GroEL antibody response determined in mice 
immunised with the arok attenuated S. typhimurium strain, the latter was more 
persistent. 
The findings indicate that the hybrid T7 bacteriophage in the form used here is not 
an efficient immunising agent compared to the purified GroEL protein administered 
with alum as adjuvant, or to the attenuated S. typhimurium strains. Nevertheless, 
detectable anti-10A secondary antibodies (measured at day 20 and day 26) directed 
towards the major capsid protein of the phage, were present after immunisation with 
the hybrid T7 bacteriophage, suggesting that the T7 bacteriophage is immunogenic 
by itself, and it is possible that expression of a high copy number of the 
immunogenic protein would be more efficient in the induction of a high and 
persistent humoral immune response. The immunogenicity of T7-AhpC is 
encouraging in this respect. Because the efficiency of a vaccine is measured by its 
capacity to induce both humoral and cellular immune responses, it would be relevant 
to investigate also the induction of cellular immune responses directed toward the S. 
typhimurium GroEL protein expressed onto the phage capsid, once a high copy 
number transfected phage has been established. 
After construction and sequencing of the hybrid T7 bacteriophage, this was purified 
prior to immunising BALB/c mice. This work is the first to report the contamination 
of the CsC1-purified hybrid T7 phage particle, with the exogenous, cellular GroEL 
protein from the E. coli BLT5615 host of the phage. Due to its chaperone function, 
the GroEL protein assists in correct folding of proteins assembled within the host 
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cell, and also is involved in early phases of bacteriophage morphogenesis (Zeilstra-
Ryalls et al., 1991). As a result, the cellular GroEL co-purifies with the hybrid T7 
bacteriophage through the CsC1 step gradient purification protocol, regardless of the 
heterologous protein expressed on the phage capsid, and may therefore alter the 
measurements of anti-GroEL antibody levels induced by immunisation of mice with 
this phage. However, in order to eliminate the cellular GroEL protein attached non-
specifically to the phage, this study provides a solution for the de-contamination of 
the T7 CsC1-purified particle, by precipitation of the phage with 1% SDS, an anionic 
detergent which has the capacity of disrupting protein complexes, and leaves the 
phage viable. 
After previous studies performed in our laboratory (Taylor, 1997), identified a single 
homologue of groEL on the S. typhimurium chromosome, and localised the groEL 
gene at 93-96 minutes on S. typhimurium chromosome, the present work is the first 
to report the full DNA sequence of the groEL gene from S. typhimurium SL1344 
chromosome. The nucleotide sequence shows 98% identity with S. typhi groEL 
gene, and 93% identity with the E. coli groEL gene, whereas the putative protein 
sequence corresponding to the sequenced groEL fragment shows 50% amino acid 
identity with the human molecule, and 100% identity with the S. typhi GroEL 
protein. These findings support further localisation of immunodominant regions on 
the S. typhimurium groEL gene, by construction of nested deletions at both carboxy-
and amino-terminal ends of the fragment fused in-frame with the GST protein from 
S. japonicum, purification of these truncated fusion proteins, and performing ELISA 
tests using sera from mice immunised with the purified S. typhimurium GroEL 
protein. 
GroEL remains a promising candidate for consideration in any potential vaccine 
against S. enterica-related illness. Previous work has shown that GroEL homologues 
from various bacterial species, such as M tuberculosis (Silva et al., 1996), M leprae 
(Gelber et al, 1994), Y. enterocolitica (Noll and Autenrieth, 1996), L. pneumophila 
(Blander and Horwitz, 1993), and H pylon (Ferrero et al., 1995) are highly 
immunogenic and induce some degree of protection against lethal challenge with the 
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respective bacteria. Moreover, the work performed in our laboratory and referred to 
above has provided evidence that GroEL from S. lyphimurium is highly 
immunogenic and induces both long-lived T and B cell responses, the efficiency of 
which depends on the method of immunisation. The Hsp65 mycobacterial protein 
(GroEL type) has been used efficiently in previous studies (Barrios et al., 1994) as 
an adjuvant by exerting a strong in vivo helper effect when conjugated to synthetic 
peptides or bacterial oligosaccharides and given in the absence of any adjuvants. 
More recently, Lehner and co-workers (2000) have demonstrated that Hsp60 
covalently linked to antigens are potent agents enhancing serum antibodies and 
CD4 T cell proliferative responses when administered by the systemic route, as 
well as secretory IgA and IgG antibodies when given by the mucosal route in 
primates. 
Nevertheless, the use of a GroEL-based vaccine is controversial (Kaufmann, 1990). 
The relationships between bacterial heat shock proteins and autoimmunity were first 
disclosed in the Mycobacteria-induced model of adjuvant arthritis: passive transfer 
of a T cell clone responding to mycobacterial Hsp60 evoked disease in naïve 
recipient animals (reviewed by Shoenfeld and Isenberg, 1988). Subsequent studies 
also concluded that high levels of IgG anti-human Hsp60 autoantibodies found in 
autoimmune diseases, such as reactive arthritis (RA), systemic lupus erythematosus 
(SLE), Reiter's syndrome, arise primarily as a consequence of the humoral immune 
responses to E. coli GroEL through the recognition of cross-reactive epitopes 
(Handley et al., 1996). The suggested explanation is that exposure to normal 
environmental bacteria expressing GroEL, or very similar Hsp60, but not 
mycobacterial Hsp65, may be responsible for the induction of most human Hsp60 
autoantibodies. However, anti-human Hsp60 autoantibodies are not indicative of 
autoimmune disease in RA and SLE, since they are found in similar titre in normal 
sera (Handley et al., 1996). 
Also, it was demonstrated that a subset of patients with a history of Salmonella 
infection developed reactive arthritis. The persistence of bacterial antigens in 
arthritic tissue and the isolation of Salmonella or Yersinia reactive CD8 T cells 
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from the joints of patients with RA support the etiological link between Gram-
negative bacterial infection and autoimmune disease. Models proposed to account 
for the link between infection and autoimmunity include inflammation-induced 
presentation of cryptic self-epitopes, antigen persistence and molecular mimicry. 
Recent studies (Lo et al., 2000) identified an immunodominant epitope derived from 
S. typhimurium GroEL, which is presented by the class lb molecule Qa-1 and is 
recognised by CD8 cytotoxic T lymphocytes induced after natural infection. This 
suggests the involvement of MHC class lb molecules in infection-induced 
autoimmune recognition and indicate a mechanism for the etiological link between 
Gram-negative infection and autoimmunity. 
GroEL is remarkably immunogenic, despite its high degree of evolutionary 
conservation. Cross-reactivity between bacterial GroEL and the homologous 
mammalian host protein was initially demonstrated on the mycobacterial GroEL 
(Kaufmann, 1990). Alignments of the M tuberculosis and human GroEL 
homologues suggest 48% identity between these two proteins (Jindal et al., 1989). 
When the protein sequence of GroEL was divided into stretches of 25 amino acids, 
and these fragments were put into a database of protein sequence, 86 human 
polypeptides were identified, which exhibited high sequence similarity to many of 
these fragments. Furthermore, 19 of these polypeptides were involved in 
autoimmune diseases such as insulin-dependent diabetes and rheumatoid arthritis 
(Jones et al., 1993a), although a causative relationship has yet to be shown. 
Moreover, the use of a S. enterica GroEL homologue as a basis for designing a 
vaccine against Salmonella would probably give rise to concerns about its safety, as 
the S. typhi GroEL shares 75% identity with the M tuberculosis homologue, and 
also shares 51% identity with the human derivative (see Figure 1.2 for an 
alignment). 
The mechanism of Hsp-induced autoimmunity may be explained by the participation 
of different factors in vivo. First, infectious agents containing homologous Hsp60 
proteins could induce an anti-self immune response through molecular mimicry in 
susceptible individuals (Schoel and Kaufmann, 1996). Additionally, vaccination 
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(particularly with heat-inactivated bacteria) may contribute to the development of 
anti-Hsp antibodies. Second, viral infection may result in incorporation of Hsp60, or 
at least of Hsp60-derived peptides, into the envelope of the budding virus (Bartz et 
al., 1994). Arising from viral infections, Hsp60 could also become immunogenic as 
a result of structural alteration or post-translational modification (Schattner and 
Rager-Zisman, 1990). Third, exposure to endogenous Hsps or mimicry proteins 
might induce immune reactions against Hsp60, or endogenous Hsps may interact 
with other immunogenic proteins (Coulie and van Snick, 1985). For example, the 
natural microbial flora may influence such immune responses to various degrees, 
e.g., GroEL of E. coli from the intestine. 
Proteins of the Hsp60 family were initially considered to be located intracellularly in 
mitochondria only, where they facilitate protein translocation and act as chaperones 
protecting proteins from harmful enzymatic attacks during folding. Accumulating 
evidence now points to an additional surface localisation of Hsp60 proteins on not 
only eukaryotic cells (Soltys and Gupta, 1996), and in response to infection (Belles 
et al., 1999), but also on prokaryotic cells, such as H. pylon (Yamaguchi et al., 
1996) and S. lyphimurium (Ensgraber and Loos, 1992). Immune responses against 
Hsps could therefore provide a general basic level of protection and limit the spread 
of infections by acting as an initial defence mechanism that immediately interacts 
with microbial invaders. In contrast to this benefit, the risk of autoimmunity must be 
taken into consideration. 
While anti-Hsp60 antibodies and yT cells reactive with Hsp60 proteins are 
involved in autoimmune diseases (reviewed in Winfield and Jarjour, 1991), there is 
no evidence that immunisation with purified Hsp60 proteins may induce chronic 
autoimmune disease. In fact, to the contrary, there is evidence that immunisation 
with GroEL-like proteins protects against autoimmune disease. Pre-treatment of rats 
with a mycobacterial Hsp65 protects against adjuvant-induced arthritis and against 
streptococcal cell wall-induced T cell dependent polyarthritis (Bahr et al., 1990; 
Cobelens et al., 2000). Immunisation of non-obese diabetic mice with the Hsp65 of 
M tuberculosis protects against spontaneous autoimmune insulin-dependent 
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diabetes mellitus (Funda et al., 1998). In other words, exposure of the immune 
system to bacterial antigens, such as GroEL, may well stimulate the immune system 
to resume control over unwanted self-reactive clones. Laboratories-OM (Geneva) 
have been producing E. coli bacterial lysates, which are used amongst others for the 
treatment of reactive arthritis. They are administered orally and have shown in 
multiple trials in RA patients a good effectiveness (Van der Zee et al., 1998), and 
recently it has been revealed that the E. coli Hsp60 molecule (Gr0EL) is one of the 
more prominent immunogens present in this material (Vischer and van Eden, 1994). 
This rather general protective potency of bacterial Hsp against arthritis seems to 
result from the capacity of strongly conserved sequences in the protein to activate T 
cells that cross-recognise the mammalian homologous Hsp sequences presented on 
cells at the site of inflammation (Van der Zee et al., 1998). 
As a final conclusion, this study provides useful information about the T7 particle as 
an immunising agent and vector for the delivery of immunogenic protein to the 
immune system of the host, the full sequence of S. typhimurium groEL gene, and 
about problems encountered throughout the purification of the T7 phage particle. It 
is important to note also that further assessment on the cellular immune responses 
induced toward the protein expressed on the phage particle, would give more 
information about the capacity of the T7 phage to function as an efficient 
immunising agent in mice. Moreover, the identification of the immunoglobulin 
isotypes involved in the humoral immune responses, and the determination of the 
level of protection induced by immunisation with the high copy T7 hybrid phage, by 
performing an LD50  test, would provide a complete image about the T7 phage 
particle and its induced immunity in mice. 
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